Author Index:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

A, F. N.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Abaza, Y.
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients with Hematological Remission and Full Chimerism at Day 30
Abbas, J.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Abboud, C.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Abdalla, H.
Outcome of Hematopoietic Stem Cell Transplantation for Children with Severe Combined Immunodeficiency (SCID). Seventeen Years Experience in Single Pediatric Transplantation Center
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Abdel-Azim, H.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Abdelsamed, H.
Non-Myeloablative TLI/ATG + Alkylator Conditioning Augments Bidirectional Immune Tolerance Via Regulatory MDSC in a Robust Murine Model of MHC-Mismatched BMT for Beta-Thalassemia
Abe, F.
CD155 Regulates Regulatory T Cell Population and Attenuates Acute Graft-Versus-Host Disease
Abe, Y.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Abe, Y.
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Abel, G. A.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Abetti, B.
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Abhyankar, S.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo-Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Single Center Experience
Abidi, M. H.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Abikoff, C.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Abinun, M.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Abounader, D.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Is G-CSF Still Needed Post-Transplant to Promote Engraftment in the Present Era? a Multi-Disciplinary Project to Evaluate Patient Safety Vs Cost Savings
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Abraham, A.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Abraham, A.
A Multi-Institutional Retrospective Data Analysis of Hematopoietic Cell Transplantation for Less Severe Sickle Cell Disease
Abramovitz, L.
A Telephone Support Group for Parents of Children Discharged after Hematopoeitic Stem Cell Transplant
ONS Foundation Awarded Lectureship: Challenges and Rewards of International Cancer Nursing: A Global Perspective
Abugideiri, M.
Factors Influencing Pulmonary Toxicity in the Setting of Total Body Irradiation-Based Myeloablative Conditioning in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Abutalib, S. A.
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Adair, J.
Presentation 3
Adams, C. E.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Adams, R.
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Adler, S.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Adler-Brecher, B.
The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease
Admiraal, R.
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Afanasyev, B.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Agarwal-Hashmi, R.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Agrawal, N.
Encouraging Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation - Single Centre Experience from Resource Poor Country
Agura, E.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Ahmed, M.
Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed By Autologous Stem Cell Transplantation: Experience at Skmch Lahore
Ahmed, N. M.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Ahmed, R.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Ahmed, R.
Encouraging Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation - Single Centre Experience from Resource Poor Country
Ahmed, S.
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Levofloxacin Versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation
Ahmed, S. O.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Ahmed, W.
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients with Hematological Remission and Full Chimerism at Day 30
Ahmed-Winston, S.
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Ahn, K. W.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Ai, W.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Ajitawi, O.
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Akashi, K.
Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Aker, C. D.
Eliminating Cross Contamination from Intravenous Cyclosporine and Tacrolimus and Accurate Blood Sampling
Akhtari, M.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Aki, S. Z.
The Role of Tuberculin Skin Test As a Guide to Preventive Chemotherapy for Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplantation in a Region with Intermediate Prevalence and Routine BCG Vaccination: A Preliminary Report from Turkey
Determinants of Physical Activity Levels in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Akinwande, A.
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Akpek, G.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Al Farsi, K.
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study
Al Hashmi, H.
Pseudotumor Cerebri Associated with All-Trans Retinoic Acid Treatment in Female Patients with Acute Promyelocytic Leukemia: A Case Series
Al Huneini, M.
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study
Al Kindi, S.
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study
Al Malki, M. M.
Outcomes of Patients with Acute Lymphoblastic Leukemia (ALL) with Central Nervous System (CNS) Involvement Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT): A Single Center Retrospective Analysis
Al Mulla, N.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Al Rawas, A.
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study
Al Sagheir, A.
Pseudotumor Cerebri Associated with All-Trans Retinoic Acid Treatment in Female Patients with Acute Promyelocytic Leukemia: A Case Series
Al-Afghani, S.
Posterior Reversible Encephalopathy Syndrome Associated with Cyclosporine Use in a Child Undergoing Allogeneic Hematopoietic Stem Cells Transplantation for Fanconi Anemia: A Case Report
Al-Antary, E. T.
Incidence and Risk Factors of Bacterial Infections in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of CMV Reactivation and Infection in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation in High CMV Exposure Population
Al-Herz, W.
Presentation and Outcome of Zap 70 Deficiency
Al-Homsi, A. S.
Ixazomib Inhibits Dendritic Cell Maturation and Function
Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
Al-kali, A.
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Al-Khabori, M.
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study
Al-Mansour, Z.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Al-Mohareb, F.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Al-Mousa, H.
Presentation and Outcome of Zap 70 Deficiency
Al-Zaben, A. I.
Incidence and Risk Factors of Bacterial Infections in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of CMV Reactivation and Infection in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation in High CMV Exposure Population
Alam, N.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Alattar, M. L.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Albano, M. S.
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Albelda, R.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Albert, C. M.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Albloushi, R.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Aldenhoven, M.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Aldoss, I.
Cytogenetics Does Not Influence Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
Outcomes of Patients with Acute Lymphoblastic Leukemia (ALL) with Central Nervous System (CNS) Involvement Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT): A Single Center Retrospective Analysis
Alessandrini, E.
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Alex, A. A.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Alexander, M.
Best Practices: Immunization Strategies and Monitoring
Alhuraiji, A.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Alhyari, M.
Acute Skin Graft Versus Host Disease Post Liver Transplantation: A Case Report
Ali, F.
Transplantation Innovation for Hemoglobinopathies: Industry Insight from Early Engagement with Single and Multi-payer Health Systems Regarding Gene Therapies
Ali, M. S.
Pseudotumor Cerebri Associated with All-Trans Retinoic Acid Treatment in Female Patients with Acute Promyelocytic Leukemia: A Case Series
Posterior Reversible Encephalopathy Syndrome Associated with Cyclosporine Use in a Child Undergoing Allogeneic Hematopoietic Stem Cells Transplantation for Fanconi Anemia: A Case Report
Ali, M.
Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model
Ali, O.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Ali, S. A.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Ali, S. A.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Aljitawi, O.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo-Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Single Center Experience
Aljurf, M. D.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Allen, C.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Allen, L. F.
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Allen, S.
Let's Talk about Sex- Post Transplant Intimacy Guidelines
Allewelt, H. B.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Allin, D.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Allison, B.
Collaboration Between CIBMTR & BMT CTN Data Collection
Alonso Guallart, P.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Alousi, A.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Graft-Versus-Host Disease: Looking Ahead
(CIBMTR Working Committee) Graft-Versus-Host Disease
Alpdogan, O.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Alsaedi, H. S.
Emergent Substitution of Fludarabine for Cyclophosphamide Due to Acute Cardiac Toxicity during Conditioning with Successful Engraftment
Alsina, M.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Altomare, D. A.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Alvarez, M.
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts
Alvarnas, J. C.
BMT CTN 0803 Primary Results
Alves de Araujo, C. A.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Alyea, E. P. III
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
(CIBMTR Working Committee) Chronic Leukemia
Alzahrani, H.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Amelung, S.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Amendola, A.
Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Amit, O.
Correlation Between Pre-Collection CD34 Blood Concentrations and CD34 Collection Yield in Difficult-to-Mobilize Patients Given Plerixafor. –a Retrospective Single Center Study
Amrolia, P.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Amtmann-Buettner, K.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Anagnostopoulos, A.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Anand, A.
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Anandi, P.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Anasetti, C.
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Anderlini, P.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
(CIBMTR Working Committee) Primary Immune Deficiencies, Inborn Errors of Metabolism and Other Non-Malignant Marrow Disorders
Andersen, S.
Related Donor Screening: An Increasingly Complex Process
Anderson, K.
Successful Transitions in Transplant Between Hospitalization and Outpatient Care
Anderson, K. C.
New Insights into Therapeutic Targets in Multiple Myeloma
Anderson, L. Jr.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Anderson, N. L.
Successful Engraftment and Full Donor Chimerism in Patients Undergoing Second Allogeneic Stem Cell Transplantation with Umbilical Cord Blood
Andersson, B. S.
Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Andreadis, C.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Andreadis, C.
BMT CTN 1201 / Alliance A051301 Study
Andreeff, M.
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Andresen, S.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Andrew, M.
Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia
Andrews, K. A.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Andritsos, L. A.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Anguita, J.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Ansari, M.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Ansell, S.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
CXCR4 Expression in Mantle Cell Lymphoma and Mobilization with Plerixafor for ASCT Does Not Negatively Impact Progression-Free Survival
Antin, J. H.
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Antony, J.
Distinctions Between Effective and Ineffective AML-Specific Autologous Peripheral Blood (PB) Cytotoxic T-Lymphocytes (CTLs)
Myeloid Derived Suppressor Cells (MDSC)-like Acute Myeloid Leukemia (AML) Cells Are Associated with Resistance to Cytotoxic Effects of Autologous (Auto) T-Lymphocytes (CTLs)
Anurathapan, U.
Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases
Bacteremia during Neutropenic Episodes in Children Underwent Hematopoietic Stem Cell Transplantation Receiving Ciprofloxacin and Penicillin Prophylaxis
Anwer, F.
Retrospective Review of Intravenous Pentamidine for Pneumocystis Pneumonia Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
Aotsuka, N.
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Apostolou, C.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Appelbaum, F. R.
What is the Optimal Conditioning Regimen?
How to Write a Paper
Closing Remarks
Welcome Address
How Does NGS Compare with Other Approaches to Measure MRD?
BMT Tandem Breakfast Symposium: Measuring Minimal Residual Disease: The Potential and Pitfalls of Next-Generation Sequencing
Appiah, J.
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Apte, S.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Aquino, J.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Aquino, V.
Increased Incidence of Fatigue in Pediatric Hematopoetic STEM CELL Transplant Recipients
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Incidence and Outcome of Rhinovirus in Children Undergoing Hematopoietic Stem Cell Transplantation
Arai, S.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Arai, Y.
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Arce-lara, C.
Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Arce-Lara, C.
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Arepally, G.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Aribas, Z.
Determinants of Physical Activity Levels in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Ariza Heredia, E.
Levofloxacin Versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation
Armand, P.
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Armenian, S. H.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Armer, J.
The Perspectives of Stakeholders in Pursuing Hematopoietic Stem Cell Transplantation in Children and Adolescents: An Integrative Review
Armeson, K.
Limited Role of Sinus CT in the Management of Febrile Allogeneic Pediatric HSCT Recipients
Armistead, P.
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Armitage, S.
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Armstrong, A. E.
Impact of High-Resolution Typing for HLA-a, -B, -C and -DRB1 on Single-Unit Cord Blood Transplantation in Pediatric Patients
Chronic Graft Vs. Host Disease of the CNS - a Rare Autopsied Case
Arnold, R.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Arnold, S.
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
Aronsson-Kurttila, W.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Arora, M.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Unique Issues in Transplant of Older Adults
Artherholt, S. B.
Preventive Care Adherence and Associated Factors in a National Sample of Hematopoietic Cell Transplantation (HCT) Survivors Recruited for an Online Randomized Controlled Trial (RCT)
Arthur, C.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Artz, A. S.
(CIBMTR Working Committee) Regimen-Related Toxicity and Supportive Care
Asano-Mori, Y.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Ashouri, N.
Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients
Askar, M.
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Atsuta, Y.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
(CIBMTR Working Committee) Health Services and International Issues
Auletta, J. J.
(CIBMTR Working Committee) Infection and Immune Reconstitution
Aungst, M. B.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Austin-Ketch, T.
Exploring Unmet Needs of Hematopoietic Cell Transplant Recipients
Avigan, D.
Cancer Vaccines and Immunomodulatory Therapy
Avila, D.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Avivi, I.
Correlation Between Pre-Collection CD34 Blood Concentrations and CD34 Collection Yield in Difficult-to-Mobilize Patients Given Plerixafor. –a Retrospective Single Center Study
Awali, R.
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Awasthi, A.
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Axelsson, R.
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Ayala, E.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Ayash, L. J.
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Ayed, A. O.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Ayello, J.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Effectively Targeting Burkitt Lymphoma By ANTI-CD20 Chimeric Antigen Receptor (CAR) Modified Expaneded Natural Killer CELLS Combined with a Histone Deacetylase Inhibitor, Romidepsin in Vitro and in Humanized NSG MICE
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Aziz, M.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin

B

Bachanova, V.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Cyclophosphamide Dose Weight Adjustment in Morbidly Obese with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation (HCT)
Pre-Transplant Consolidation Chemotherapy for Acute Lymphocytic Leukemia (ALL) Does Not Impact Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Bachier, C.
Tbo-Filgrastim Versus Filgrastim during Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation
A Network Approach to Standardization of BMT Pathways
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Badar, F.
Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed By Autologous Stem Cell Transplantation: Experience at Skmch Lahore
Badar, T.
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Bader, P.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Badshah, C.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Baggott, C.
A Telephone Support Group for Parents of Children Discharged after Hematopoeitic Stem Cell Transplant
Bajel, A.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Bajwa, R.
Anicteric Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation in Children
Bakabak, S.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Baker, C.
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Baker, J.
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts
Baker, K. S.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Bakhshi, S.
Cyclophosphamide Followed By Busulphan in Place of Standard BuCy Regimen for Patients Undergoing Allogeneic Stem Cell Transplantation: A Preliminary Experience from a Single Centre in India
Balakas, K.
Production, Implementation, and Utilization of a Multidisciplinary Assessment for Those Undergoing Hematopoietic Cell Transplantation
Ballabio, M.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Ballarini, N.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Ballen, K. K.
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Balsalobre, P.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Banaglorioso, C.
IMPACT of Chlorhexidine Bathing on Hospital-Acquired Infections and Skin Tolerance Among STEM CELL Transplant Patients
Banavage, A.
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
HSCT Education: Bridging the Gap
Bandiera, V.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Bandlamudi, R.
Donor Derived Systemic Lupus Erythematosus (SLE) after Allogeneic Transplantation
Bangdiwala, A.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Banugaria, S.
The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease
Bar, M.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Metabolic Syndrome Occurs within the First Year after Hematopoietic Cell Transplant
Bargi, G.
Determinants of Physical Activity Levels in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Barker, J.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
Cluster of Fulminant Toxoplasmosis in T-Cell Depleted (TCD) and Cord Blood (CB) Stem Cell Transplant (SCT) Recipients: Impact of Aggressive Prophylaxis and Routine Monitoring By Toxoplasma PCR for High Risk Patients
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Barkley, G.
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Barman, P.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Barnette, P.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Barnhart, C.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Barnhouse, M.
Fall Innovations: A Multimodal Initiative to Decrease Falls in the Blood and Marrow Transplant Setting
Baron, F.
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Barone, J.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Barowski, K.
HLA Data Collection Updates
BMT CTN 1101 Haplo Bone Marrow Vs. Double Cord Blood Trasnplantation
Barreras, H.
In Situ Manipulation of Tregs Via Combined IL-2 and TNFRSF25 Signaling Pre- and Post-Transplant: A Novel Approach to Regulate Gvhd By Marked Expansion of CD4+Foxp3+ T Cells
Barrett, A. J.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Barsony, J.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Barsoumian, A. E.
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Barta, S. K.
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Bartelink, I.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Bartling, C.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Bartoo, G.
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Baruffaldi, J. L.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Bashir, Q.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Bassett, R. Jr.
Dnase I Treatment Reduces Gvhd in Mice
Bastos-Oreiro, M.
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Batra, S.
Incidence and Risk Factors for Metabolic Syndrome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients- a Tertiary Care Center Experience
Batsis, I.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Batterson, L.
Panel Discussion: GVHD and Co-Morbidities
Battiwalla, M.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Baucco, P.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Baur, R. A.
A Review of Radiographic Findings in Gvhd
Bauters, T.
Stability of High Concentration Etoposide (10mg/ml) in Physiologic Saline for Use in Conditioning Regimens
Pharmaceutical Care for Pediatric Oncology and Hematopoietic Stem Cell Transplantation Patients: Need for Education and Training
Baveja, S.
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Baxter Lowe, L. A.
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Baxter-Lowe, L. A.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Baygan, A.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Beaman, M.
(NMDP) CIBMTR Consumer Advocacy Committee Meeting
Beato, F.
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Beaupierre, A.
Life after Transplant: The Use of Group in Preparation for Transition Home
Let's Talk about Sex- Post Transplant Intimacy Guidelines
Bednarik, J.
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Beduhn, B.
Registry Efforts to Improve Success of Unrelated Donor Searching for African American Patients
Beebe, D.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Beechinor, R.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Behfar, M.
Comparing the Results of Non-TBI Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) with and without CNS Involvement
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
The Safety of Granulocyte Colony Stimulating Factor (G-CSF) Administration in Pediatric Donors before Peripheral Hematopoietic Stem Cell Donation
Beitinjaneh, A.
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Bejanyan, N.
Pre-Transplant Consolidation Chemotherapy for Acute Lymphocytic Leukemia (ALL) Does Not Impact Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Belkaid, Y.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Bell, A.
Increasing Adls Is Easy As 1-2-3
Bellerjeau, M. M.
Welcome
Bellman, D.
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Ben Arush, M.
Outcome of Hematopoietic Stem Cell Transplantation for Children with Severe Combined Immunodeficiency (SCID). Seventeen Years Experience in Single Pediatric Transplantation Center
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Bensinger, W.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Bento, L.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Berdeja, J. G.
A Network Approach to Standardization of BMT Pathways
Berglund, S.
In Vitro Expanded Umbilical Cord Blood T Cells Used for Donor Lymphocyte Infusions after Umbilical Cord Blood Transplantation
Bergman, E.
Kickoff and Welcome
CIBMTR Data Sharing Roadmap to the Future
CIBMTR IT Forum Q&A, Recap and 2016 Planning
Berka, N.
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
Berman, D.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Bermúdez, A.
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Bernanke, A.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Bernhard, L.
30 Day Readmissions – a 4 Year Look Back of Multi-Disciplinary Efforts
Is G-CSF Still Needed Post-Transplant to Promote Engraftment in the Present Era? a Multi-Disciplinary Project to Evaluate Patient Safety Vs Cost Savings
30 Day Readmissions Rate- How Many Ways Can We Calculate Thee?
Subcutaneous Ports for Outpatient Transplant Patients to Reduce the Risk of Central Line Associated Blood Stream Infections
Berteotti, G.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) – a Single Institutio
Berthelsen, A. M.
Optimizing Data Collection
Bertin, P.
Bone Health Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Characteristics and Preliminary Clinical Results of a Cohort of Patients in Santiago, Chile, Undergoing Haploidentical Hematopoietic Cell Transplantation with Postransplant Cyclophosphamide
Bertolo, J. E.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Besra, G.
CD4+CD25+ Invariant Natural Killer T Cells Are Enriched in Cord Blood: Implication on Immune-Regulation
Besser, R. M.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Best, D.
Increasing Adls Is Easy As 1-2-3
Betcher, J.
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Nurse-Initiated Protocol for Central Venous Catheter (CVC) Selection for Blood and Marrow Transplant (BMT) Recipients
Betts, B.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Bhamidipati, P. K.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Bharadwaj, P.
Medical Marijuana: Is Green and Leafy Really Good for You?
Bhartia, S.
Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Haematopoietic Stem Cell Transplantation- a Single Center Experience
Bhat, G.
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Bhatia, M.
A Multi-Institutional Retrospective Data Analysis of Hematopoietic Cell Transplantation for Less Severe Sickle Cell Disease
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Bhatia, S.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Bhatt, A. S.
Explorations of Transplantation-Associated Diseases: The Microbial Frontier
Bugs, Drugs and Stem Cells: The Human Microbiome in Transplantation
Bhatt, V.
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Bhattacharya, S.
Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Haematopoietic Stem Cell Transplantation- a Single Center Experience
Bhavsar, K.
Collaboration Between CIBMTR & BMT CTN Data Collection
Bhella, S. D.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Bhethanabhotla, S.
Cyclophosphamide Followed By Busulphan in Place of Standard BuCy Regimen for Patients Undergoing Allogeneic Stem Cell Transplantation: A Preliminary Experience from a Single Centre in India
Bhojwani, D.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Bhurani, D.
Encouraging Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation - Single Centre Experience from Resource Poor Country
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Bhushan, V.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Bhutani, D.
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Bhutani, D.
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Bierings, M.
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Predicted Indirectly Recognizable Hla Epitopes (PIRCHE) Provide a Novel Strategy to Individualize Donor Selection That Optimizes Survival Chances
Billen, A.
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
A Change in Donor Medical Suitability Criteria Resulted in Decreased Rates of Donor Attrition at CT Stage in a Registry Study
Billups, R.
A Network Approach to Standardization of BMT Pathways
Medicare Coverage and Reimbursement Project Update
Binder, M.
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Comprehensive Meta-Analysis
Birch, A.
Panel Discussion: GVHD and Co-Morbidities
Bishop, M. R.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Bishop, R. J.
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Bitencourt, M.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Bittencourt, H.
Outcomes of Bone Marrow or Cord Blood Matched Related Transplantation for Children with Sickle Cell Disease: Experience of a Canadian Center
Development of a Standardized Follow up for Pediatric Transplant Long Term Survivors By Family Physicians
Blackburn, R.
Shared Leadership: Clinical Nurse Leaders Improving Continuity of Care and Quality Outcomes for Hospitalized Stem Cell Transplant Patients
Blacklock-Schuver, B. A.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Blaise, D.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Blaise, D.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Blake, A.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Blake, J.
Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft Interaction
Blazar, B. R.
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
T-Cell Transcriptome Analysis Reveals the Mechanisms Controlling Synergy Between Costimulation Blockade and mTOR Inhibition during Gvhd Prevention
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
Germinal Center B-Cells in Chronic GVHD
Pediatric Lifetime Achievement Award
Bleakley, M.
Novel Prevention Strategies (inc. Naïve T Cell Depleted PBSCT)
Bleesing, J.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Bleul, C. C.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Blokland, N.
Preclinical Development of Cord Blood-Derived Dendritic Cell-Based Immunotherapies after Hematopoietic Cell Transplantation in Children with AML
Upregulation of Class I MHC on Neuroblastoma Cells By NK Cell Exposure for Enhanced CTL Reactivity
Blum, W.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Bock, F.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Bodge, M.
Preparative Regimens: Dosing Considerations in Special Populations
Boeckh, M. J.
Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients: Seasonality and Factors Associated with Progression to Lower Respiratory Tract Disease
Recurrent Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT): Incidence, Clinical Manifestations, Risk Factors and Outcome
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Advances in Pharmacologic Therapies
(CIBMTR Working Committee) Infection and Immune Reconstitution
Boehrer, A. C.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Boelens, J. J.
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Preclinical Development of Cord Blood-Derived Dendritic Cell-Based Immunotherapies after Hematopoietic Cell Transplantation in Children with AML
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Upregulation of Class I MHC on Neuroblastoma Cells By NK Cell Exposure for Enhanced CTL Reactivity
Predicted Indirectly Recognizable Hla Epitopes (PIRCHE) Provide a Novel Strategy to Individualize Donor Selection That Optimizes Survival Chances
Leukodystrophies in Older Children and Adults
(CIBMTR Working Committee) Primary Immune Deficiencies, Inborn Errors of Metabolism and Other Non-Malignant Marrow Disorders
Boes, M.
Preclinical Development of Cord Blood-Derived Dendritic Cell-Based Immunotherapies after Hematopoietic Cell Transplantation in Children with AML
Upregulation of Class I MHC on Neuroblastoma Cells By NK Cell Exposure for Enhanced CTL Reactivity
Bogema, M.
Ixazomib Inhibits Dendritic Cell Maturation and Function
Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
Boitano, A. E.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Bolaños-Meade, J.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Alternative Donors Beyond the Matched Sibling
Bollard, C. M.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
Serotherapy with Alemtuzumab but Not ATG Is Associated with Increased Adenovirus Infection in Pediatric Recipients of Cord Blood Grafts
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
What's "Driving CAR" Cell Therapy?
Bolwell, B.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Bona, K.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Bonfim, C.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Bonney, D.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Boo, M.
A Tribute To Altruism: Celebration of 25 Million Volunteer Donors Worldwide
Bordon, V.
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Borich, A.
Rounding with Purpose:Improving Communication, Safety and Collaboration with Nurse Driven, Multidisciplinary Family Rounds
Borrello, I. M.
Vaccines and Adoptive T-Cell Therapy in Myeloma
Borrill, R. E.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Bosselut, R.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Bouabdallah, R.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Boubaker, A.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Bouinta, A.
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Boulad, F.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Bouladoux, N. J.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Bourke, J.
Weight Based Plerixafor Dosing Reduces Side Effects in Stem Cell Mobilization
Boussery, K.
Pharmaceutical Care for Pediatric Oncology and Hematopoietic Stem Cell Transplantation Patients: Need for Education and Training
Boussiotis, V. A.
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Boussiou, Z.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Bouzas, L. F. S.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Boyce, L.
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Boyle, D. A.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Boyle, N.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Bradstock, K.
Identifying the Need for a Regional Nurse–Led Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) Late Effects Follow up Program
Braga, F. T. M. M.
Catheter-Related Bloodstream Infections during Use of Chlorhexidine Gluconate-Impregnated Dressings
Brager, R.
Presentation and Outcome of Zap 70 Deficiency
Bramanti, S.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Brammer, J. E.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
Brammer, J. E.
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Brand, P.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
Brånvall, E.
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Comprehensive Meta-Analysis
Brassil, K.
Shared Leadership: Clinical Nurse Leaders Improving Continuity of Care and Quality Outcomes for Hospitalized Stem Cell Transplant Patients
Braun, T.
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Brazauskas, R.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Allogeneic Transplant for Acute Biphenotypic Leukemia: Characteristics and Outcome in the CIBMTR Database
Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Bredius, R.
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Breen, A.
Innovative Patient and Family Education
Brehm, C.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Breitwieser, E. J.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Bremm, M.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Brennan, T.
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
Brenner, M.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Brenner, M. K.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Brethon, B.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Briamonte, C.
A Multi-Institutional Retrospective Data Analysis of Hematopoietic Cell Transplantation for Less Severe Sickle Cell Disease
Briggs, A.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Brister, L.
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
Brochstein, J.
Title - Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of “Late” Alemtuzumab
Brodin, P.
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Brogan, P.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Broglie, L.
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Brown, A. W.
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
A Review of Radiographic Findings in Gvhd
Brown, A. D.
Life after Transplant: The Use of Group in Preparation for Transition Home
Brown, A. D.
Improvement of Patient Education in Preparation for the Inpatient Transplant Stay
Brown, J. R.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Brown, K.
Acute Skin Graft Versus Host Disease Post Liver Transplantation: A Case Report
Brown, L.
Identifying the Need for a Regional Nurse–Led Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) Late Effects Follow up Program
Brown, R.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Brown, S.
Coordinator Perspective: Promoting BMT CTN Studies at Your Center
Bruce, A. J.
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
Bruce, J. G.
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Brundage, T. M.
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Brunner-Grady, J.
Janet’s Inbox – A Potpourri of Questions & Answers
Brunstein, C. G.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Cyclophosphamide Dose Weight Adjustment in Morbidly Obese with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Pre-Transplant Consolidation Chemotherapy for Acute Lymphocytic Leukemia (ALL) Does Not Impact Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
BMT CTN 1101 Haplo Bone Marrow Vs. Double Cord Blood Trasnplantation
Bryk, A. W.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Bryson, E.
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Buadi, F.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
A Study of Dietary Intake and the Relationship to Neutrophil Engraftment Among Outpatient Hematopoietic Stem Cell Transplant Patients with Multiple Myeloma
Bubalo, J.
Preparative Regimens: Dosing Considerations in Special Populations
Transplant in the Morbidly Obese Patient
Buces, E.
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Buchanan, S.
Picture This: A Better Transplant Experience for Pediatric Patients
Buchbinder, D.
Successful Treatment of Secondary Graft Failure Following Unrelated Cord Blood Transplant with Hematopoietic Growth Factors in a Patient with Fanconi Anemia
Buckley, R. H.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Buechele, C.
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells
Bühler, L.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Buhrmann, K.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Bukannan, A.
Acute Skin Graft Versus Host Disease Post Liver Transplantation: A Case Report
Bunch, J.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Bunin, N.
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
Bunjes, D. W.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Buño, I.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Burgess, M. L.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Burgin, C.
Panel Discussion: GVHD and Co-Morbidities
Burguette-Hernandez, E.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Burke, E.
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Burns, L. J.
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
Keeping Bones Strong - What's to Know?
Burns, L. J.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Cyclophosphamide Dose Weight Adjustment in Morbidly Obese with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation (HCT)
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Burroughs, L.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Butker, C.
Factors Influencing Pulmonary Toxicity in the Setting of Total Body Irradiation-Based Myeloablative Conditioning in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Butker, E.
Factors Influencing Pulmonary Toxicity in the Setting of Total Body Irradiation-Based Myeloablative Conditioning in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Butler, A.
CMV and EBV Reactivation after Allogeneic Transplantation
Butterton, J. R.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Butts, R.
Late Onset Pulmonary Arterial Hypertension after Successful HSCT for Familial HLH
Buxbaum, N. P.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Byam, C.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Byars, K.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Byersdorfer, C. A.
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Byrd, J. C.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Byrne, M.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Cyclophosphamide Is an Effective and Well-Tolerated Maintenance Therapy in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

C

Caballero, D.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Cadena, J. A.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Caimi, P.
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
Cain, W.
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Cairo, M. S.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Effectively Targeting Burkitt Lymphoma By ANTI-CD20 Chimeric Antigen Receptor (CAR) Modified Expaneded Natural Killer CELLS Combined with a Histone Deacetylase Inhibitor, Romidepsin in Vitro and in Humanized NSG MICE
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Rescue of the Mucocutaneous Manifestations in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa (RDEB) By Human Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs)
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
(CIBMTR Working Committee) Autoimmune Diseases and Cellular Therapies
Calabrese, C. A.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Calafiore, M.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Call, T.
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Callander, N.
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Campagnaro, E.
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
Campbell, A. P.
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Campbell-Lee, S.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Camphausen, K.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Campusano, C.
Bone Health Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Cancro, M. P.
Autoimmunity and B-Cell Biology: Back to Basics
Candotti, F.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Cant, A. J.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Cantilena, C.
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Cantwell, L.
Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Cao, Q.
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Caplan, M.
Late Onset Pulmonary Arterial Hypertension after Successful HSCT for Familial HLH
Carabasi, M.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Carbonaro, D. A.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Carbonell, D.
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Cardona, D.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Carella, A. M.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Carlin, K.
Preparation of the New Graduate RN for Care of the Hematopoietic Cell Transplant Patient:: An Orientation Reconstruction Story
Carlson, J.
Estimated Cost-Effectiveness of Brentuximab Vedotin Vs. Best Supportive Care Following Autologous Stem Cell Transplant in Hodgkin's Lymphoma
Carlstrom, K. D.
Is G-CSF Still Needed Post-Transplant to Promote Engraftment in the Present Era? a Multi-Disciplinary Project to Evaluate Patient Safety Vs Cost Savings
Carpenter, B.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Carpenter, P. A.
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
Point-Counterpoints
Chronic GVHD
Acute & Chronic GVHD Data Reporting/Case Studies
How to Build a Long-Term Follow-up Program
(PEDS) Controversies in Supportive Care
Carreras, E.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Carreras, J.
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Carroll, M.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Carrum, G.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Carvallo, C.
Characteristics and Preliminary Clinical Results of a Cohort of Patients in Santiago, Chile, Undergoing Haploidentical Hematopoietic Cell Transplantation with Postransplant Cyclophosphamide
Casey, L.
Trend, Risk Factors and Outcome of Respiratory Syncytial Viral Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review
Cash, M.
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Cashen, A.
Cytogenetic Patterns of Relapse Following Stem Cell Transplantation in Morphologic Complete Remission in Patients with Cytogenetically Abnormal Acute Myeloid Leukemia
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Cassaday, R. D.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Castagna, L.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Castanho, L. C.
Removal of Chlorhexidine Gluconate-Impregnated Dressings Due to Skin Irritation in Patients Under Hematopoietic Stem Cell Transplantation
Catheter-Related Bloodstream Infections during Use of Chlorhexidine Gluconate-Impregnated Dressings
Castilla-Llorente, C.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Castillo, P.
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Castro, E.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Castro-Malaspina, H.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Cluster of Fulminant Toxoplasmosis in T-Cell Depleted (TCD) and Cord Blood (CB) Stem Cell Transplant (SCT) Recipients: Impact of Aggressive Prophylaxis and Routine Monitoring By Toxoplasma PCR for High Risk Patients
Cavazzana, M.
Early Results of a Phase I/ II Study of Gene Therapy for ß -Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-Vivo with a Lentiviral ß AT87Q -Globin Vector
Caywood, E.
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Cellot, S.
Development of a Standardized Follow up for Pediatric Transplant Long Term Survivors By Family Physicians
Cerda, K.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Cerny, J.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Allogeneic Stem Cell Transplant Improves the Outcome of Patients with Acute Erythroleukemia: Single Center Analysis
Experience with Administration of Ruxolitinib after Allogeneic Stem Cell Transplantation (alloSCT) in Patients with Myelofibrosis
Chabannon, C.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Chafee, A.
Providing a Safety Net for Bone Marrow Transplant (BMT) Survivors: Nurses and Telephone Triage
Chai, A.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Chai, X.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
The Impact of Oral Chronic Graft-Versus-Host Disease on Global Measures of Quality of Life
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Chakrabarti, A.
Pretransplant Sirolimus Improves Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Patients with Severe Aplastic Anemia
Chakrabarti, S.
Developing a Haploidentical Transplant Program: An Indian Experience
Pretransplant Sirolimus Improves Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Patients with Severe Aplastic Anemia
Chakrabartty, J.
Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Haematopoietic Stem Cell Transplantation- a Single Center Experience
Chakravarti, A.
Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Haematopoietic Stem Cell Transplantation- a Single Center Experience
Champ, D.
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Champlin, R. E.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Spinal Cord Injection of Stem Cells for Pediatric ALS
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Dnase I Treatment Reduces Gvhd in Mice
Adverse Events during Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis Patients
Oral Abstracts - Session A - Allogeneic Transplants
Chandra, S.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Chandrasekar, P.
Cytomegalovirus (CMV) Infection in Autologous Stem Cell Transplant (ASCT) Recipients in the Era of Rituximab (R) Use
Chang, A.
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Chang, A. K.
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
The Significance of Daily Blood Cultures in Febrile Pediatric Hematopoietic Cell Transplant Recipients
Chang, B. H.
Targeting BCL-2 and BCR-Abl Activity in Ph+ALL
Chang, K.
Women's Health and Hormonal Treatment Options for Therapeutic Amenorrhea and Contraception during the Peri-Transplant Period
Chang, M.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Cyclophosphamide Is an Effective and Well-Tolerated Maintenance Therapy in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Chao, N. J.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Immune Reconstitution after Bone Marrow Transplant
Chaparro, M.
Hematopoietic Stem Cell Transplantation for Children Acute Myeloid Leukemia, a Single Center Experience
Charalampidou, S.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Chaturvedi, V.
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Chaudhari, P.
Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
Chaudhry, H. M.
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
Chaudhry, R.
Serotherapy with Alemtuzumab but Not ATG Is Associated with Increased Adenovirus Infection in Pediatric Recipients of Cord Blood Grafts
Chaudhury, S.
Impact of High-Resolution Typing for HLA-a, -B, -C and -DRB1 on Single-Unit Cord Blood Transplantation in Pediatric Patients
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Chaudri, N.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Chauncey, T.
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Chebbo, W.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Cheerva, A.
Voriconazole Therapeutic Drug Monitoring in a Pediatric Hematopoietic Stem Cell Transplant Center
Pharmacoeconomic Impact of Thiotepa-Containing Conditioning Regimens in a Pediatric Hematopoetic Stem Cell Transplant Center
Chemaly, R. F.
The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis in Transplant Recipients
BMT Tandem Luncheon Symposium: The Role of IGRAs in Immunocompromised Patients: Predicting CMV Infection and Diagnosing Latent or Active TB
Chen, A.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Chen, A.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Chen, B. J.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Chen, C.
Building a Quality Plan for a Blood and Marrow Transplant Program: Quality Framework and Indicator Development
Chen, C.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Chen, D.
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Chen, G. L.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Chen, J.
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome
Chen, J.
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Chen, L.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Chen, M. Y.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Chen, X.
Distinctions Between Effective and Ineffective AML-Specific Autologous Peripheral Blood (PB) Cytotoxic T-Lymphocytes (CTLs)
Myeloid Derived Suppressor Cells (MDSC)-like Acute Myeloid Leukemia (AML) Cells Are Associated with Resistance to Cytotoxic Effects of Autologous (Auto) T-Lymphocytes (CTLs)
Chen, Y. B.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Oral Abstracts - Session B - Allogeneic Transplants
Cheng, G. S.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
Chewning, J. H.
Use of Double Lumen Central Venous Cathethers for Hematopoeitic Stem Cell Pheresis
Chhabra, S.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Anti CD20 Radioimmunotherapy and mTOR Inhibition in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas
Chiang, K. Y.
A Multi-Institutional Retrospective Data Analysis of Hematopoietic Cell Transplantation for Less Severe Sickle Cell Disease
Chiesa, R.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Chiffelle, R.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Childs, R. W.
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Chima, R.
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Chinn, T.
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Chitphakdithai, P.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Chitti, R.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Chittick, G.
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Cho, C.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Cho, E.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Choeyprasert, W.
Bacteremia during Neutropenic Episodes in Children Underwent Hematopoietic Stem Cell Transplantation Receiving Ciprofloxacin and Penicillin Prophylaxis
Choi, I.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Choi, S. W.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Oral Abstracts - Session F - Allogeneic Transplants & Supportive Care & Graft Processing
Chokshi, P. D.
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Chong, P. P.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Chow, V.
Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Allograft Recipients on High-Dose Glucocorticoids for Treatment of Graft-Versus-Host-Disease
Choyke, P.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Christian, J. A.
Quality Improvement Initiatives/Donor Evaluation and Product Collection
Chu, Y.
Effectively Targeting Burkitt Lymphoma By ANTI-CD20 Chimeric Antigen Receptor (CAR) Modified Expaneded Natural Killer CELLS Combined with a Histone Deacetylase Inhibitor, Romidepsin in Vitro and in Humanized NSG MICE
Chung, D. J.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Chung, D.
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Chung, H.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Case Report: 52 Year-Old Male 11 Months after MUD for Angionimmunoblastic T Cell Lymphoma Developed Acute Fibrinous Organizing Pneumonitis Successfully Treated with Etanercept Suggesting TNF Alpha in the Pathogenesis in This Sub-Type of Pulmonary GVHD
Chung, J.
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
Chung, Y.
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Churay, T. L.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Chwieseni, E.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Ciceri, F.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Is There a Stronger Graft-Versus-Leukemia Effect Using HLA-Haplo-Identical Donors Compared to HLA-Identical Sibling Donors?
Cimino, M.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Ciocci, G.
Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases
Cirrincione, C.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Ciurea, S. O.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Clark, A.
Intravenous Pentamidine for Pneumocystis Carinii/Jiroveci Pneumonia (PCP) Prophylaxis
Clark, W.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Case Report: 52 Year-Old Male 11 Months after MUD for Angionimmunoblastic T Cell Lymphoma Developed Acute Fibrinous Organizing Pneumonitis Successfully Treated with Etanercept Suggesting TNF Alpha in the Pathogenesis in This Sub-Type of Pulmonary GVHD
Coghill, J.
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Coghlin Dickson, T.
Prevalence of Vitamin D Deficiency in Allogeneic HCT Recipients and Its Association with Graft Versus Host Disease
Cogle, C. R.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Cohen, A.
Related Donor Screening: An Increasingly Complex Process
Cohen, H. J.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Cohen, J. A.
Cellular Therapy with Mesenchymal Stem Cells for Multiple Sclerosis
Cohen, L.
Risk Factors and Prognostic Scale for CMV Reactivation in CMV Seropositive Patients after Allogeneic Hematopoietic Cell Transplantation – a Single Center Cohort Study
Cohen, M. Z.
African-American, Latino and Caucasian Patients' Experience before, during and after Stem Cell Transplantation: A Phenomenological Study
Colburn, M.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Cole, K.
Ixazomib Inhibits Dendritic Cell Maturation and Function
Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
Cole, S.
Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences
Coleman, K. M.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
Collins, R. H.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Collum, K.
Transplant Continuing Education Activities: Who Does This Affect and Examples on How to Comply
Colon-Gonzalez, F.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Colosimo, D. A.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Colt, L.
Data Matters Jeopardy
Colvin, K.
Piloting a Clinical Resource Nurse Role
Preparation of the New Graduate RN for Care of the Hematopoietic Cell Transplant Patient:: An Orientation Reconstruction Story
Comenzo, R.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma
Commeyne, S.
Stability of High Concentration Etoposide (10mg/ml) in Physiologic Saline for Use in Conditioning Regimens
Pharmaceutical Care for Pediatric Oncology and Hematopoietic Stem Cell Transplantation Patients: Need for Education and Training
Confer, D. L.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Transplants for All: Progress We Have Made, Challenges We Face
Challenges in the Future of Hematopoietic Cell Transplantation
Conn, S.
Happy Birthday…Again: Educating BMT Nurses and Patients about Infusion of Stem Cells
Connelly, B.
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Connelly, J. A.
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Conway, C.
Benchmarking and Key Metrics Used by HCT Administrators
Cook Gannon, L.
Life after Transplant: The Use of Group in Preparation for Transition Home
Cooke, K. R.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Cooke, L.
Pre-Transplant Caregiver Education for out-Patient Multiple Myeloma Hematopoeitic Transplant Admission in New Day Hospital: Caregiver Role and Contract in Outpatient Transplant Patient Care
Patient and Family Education
Cooke, M.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Cooley, S.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Natural Killer Cells Enhance Transplantation Outcomes
Panelist: How Can Technology Further BMT Research
Cooper, B.
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
Cooper, L. J. N.
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Copik, A. J.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Corbacioglu, S.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Corbet, K.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Cornelison, A. M.
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Cornelissen, J.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Cortes, J.
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Cortright, K.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Cossor, F.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
Costa, K.
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
Costa, L. J.
Anti CD20 Radioimmunotherapy and mTOR Inhibition in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas
Costa, L. J.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Costa, L. V.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Coulter, D. W.
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
Couriel, D. R.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Oral Abstracts - Session I - GVH/GVL & Autologous Transplants
(CIBMTR Working Committee) Graft-Versus-Host Disease
Courtnage, T.
Optimizing Transplant Ambulatory Care Utilizing Multidisciplinary Rounds
Coussons, M.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Coutre, S.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Couture, C.
Preparing for a BMT CTN Audit
Moderator
Infection Data Reporting
Completing Site Visit Action Items
Covington, D.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Cowan, A. J.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Cowan, M. J.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Cowen, E. W.
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Cowens, K.
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Cox, T.
A Network Approach to Standardization of BMT Pathways
A Network Approach to Creation and Maintenance of Standardized Standard Operating Procedures
Coyle, D.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Craddock, C.
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
Strategies to Prevent and Treat Relapse Post-Allograft
Adult AML Introduction
Adult AML
Crank, C. W.
Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
Creger, R.
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
Crivello, P.
The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
Crocchiolo, R.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Crochunis, A.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Crooks, G. M.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Cross, S.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Cruz, J. C.
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Cruz, R.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Curran, K. J.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Curtis, J.
30 Day Readmissions – a 4 Year Look Back of Multi-Disciplinary Efforts
30 Day Readmissions Rate- How Many Ways Can We Calculate Thee?
Curtis, L. M.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Curtsinger, J.
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Custodio, M.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
A Network Approach to Creation and Maintenance of Standardized Standard Operating Procedures
Cutler, C. S.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Comprehensive Meta-Analysis
The Impact of Oral Chronic Graft-Versus-Host Disease on Global Measures of Quality of Life
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
B-Cell Directed Therapy for Chronic GVHD
Update in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation
(CIBMTR Working Committee) Graft-Versus-Host Disease
Cuvelier, G.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Cuvellier, G.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901

D

D'Souza, A.
Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Dabney, J.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
System Capacity Initiative Social Work Workforce Working Group
Daguindau, E.
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Dahi, P.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Dahlberg, A.
Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral Nutrition in Patients Receiving Myeloablative Cord Blood Transplantation
Dai, Y.
Cyclophosphamide Is an Effective and Well-Tolerated Maintenance Therapy in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Dalal, J.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Trend, Risk Factors and Outcome of Respiratory Syncytial Viral Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review
(CIBMTR Working Committee) Health Services and International Issues
Dalal, N.
Single Donor Vs. Acrodose Platelets in Oncology Patients: A Single Institutional Experience
Dalovisio, A.
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Dame, B.
Life after Transplant: The Use of Group in Preparation for Transition Home
Damlaj, M.
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Damodar, S.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Damon, L. E.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Damon, L. E.
Oral Abstracts - Session L - Lymphoma/Multiple Myeloma
Dandoy, C. E.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Outcomes Resilience after System Stress: A Rapid-Cycle Response to Mitigate the Impact of Care Delivery System Stress on Primary Blood Stream Infections
Increasing Adls Is Easy As 1-2-3
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Danner-Koptik, K.
Incidence and Risk Factors for Metabolic Syndrome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients- a Tertiary Care Center Experience
Danziger-Isakov, L.
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Intravenous Pentamidine for Pneumocystis Carinii/Jiroveci Pneumonia (PCP) Prophylaxis
Danziger-Isakov, L.
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Darrigo, L. G. Jr.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Dasgupta, A.
Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
Daskalakis, C.
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
Datiles, M. B. III
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Daudt, L. E.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Daver, N.
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Davies, S. M.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
A Pilot Study of Donor Enteral Human Milk to Modulate the Gut Microbiome in Children Receiving Stem Cell Transplant
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Intravenous Pentamidine for Pneumocystis Carinii/Jiroveci Pneumonia (PCP) Prophylaxis
Outcomes Resilience after System Stress: A Rapid-Cycle Response to Mitigate the Impact of Care Delivery System Stress on Primary Blood Stream Infections
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
Davila, A.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Davis, C.
Preparation of the New Graduate RN for Care of the Hematopoietic Cell Transplant Patient:: An Orientation Reconstruction Story
Davis, D.
Successful Transitions in Transplant Between Hospitalization and Outpatient Care
Davis, J. H.
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Davis, L.
Picture This: A Better Transplant Experience for Pediatric Patients
De Goey, S. R.
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
de Haar, C.
Preclinical Development of Cord Blood-Derived Dendritic Cell-Based Immunotherapies after Hematopoietic Cell Transplantation in Children with AML
De Kesel Lofthus, A.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
de Koning, T. J.
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
de la Fuente, J.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
de Lavallade, H.
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
de Lima, M. J. G.
NOVEL Strategy to Enhance NK CELL Activity
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
MDS in Children: Is it Different from Adults
(CIBMTR Working Committee) Acute Leukemia
de Melo, A. L. R.
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
De Oliveira, S.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
de Weger, R. A.
Predicted Indirectly Recognizable Hla Epitopes (PIRCHE) Provide a Novel Strategy to Individualize Donor Selection That Optimizes Survival Chances
de Wildt, A.
Predicted Indirectly Recognizable Hla Epitopes (PIRCHE) Provide a Novel Strategy to Individualize Donor Selection That Optimizes Survival Chances
de Witte, M.
ALPHA/Beta T- CELL Depleted Allogeneic STEM CELL Transplantation from Matched Related and Unrelated DONOR Grafts in Patients with Poor Risk Leukemia
De Yao, J.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) – a Single Institutio
Dean, R. M.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
DeBerry, L. J.
A Model for Building a New Adult Blood and Marrow Program
Dees, J.
A Team Approach to Decreasing Clabsi Rates in a Bmtu
Defor, T. E.
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Response and Survival Following Second-Line Therapy in 113 Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
DeGregory, K.
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
Dehn, J.
Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
Registry Efforts to Improve Success of Unrelated Donor Searching for African American Patients
Del Papa, N.
Autotransplants for Scleroderma: Ready for Standard of Care?
Delaney, C.
Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft Interaction
Impact of Pre-Transplant Minimal Residual Disease in Patients with AML Undergoing Myeloablative Cord Blood Transplantation
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral Nutrition in Patients Receiving Myeloablative Cord Blood Transplantation
Successful Engraftment and Full Donor Chimerism in Patients Undergoing Second Allogeneic Stem Cell Transplantation with Umbilical Cord Blood
Off-the-Shelf Expanded Hematopoietic Progenitor Cells for Clinical Application
(PEDS) Graft Engineering
Delbrook, C.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Delgado, R.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
DeMasi, J.
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Incidence and Outcome of Rhinovirus in Children Undergoing Hematopoietic Stem Cell Transplantation
Demmel, K. M.
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Outcomes Resilience after System Stress: A Rapid-Cycle Response to Mitigate the Impact of Care Delivery System Stress on Primary Blood Stream Infections
Increasing Adls Is Easy As 1-2-3
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Demont, L.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Dennert, K.
Algorithm for Administration of Plerixafor Pre-Apheresis for Adult Autologous Stem Cell Transplantation
Dennison, D.
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study
Denoncourt, E.
A Phase 2 Study of the Hedgehog Pathway Smoothened Inhibitor PF-04449913 to Reduce Relapse in High Risk Acute Leukemia and MDS Patients Following Allogeneic Stem Cell Transplantation
Denzen, E. M.
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Psychosocial Distress Screening: Application of the Oncology Standard to HCT
Deol, A.
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Deoliveira, D.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
DePalo, J.
The Impact of Oral Chronic Graft-Versus-Host Disease on Global Measures of Quality of Life
Derouin, A.
Therapeutic Passes: Highlighting Caregivers' Attitudes and Beliefs Among the Pediatric Blood and Marrow Transplant Population
Desai, Z.
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Desmarais, C.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Detweiler, C.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Devillier, R.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Devine, S. M.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
BMT CTN 0502 / CALGB 100103 Primary Results
Oral Abstracts - Session D - Allogeneic Transplants
(CIBMTR Working Committee) Acute Leukemia
Devlin, S.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Dey, B. R.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Dhakal, B.
Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Dharmani, P.
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
di Stasi, A.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Diab, M.
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Diaz, J.
Characteristics and Preliminary Clinical Results of a Cohort of Patients in Santiago, Chile, Undergoing Haploidentical Hematopoietic Cell Transplantation with Postransplant Cyclophosphamide
Diaz, L.
Increasing Compliance in BMT Patients By Creating a Patient Education Binder
Diez-Martin, J. L.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
DiGrazia, L. M.
Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
Ding, W.
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Dingli, D.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Dinh, Y.
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Dioguardi, J.
A Multi-Institutional Retrospective Data Analysis of Hematopoietic Cell Transplantation for Less Severe Sickle Cell Disease
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
NP/PA SIG Research Meeting
Diouf, O.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
DiPersio, J. F.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Diri, R.
Retrospective Review of Intravenous Pentamidine for Pneumocystis Pneumonia Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
Dispenzieri, A.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Divanbeigi, J.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Divine, C. L.
In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo-Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Single Center Experience
Benchmarking and Key Metrics Used by HCT Administrators
Staffing Topic
Doan, V. P.
Levofloxacin Versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation
Dobbin, M.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Dobrila, N. L.
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Docampo, M. D.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
Dodd, T.
Quality Improvement/Performance Improvement (QI/PI) Models
FACT Quality Management Hot Topics: Managing Audits and Deviations
Doki, N.
The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Domen, J.
High Doses of Myeloid Progenitor Cells Induce Tolerance in the Context of Autologous HSC Transplantation
Donahoo, L. B.
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Donato, M. L.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Immune Reconstitution Analysis of Patients Undergoing Extracorporeal Photopheresis for the Treatment of Chronic Graft-Versus-Host Disease
Donegan, C.
Fall Innovations: A Multimodal Initiative to Decrease Falls in the Blood and Marrow Transplant Setting
Doney, K. C.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Dong, Y.
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
Dontsiou, A.
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Dörken, B.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Dougherty, V.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Doughman, C.
Increasing Adls Is Easy As 1-2-3
Douvas, M. G.
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Downey, C.
Implementation of Chemotherapy Order and Administration Checklists Ensures Adherence to National Chemotherapy Guidelines
Dozeman, L.
Faxing Physicians for Follow-up Information through Microsoft Outlook® Using Access®
Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution
Addressing the Need for Standardized Adverse Event (AE) Documentation within the Electronic Medical Record (EMR)
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Dozor, A. J.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Draganski, E.
Nurse-Initiated Protocol for Central Venous Catheter (CVC) Selection for Blood and Marrow Transplant (BMT) Recipients
Drake, C.
Combination Immunotherapy Approaches
Drexler, R. J.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Dreyer, J.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Driscoll, J.
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Driscoll, T. A.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases
Drobyski, W.
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Druker, B.
Targeting BCL-2 and BCR-Abl Activity in Ph+ALL
Dudakov, J. A.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Duerst, R. E.
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Duffner, U.
Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
Dufour, A. M.
Exploring the Role of Exercise in Patients with Multiple Myeloma
Dumitriu, A.
Limited Role of Sinus CT in the Management of Febrile Allogeneic Pediatric HSCT Recipients
Dunavin, N.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Duncan, C.
Factors Associated with CMV Disease in Pediatric Hematopoietic Stem Cell Transplantation
(CIBMTR Working Committee) Late Effects and Quality of Life
Dunnebach, E.
Preclinical Development of Cord Blood-Derived Dendritic Cell-Based Immunotherapies after Hematopoietic Cell Transplantation in Children with AML
Duong, H. K.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Duong, N. Q. T.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Dupuis Rosen, L.
Prevalence of Vitamin D Deficiency in Allogeneic HCT Recipients and Its Association with Graft Versus Host Disease
Duran-Struuck, R.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Durbin, L.
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Dürken, M.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Durning, N.
The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease
Duska, L. R.
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Duval, M.
Outcomes of Bone Marrow or Cord Blood Matched Related Transplantation for Children with Sickle Cell Disease: Experience of a Canadian Center
Development of a Standardized Follow up for Pediatric Transplant Long Term Survivors By Family Physicians
Dvorak, C. C.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Point-Counterpoints
(PEDS) Best Pediatric Abstracts
Dvorak, C. C.
Oral Abstracts - Session G - Pediatric Disorders
Dwiggins, A.
A Single Center Survey of Distress Amongst Bone Marrow Transplant Recipients
Rhythmic Entrainment: A Music Therapy Intervention to Elicit Relaxation and Decrease Anxiety for the Bone Marrow Transplant Recipient
Dworsky, S.
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Dyer, M.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Dziopa, E.
Biomimetic Nanofibrous Mesh for Long-Term Preservation of Intestinal Epithelial Cells

E

E, S.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Non-Myeloablative TLI/ATG + Alkylator Conditioning Augments Bidirectional Immune Tolerance Via Regulatory MDSC in a Robust Murine Model of MHC-Mismatched BMT for Beta-Thalassemia
Eapen, M.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Eaton, K.
The Perceived Value of the Case Manager Role By Blood and Marrow Transplant Patients
Eckert, C.
Discharge Essentials: A Program for Preparing Adult Blood and Marrow Transplant Patients for Self -Care after Transplant
Eckhaus, M.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Eckrich, M. J.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Eddy, B.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Egberts, A.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Egeler, R. M.
Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model
Ehninger, G.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Ehrlich, K.
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Einsele, H.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Immuno-reconstitution and Adjunct Immunotherapy Against Fungi in SCT: From Lab to the Bed Side
Eiten, E. C.
Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
El Cheikh, J.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
El-Bietar, J.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
El-Hassan, T.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
El-Jawahri, A.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Elayan, M. M.
Tbo-Filgrastim Versus Filgrastim during Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation
A Network Approach to Standardization of BMT Pathways
Elder, J.
Voriconazole Therapeutic Drug Monitoring in a Pediatric Hematopoietic Stem Cell Transplant Center
Pharmacoeconomic Impact of Thiotepa-Containing Conditioning Regimens in a Pediatric Hematopoetic Stem Cell Transplant Center
Elgar, S. D.
Alternative to Inpatient Transplants
Elgohary, G.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Elhasid, R.
Outcome of Hematopoietic Stem Cell Transplantation for Children with Severe Combined Immunodeficiency (SCID). Seventeen Years Experience in Single Pediatric Transplantation Center
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Elledge, C.
Implementation of Chemotherapy Order and Administration Checklists Ensures Adherence to National Chemotherapy Guidelines
Exploring the Role of Exercise in Patients with Multiple Myeloma
Elmacken, M.
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Emole, J.
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Engemann, A. M.
Preparative Regimens Debate: Bu/Cy Versus Bu/Flu for Myeloid Malignancies
Englund, J. A.
Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients: Seasonality and Factors Associated with Progression to Lower Respiratory Tract Disease
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Engström, M.
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
Ent vd, K.
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
Epstein, R. B.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Epstein, S.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Erba, H. P.
SGN-CD33A: Case Reports of Anti-Leukemic Activity and Bridge to Allogeneic Stem Cell Transplant (SCT) in Patients with Acute Myeloid Leukemia (AML)
Erkers, T.
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Ernst, D.
Bone Health Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Escalante, T. D.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Escobar, C.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
Escolar, M. L.
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Esfandbod, M.
Comparing the Results of Non-TBI Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) with and without CNS Involvement
Eshel, R.
Correlation Between Pre-Collection CD34 Blood Concentrations and CD34 Collection Yield in Difficult-to-Mobilize Patients Given Plerixafor. –a Retrospective Single Center Study
Esiashvili, N.
Factors Influencing Pulmonary Toxicity in the Setting of Total Body Irradiation-Based Myeloablative Conditioning in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Espinoza, M.
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Espiritu, N.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Esteeve, J.
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Estupinan, M.
Hematopoietic Stem Cell Transplantation for Children Acute Myeloid Leukemia, a Single Center Experience
Eto, T.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Etzioni, A.
Outcome of Hematopoietic Stem Cell Transplantation for Children with Severe Combined Immunodeficiency (SCID). Seventeen Years Experience in Single Pediatric Transplantation Center
Eusebio, J.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Evans, R.
Outpatient Transplant Management Affects ANC Recovery Data Endpoin
Evens, A.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
Evenson, A.
Fall Innovations: A Multimodal Initiative to Decrease Falls in the Blood and Marrow Transplant Setting
Everett, M. M.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center

F

Faber, J.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Fabricatore, S.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
Fabricatore, S.
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Faghihi-Kashani, S.
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
The Safety of Granulocyte Colony Stimulating Factor (G-CSF) Administration in Pediatric Donors before Peripheral Hematopoietic Stem Cell Donation
Faham, M.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Fajardo, N.
Ensuring Quality and Standardizing Care for BMT Patients in an Expanding Program
Fan, G.
Placental Growth Factor (PlGF) in Allogeneic Hematopoietic Cell Transplantation (HCT): Clinical, Immunologic, and Pathologic Correlates
Fanning, S.
Immune Reconstitution Analysis of Patients Undergoing Extracorporeal Photopheresis for the Treatment of Chronic Graft-Versus-Host Disease
Fantuzzi, G.
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective
Fardis, M.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Farhan, R.
Tbo or Not Tbo-That Is the Question!
Farhan, S.
Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Acute Skin Graft Versus Host Disease Post Liver Transplantation: A Case Report
Faridi, R. M.
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
Farmer, A.
Piloting a Clinical Resource Nurse Role
Preparation of the New Graduate RN for Care of the Hematopoietic Cell Transplant Patient:: An Orientation Reconstruction Story
Farnia, S. A.
Meeting Retrospective: Defining Quality and Value in Stem Cell Transplant 2014 Forum
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Medicare Coverage and Reimbursement Project Update
Farrell, T.
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
Farthing, D. E.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Fauble, V.
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Faucher, C.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Fay, K.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Fazal, S.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Fazlollahi, M. R.
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
Featherstone, C.
Management of Cytokine Release Syndrome (CRS) in Patients Undergoing Chimeric Antigen Receptor Modified (CAR) T-Cell Therapy Following Autologous Stem Cell Transplant (ASCT)
Feinstein, L.
“Let's Get Physical” – Developing an Evidence-Based Exercise Protocol for Blood and Marrow Transplant (BMT) Survivors
Feldman, A. L.
New Insights in the Genomics of PTCL
Feldman, E.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Feldman, T.
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Feliciano, N.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Feng, Y.
Ixazomib Inhibits Dendritic Cell Maturation and Function
Fernandes, H. D.
Cerebral Venous Thrombosis after Autologous Stem Cell Transplantation
Fernandes, J. F.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Fernandez, H.
Hardwiring Advance Care Planning in BMT: More Than Just the Paper
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Fernandez, I.
CD4+CD25+ Invariant Natural Killer T Cells Are Enriched in Cord Blood: Implication on Immune-Regulation
Fernandez-Vina, M.
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Oral Abstracts - Session K - Histocompatibility & Clinical Cellular Therapy
Ferrá, C.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Ferrara, J. L. M.
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
How the GI Tract Protects Itself from GVHD
Ferraro, C.
Subcutaneous Ports for Outpatient Transplant Patients to Reduce the Risk of Central Line Associated Blood Stream Infections
Ferrey, S.
Welcome
Ferzoco, R. M.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Fesler, M.
Donor Derived Systemic Lupus Erythematosus (SLE) after Allogeneic Transplantation
Cerebral Venous Thrombosis after Autologous Stem Cell Transplantation
A Single Center Survey of Distress Amongst Bone Marrow Transplant Recipients
Rhythmic Entrainment: A Music Therapy Intervention to Elicit Relaxation and Decrease Anxiety for the Bone Marrow Transplant Recipient
Field, T.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Filicko, J.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Filicko-O'Hara, J.
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Filipek, R.
Abstract 5246: Comparison of Outcomes of Two Preparative Regimens for Lymphoma Patients Who Are Receiving Autologous Hematopoietic Stem Cell Transplantations
Filipovich, A.
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Finetto, G.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Fink, A.
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective
Finke, J.
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Finn, L.
Predictors and Outcomes of Intensive Care Utilization in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant at Mayo Clinic, Florida
Finstermeier, K.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Fischer, A.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Fischer, J. C.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Fleischhauer, K.
The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
(CIBMTR Working Committee) Immunobiology
Fleisher, T.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Flemming, M.
Increasing Adls Is Easy As 1-2-3
Flesch, L.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Outcomes Resilience after System Stress: A Rapid-Cycle Response to Mitigate the Impact of Care Delivery System Stress on Primary Blood Stream Infections
Increasing Adls Is Easy As 1-2-3
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Flomenberg, N.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Florenzano, P.
Bone Health Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Flores, T.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Flowers, M. E. D.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Risk Factors for Depression and Fatigue Among Hematopoietic Cell Transplant (HCT) Recipients
Preventive Care Adherence and Associated Factors in a National Sample of Hematopoietic Cell Transplantation (HCT) Survivors Recruited for an Online Randomized Controlled Trial (RCT)
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Oral Abstracts - Session J - Late Effects/Quality of Life
(CIBMTR Working Committee) Late Effects and Quality of Life
Flynn, R.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Foca, M.
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
The Significance of Daily Blood Cultures in Febrile Pediatric Hematopoietic Cell Transplant Recipients
Foldi, J.
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Fong, J. L.
Abstract 5410: Dose-Escalated G-CSF Does Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation
Tbo or Not Tbo-That Is the Question!
Fonstad, R.
Registry Efforts to Improve Success of Unrelated Donor Searching for African American Patients
Foran, J.
Predictors and Outcomes of Intensive Care Utilization in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant at Mayo Clinic, Florida
Forbes, L.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Forcade, E.
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Ford, R.
Follow-up of Related Stem Cell Donors One Week Post Donation
Optimizing Transplant Ambulatory Care Utilizing Multidisciplinary Rounds
Forman, S. J.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Cytogenetics Does Not Influence Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
Outcomes of Patients with Acute Lymphoblastic Leukemia (ALL) with Central Nervous System (CNS) Involvement Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT): A Single Center Retrospective Analysis
Foster, J.
Psychosocial Distress Screening: Application of the Oncology Standard to HCT
Foster, L. H.
Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused
Fowler, D.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
(CIBMTR Working Committee) Graft Sources and Manipulation
Fox, P. S.
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Francisco, L.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Frangoul, H. A.
Incidence and Risk Factors of Bacterial Infections in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of CMV Reactivation and Infection in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation in High CMV Exposure Population
Franke, G. N.
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Frary, A.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Frey, N. V.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Freytes, C. O.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Friedman, A.
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
Friedman, D.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Friedrichi, C.
Development of a Standardized Follow up for Pediatric Transplant Long Term Survivors By Family Physicians
Friswell, M.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Froelich, J.
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Fromm, J. R.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Fry, T. J.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Presentation 2
Fu, P.
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
Fu, Q.
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Fu, S.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Fuchs, E. J.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
BMT CTN 1101 Haplo Bone Marrow Vs. Double Cord Blood Trasnplantation
Oral Abstracts - Session A - Allogeneic Transplants
Fuji, S.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Fujii, H.
Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model
Fujisaki, T.
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Fukuda, T.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Fukuda, T.
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Fukushima, N.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Fung, H. C.
Severe Mucositis with Bendamustine Etoposide Ara-C and Melphalan (Be-EAM) As Conditioning Regimen in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (AutoSCT)
Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Funke, V. A. M.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Furlan, S. N.
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
T-Cell Transcriptome Analysis Reveals the Mechanisms Controlling Synergy Between Costimulation Blockade and mTOR Inhibition during Gvhd Prevention
Furlong, T.
Coordinator Perspective: Managing a Research Subject in a Clinical Environment
Fürst, D.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Complete Loss of HLA Class I Heterozygosity in a Patient with Acute Myeloid Leukemia
Furst, S.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade

G

Gaballa, S.
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Gabriel, D. A.
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Gaensler, K. M.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Gafken, P. R.
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Galasso, J. A.
Implementing a Screening and Treatment Protocol for Latent Tuberculosis in Patients with Hematologic Malignancies in a Southern California Medical Center
Gale, R. P.
MRD in AML: Much Ado About Nothing?
Mortimer M. Bortin Lecture
Galindo-Becerra, S. L.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Reduced-Intensity Stem Cell Allografting for PNH Patients in the Eculizumab Era: The Mexican Experience
Gallagher, E.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Gallego, A. Jr.
A Change in Donor Medical Suitability Criteria Resulted in Decreased Rates of Donor Attrition at CT Stage in a Registry Study
Galvez Silva, J.
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Galvin, J. P.
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Pain Following Hematopoietic Stem Cell Transplant: A Prospective Observational Study
Tbo or Not Tbo-That Is the Question!
Gamal, A. Y.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Gamper, C.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Ganapule, A.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Gandhi, M.
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Ganetsky, A.
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
New Drug Update
Ganguly, S.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo-Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Single Center Experience
Ganser, A.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Gao, A.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Gao, L.
A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma
Garabedian, E.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Garces-Eisele, J.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Garcia, M. J.
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Garcia-Jennings, L.
Experiences with Design and Implementation of a Related Donor Coordinator Position
Garcia-Villasenor, A.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Gardner, K.
Welcome/Staff Introductions
Welcome
Garner, M.
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Garvin, J.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
Gaspar, H. R.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Gasparetto, C.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Engraftment Failure or Aplastic Anemia: A Case Report
(CIBMTR Working Committee) Plasma Cell Disorders and Adult Solid Tumors
Gastecki, K.
C. the Difference with Steriplex
Gastineau, D. A.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Gates, M.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Gautério, T. L.
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Gayoso, J.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Gazi, M.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Gea-Banacloche, J.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Gee, A. P.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Gee, K.
Breakfast with CIBMTR Information Technology (CIT) Forum
Kickoff and Welcome
CIBMTR IT, Research Data Lifecycle & You
CIBMTR Data Sharing Roadmap to the Future
CIBMTR IT Forum Q&A, Recap and 2016 Planning
Gefen, A.
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Gelfand, M. J.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
George, B.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
George, D.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
George, M.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Georges, G.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Gerds, A.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Gergis, U.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Germann, J.
Increased Incidence of Fatigue in Pediatric Hematopoetic STEM CELL Transplant Recipients
Gersten, I. D.
Introductions
New Coordinator/BMT CTN Basics
Gertow, J.
In Vitro Expanded Umbilical Cord Blood T Cells Used for Donor Lymphocyte Infusions after Umbilical Cord Blood Transplantation
Gertz, M.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Geswein, L.
Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
Getzendaner, L.
The Great Search- HLA Typing, Donor Selection and Beyond
Ghavamzadeh, A.
Comparing the Results of Non-TBI Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) with and without CNS Involvement
Post-HSCT Fertility in Patients Receiving Non-TBI-Based Conditioning Regimen: A 23-Year of Iranian Experience
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
Assessment of Additional Consolidation Chemotherapy Effects in Patients with Acute Myeloid Leukemia before Allogeneic Stem Cell Transplantation
The Safety of Granulocyte Colony Stimulating Factor (G-CSF) Administration in Pediatric Donors before Peripheral Hematopoietic Stem Cell Donation
Gianni, A. M.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Gibson, B.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Gibson, C.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Gibson, D.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Giebel, S.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Regional Cost Differences of Matched, Haploidentical and Cord Blood HCT
Gijima, D.
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Gill, S.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Giller, R.
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Gillespie, G. Y.
Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
Gilligan, P. H.
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Gillio, A. P.
The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Gilman, A.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Giralt, S. A.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
Related Donor Screening: An Increasingly Complex Process
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Cluster of Fulminant Toxoplasmosis in T-Cell Depleted (TCD) and Cord Blood (CB) Stem Cell Transplant (SCT) Recipients: Impact of Aggressive Prophylaxis and Routine Monitoring By Toxoplasma PCR for High Risk Patients
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Transplanting Relapsed Refractory Acute Leukemia: Why We Should Continue
Panelist: How Can Technology Further BMT Research
Welcome, Introduction, and Poll: The Clinical Challenge of VOD in the Transplant Setting
Insights on Preventing VOD and Other Post-Transplant Complications
Q&A and Concluding Remarks
BMT Tandem Luncheon Symposium: Veno-Occlusive Disease and the Transplant-Recipient: Addressing Prevention, Treatment and Patient Needs
Giver, C.
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
Glanville, J.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Glass, B.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Goebel, J.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Goldenberg, D. M.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Goldman, F.
Use of Double Lumen Central Venous Cathethers for Hematopoeitic Stem Cell Pheresis
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Goldstein, S. C.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Gomez-Almaguer, D.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Reduced-Intensity Stem Cell Allografting for PNH Patients in the Eculizumab Era: The Mexican Experience
Gomez-de-Leon, A.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Gonsalves, W. I.
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Gonzalez, R.
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Gonzalez-Cortes, A.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Gonzalez-Ramirez, M. P.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Gooley, T.
Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients: Seasonality and Factors Associated with Progression to Lower Respiratory Tract Disease
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
Beyond the Threshold: Impact of and Assumptions Related to Modeling Continuous Data in HCT
Gooptu, M.
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Gopal, A. K.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Review the Current Use of Bone Marrow Transplantation for Patients with Lymphoma
Gordeuk, V.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Gordon, L. I.
Stem Cell Infusion Adverse Reaction (SCIAR). a Review of Published Literature from Recent Years
Gore, L.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Gorin, N.
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Gormley, N.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Gorospe, G.
Pre-Transplant Caregiver Education for out-Patient Multiple Myeloma Hematopoeitic Transplant Admission in New Day Hospital: Caregiver Role and Contract in Outpatient Transplant Patient Care
Gosselin, T.
Distress Screening - CoC Requirements
Gottsacker, C.
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Gottschalk, S.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Gottschalk, S.
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Gounopoulos, S.
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Goyal, M.
Grading Acute GVHD: Getting It Right Every Time!
Goyal, R. K.
Grading Acute GVHD: Getting It Right Every Time!
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Goyal, S. D.
Donor Derived Systemic Lupus Erythematosus (SLE) after Allogeneic Transplantation
Cerebral Venous Thrombosis after Autologous Stem Cell Transplantation
A Single Center Survey of Distress Amongst Bone Marrow Transplant Recipients
Rhythmic Entrainment: A Music Therapy Intervention to Elicit Relaxation and Decrease Anxiety for the Bone Marrow Transplant Recipient
Grady, L.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Graf, S. A.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Gramatzki, M.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Granata, A.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Grandage, V.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Graubert, T.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Green, D. J.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Green, M. L.
Recurrent Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT): Incidence, Clinical Manifestations, Risk Factors and Outcome
Green, M. M. B.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Greene, J.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Greene, K.
Ensuring Quality and Standardizing Care for BMT Patients in an Expanding Program
Greenwood, M.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Greer, J.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Gregianin, L.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Gresh, R. C.
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Gress, R.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Griesemer, A.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Griffin, J.
Nurse-Initiated Protocol for Central Venous Catheter (CVC) Selection for Blood and Marrow Transplant (BMT) Recipients
Griffith, L. M.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Griffith, M.
C. the Difference with Steriplex
Grimley, M. S.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Grobe, C.
Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Grochowski, D. L.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Groff, P.
Follow-up of Related Stem Cell Donors One Week Post Donation
Optimizing Transplant Ambulatory Care Utilizing Multidisciplinary Rounds
Grossman, A.
Decreasing Clostirdium Difficile Infection Rates through Enhanced Practice Guidelines
Grossman, B.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Grosso, D.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Grosveld, G.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Gruenewald, T.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Grunebaum, E.
Presentation and Outcome of Zap 70 Deficiency
Grupp, S. A.
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Cellular Therapies: Breakthrough Treatment?
Guclu, M. B.
Determinants of Physical Activity Levels in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Guinan, E.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Gulbis, A.
Levofloxacin Versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation
Gungor, T.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Gupta, A.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Gupta, A.
Encouraging Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation - Single Centre Experience from Resource Poor Country
Gupta, J.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
Gupta, V.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Stem Cell Transplantation for Myelofibrosis in the Era of JAK Inhibitors
Identifying the Risk Factors and Optimal Timing of HCT Myelofibrosis
Gurevitch, J. H.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Gurney, J.
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Gushiken, F.
Contributing Factors to Renal Dysfunction during Engraftment Syndrome
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Gustafsson, B.
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Gutman, J. A.
A Phase 2 Study of the Hedgehog Pathway Smoothened Inhibitor PF-04449913 to Reduce Relapse in High Risk Acute Leukemia and MDS Patients Following Allogeneic Stem Cell Transplantation
Gyurkocza, B.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

H

Ha, D. R.
Combination Antifungal Therapy Experience at an Academic Health System
Posaconazole DR Tablet Serum Concentrations in the Bone Marrow Transplant Population: Association with Prevention or Treatment of Invasive Fungal Infections
Haagenson, M.
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Hacker, E. D.
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective
Haddad, E.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Hahn, T.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
(CIBMTR Working Committee) Health Services and International Issues
Haile, D. J.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Haines, H.
Use of Double Lumen Central Venous Cathethers for Hematopoeitic Stem Cell Pheresis
Hakim, F.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Hale, G. A.
(CIBMTR Working Committee) Pediatric Cancer
Haley, R.
Use of Laboratory Data to Enhance Donor Experience and Implement a New Collection Device for HPC, Apheresis
Hall, C.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Hall, M.
Trend, Risk Factors and Outcome of Respiratory Syncytial Viral Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review
Hall, S.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Hallek, M.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Halverson, D.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Hamadani, M.
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Hamblin, F.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Hamby, C.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Hamerschlak, N.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Hamidieh, A. A.
Comparing the Results of Non-TBI Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) with and without CNS Involvement
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
The Safety of Granulocyte Colony Stimulating Factor (G-CSF) Administration in Pediatric Donors before Peripheral Hematopoietic Stem Cell Donation
Hamilton, B. K.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Hanash, A. M.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Hanauer, D.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Hanbali, A.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Hanby, C.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Hanchett, S.
Improving Transitions from the Inpatient to Outpatient Setting in BMT Patients
Handgretinger, R.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Hankins, S.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Hanley, P. J.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
Hanna, R.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Hannah, A.
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Hansen, B.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Hansen, J. A.
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Hanson, I. C.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Harada, M.
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Harbi, S.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Harden, K. L.
Discharge Essentials: A Program for Preparing Adult Blood and Marrow Transplant Patients for Self -Care after Transplant
Happy Birthday…Again: Educating BMT Nurses and Patients about Infusion of Stem Cells
Early Intervention with HSCT Patients to Improve Access to and Knowledge of Palliative Care
Hari, P. N.
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Introduction
The Increased Use of Stem Cell Transplantation in Combination with JAK Inhibitor Treatment
BMT Tandem Saturday Concurrent Luncheon Symposium: Risk Factors and New Methods for Treatment of Myelofibrosis: Transplantation in the Era of JAK Inhibitors
Harris, A. C.
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Harris, E.
Engraftment in Sibling Allogeneic Stem Cell Transplant Recipients Following the Change in Bone Marrow Collection Devices
Harrison, L.
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Hasan, A. N.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Hashida, R.
Effect of Linozolid Administration on Myeloid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation
Hashimoto, D.
Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation
Hashmi, S.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
A Study of Dietary Intake and the Relationship to Neutrophil Engraftment Among Outpatient Hematopoietic Stem Cell Transplant Patients with Multiple Myeloma
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
How Suppressed is Suppressed Enough? Present and Future Trends in Immune Suppression
Haslam, D.
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Hassoun, H.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Haste, N.
Combination Antifungal Therapy Experience at an Academic Health System
Posaconazole DR Tablet Serum Concentrations in the Bone Marrow Transplant Population: Association with Prevention or Treatment of Invasive Fungal Infections
Hathcock, M.
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Haugh, J.
The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease
Hauptfeld, V.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Hausfeld, J.
Outcomes Resilience after System Stress: A Rapid-Cycle Response to Mitigate the Impact of Care Delivery System Stress on Primary Blood Stream Infections
Haut, P.
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Hauzenberger, D.
HLA-C Mismatch without Impact on Outcome after Allogeneic HSCT
Haven, D.
Are You Connected? Social Media, Transplant and YOU!
Haverkos, B.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Havey, C.
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Havlicek, J. P.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Hawkins, D.
Outcomes Resilience after System Stress: A Rapid-Cycle Response to Mitigate the Impact of Care Delivery System Stress on Primary Blood Stream Infections
Increasing Adls Is Easy As 1-2-3
Hawks, K.
Overview
Wrap-up
Hayashi, R. J.
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Hayes, C. A.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Hayes, J.
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Hayes,, C.
Bendamustine-Brentuximab: Bridging to Transplant
Hayes-Lattin, B.
Targeting BCL-2 and BCR-Abl Activity in Ph+ALL
Hayman, S.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Haynes, A.
Presentation and Outcome of Zap 70 Deficiency
Hayward, M.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
He, F.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
He, J.
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Heemskerk, M.
Upregulation of Class I MHC on Neuroblastoma Cells By NK Cell Exposure for Enhanced CTL Reactivity
Hefazi, M.
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Heh, J.
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Heimall, J.
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Heimgartner, J. R.
A Study of Dietary Intake and the Relationship to Neutrophil Engraftment Among Outpatient Hematopoietic Stem Cell Transplant Patients with Multiple Myeloma
Heissenbuttel, A.
Providing a Safety Net for Bone Marrow Transplant (BMT) Survivors: Nurses and Telephone Triage
Helenowski, I.
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Helmut, H.
Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia
Hemmati, P.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Hemmelgarn, T.
Intravenous Pentamidine for Pneumocystis Carinii/Jiroveci Pneumonia (PCP) Prophylaxis
Hempel, G.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Heras, I.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Hernandez-Reyes, J. A.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Herrera, J. M.
Unmanipulated Bone Marrow As Third Party Donor for Unrelated Cord Blood Transplant Decreases 100-Day Mortality in Children
Herrera, P.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Herrera-Rojas, M. A.
Reduced-Intensity Stem Cell Allografting for PNH Patients in the Eculizumab Era: The Mexican Experience
Herscovici, K.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Hershfield, M.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Heslop, H. E.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Innovative Technologies in BMT
Hexner, E. O.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Hickstein, D.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Hiemenz, J.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Hilden, P.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Hill, B.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Hillgruber, R.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Hillmen, P.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Hinshaw, B.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Hippen, K.
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Hiregange, M.
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Hirokawa, M.
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Hiroshima, Y.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Hirsch, R.
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
Hiwarkar, P.
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Ho, V. T.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
Update from the EMR Interoperability Working Group
Ho, Y. S.
Race Influences the Response to Conventional Induction Chemotherapy in Asian Patients with Acute Myeloid Leukemia
Hochberg, J.
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Hoenig, M.
Presentation and Outcome of Zap 70 Deficiency
Hoffman, M. R.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Hoffmann, R.
(CEC) NP/PA Oral Abstract Presentation/Award
Hogan, W.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
A Study of Dietary Intake and the Relationship to Neutrophil Engraftment Among Outpatient Hematopoietic Stem Cell Transplant Patients with Multiple Myeloma
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Hogg, M. Sr.
Identifying the Need for a Regional Nurse–Led Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) Late Effects Follow up Program
Hohwart, C.
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Hollowell, S.
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Holmberg, L.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Holmes, S.
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Incidence and Outcome of Rhinovirus in Children Undergoing Hematopoietic Stem Cell Transplantation
Holowiecki, J.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Holtan, S.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Placental Growth Factor (PlGF) in Allogeneic Hematopoietic Cell Transplantation (HCT): Clinical, Immunologic, and Pathologic Correlates
Holter Chakrabarty, J.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Holtmann, M.
Production, Implementation, and Utilization of a Multidisciplinary Assessment for Those Undergoing Hematopoietic Cell Transplantation
Holtzapfel, C.
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Honda, K.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
Hongeng, S.
Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases
Bacteremia during Neutropenic Episodes in Children Underwent Hematopoietic Stem Cell Transplantation Receiving Ciprofloxacin and Penicillin Prophylaxis
Hoover, E.
Coordinator Perspective: Managing a Research Subject in a Clinical Environment
Hopps, S.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Horan, J.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
A Multi-Institutional Retrospective Data Analysis of Hematopoietic Cell Transplantation for Less Severe Sickle Cell Disease
Horn, B.
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Horowitz, J. G.
Tbo-Filgrastim Versus Filgrastim during Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation
Horowitz, M. M.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Breakfast with Mary M. Horowitz, MD, MS
How to Get the Most Out of Mentorship
ASBMT President's Symposium: Panel Discussion
Horton, B. J.
Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused
Horwitz, M. E.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Oral Abstracts - Session B - Allogeneic Transplants
Hosing, C.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Hossain, N. M.
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Hosseini, A. S.
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
The Safety of Granulocyte Colony Stimulating Factor (G-CSF) Administration in Pediatric Donors before Peripheral Hematopoietic Stem Cell Donation
Hou, G.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Hou, K.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Hough, R.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Hourigan, C. S.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Hovgaard, D.
Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
Howe, K. A.
Registry Efforts to Improve Success of Unrelated Donor Searching for African American Patients
Howell, J. C.
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Hrnicek, A. K.
Improving Channels of Communication to Ensure Multidisciplinary Knowledge and Participation in BMT Quality and Process Improvement
Hsieh, L.
Successful Treatment of Secondary Graft Failure Following Unrelated Cord Blood Transplant with Hematopoietic Growth Factors in a Patient with Fanconi Anemia
Hsieh, M.
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Hsu, J. W.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Hsu, J.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Hu, K.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Hu, Z. H.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Hua, G.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Huang, X.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Huang, Y. T.
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Cluster of Fulminant Toxoplasmosis in T-Cell Depleted (TCD) and Cord Blood (CB) Stem Cell Transplant (SCT) Recipients: Impact of Aggressive Prophylaxis and Routine Monitoring By Toxoplasma PCR for High Risk Patients
Hudspeth, M.
Emergent Substitution of Fludarabine for Cyclophosphamide Due to Acute Cardiac Toxicity during Conditioning with Successful Engraftment
Limited Role of Sinus CT in the Management of Febrile Allogeneic Pediatric HSCT Recipients
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Late Onset Pulmonary Arterial Hypertension after Successful HSCT for Familial HLH
Huebner, D.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Huenecke, S.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Huffman, A. P.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Pharamacodynamic Assessment Shows That CCR5 Surface Expression May Serve As an Indicator for Effective CCR5 Blockade in Allogeneic Stem Cell Transplant (alloSCT) Recipients Treated with Maraviroc
Hulskotte, E.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Hume, R.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Hunder, N. N. H.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Hunger, S.
Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Hunt, T.
Panel Discussion: GVHD and Co-Morbidities
Huntsinger, L.
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
HSCT Education: Bridging the Gap
Hurd, D.
Abstract 5246: Comparison of Outcomes of Two Preparative Regimens for Lymphoma Patients Who Are Receiving Autologous Hematopoietic Stem Cell Transplantations
Hussein, A. A.
Incidence and Risk Factors of Bacterial Infections in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation
Incidence of CMV Reactivation and Infection in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation in High CMV Exposure Population
Hutcherson, D.
Preparative Regimens Debate: BuCy Versus BuFlu for Myeloid Malignancies
Huynh, V.
Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients
Hwang, J.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Hwang, W. T.
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Hwang, W. Y. K.
Race Influences the Response to Conventional Induction Chemotherapy in Asian Patients with Acute Myeloid Leukemia
Hylton, H. M.
Management of Cytokine Release Syndrome (CRS) in Patients Undergoing Chimeric Antigen Receptor Modified (CAR) T-Cell Therapy Following Autologous Stem Cell Transplant (ASCT)

I

Ibrahim, K.
Combination Antiretroviral Therapy during Autologous Stem Cell Transplant for HIV Infected Patients with Haematological Malignancies
Ibrahim, K. T.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Ibrahimova, A.
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Ichikawa, N.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Ichinohe, T.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Igarashi, A.
The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Igarashi, R. Y.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Ikeda, M.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Ikegame, K.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model
Im, J. S.
CD4+CD25+ Invariant Natural Killer T Cells Are Enriched in Cord Blood: Implication on Immune-Regulation
Imlay-Gillespie, L.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Inamoto, Y.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Innis-Shelton, R.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
SGN-CD33A: Case Reports of Anti-Leukemic Activity and Bridge to Allogeneic Stem Cell Transplant (SCT) in Patients with Acute Myeloid Leukemia (AML)
Inoue, M.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Inoue, T.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Inoue, Y.
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Inwards, D. J.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
CXCR4 Expression in Mantle Cell Lymphoma and Mobilization with Plerixafor for ASCT Does Not Negatively Impact Progression-Free Survival
Ippoliti, C.
Weight Based Plerixafor Dosing Reduces Side Effects in Stem Cell Mobilization
Irby, S.
Related Donor Screening: An Increasingly Complex Process
Ishida, T.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Ishii, K.
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Comprehensive Meta-Analysis
Ishii, S.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Ishikawa, J.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Ishiwata, K.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Isola, L.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Bendamustine-Brentuximab: Bridging to Transplant
Israel, D.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Israeli, M.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Itamura, H.
The MEK Inhibitior Trametinib Selectively Suppresses Gvhd, While Sparing GVT Effects
Ito, R.
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Ito, S.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Itoyama, T.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Ivanov, J.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Ivanova, A.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Ivanova, L.
Rescue of the Mucocutaneous Manifestations in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa (RDEB) By Human Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs)
Izutsu, K.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases

J

Jabbour, E.
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Jacks, D. I.
Predictors and Outcomes of Intensive Care Utilization in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant at Mayo Clinic, Florida
Jackson, J. E.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Jackson, M. L.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Jackson, V.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Jacob, E. K.
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Jacobberger, J.
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
Jacobs, J.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
Jacobsen, P.
Risk Factors for Depression and Fatigue Among Hematopoietic Cell Transplant (HCT) Recipients
Jacobsohn, D. A.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Serotherapy with Alemtuzumab but Not ATG Is Associated with Increased Adenovirus Infection in Pediatric Recipients of Cord Blood Grafts
Jacobson, A. K.
Falls in BMT Patients
Jagadeesh, D.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Jagasia, M. H.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Jaglowski, S.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Jahagirdar, B.
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Jain, A.
Title - Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of “Late” Alemtuzumab
Jain, N. A.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Jain, N.
Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Haematopoietic Stem Cell Transplantation- a Single Center Experience
Jain, R.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Jain, T.
Cytomegalovirus (CMV) Infection in Autologous Stem Cell Transplant (ASCT) Recipients in the Era of Rituximab (R) Use
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Jaiswal, S.
Developing a Haploidentical Transplant Program: An Indian Experience
Pretransplant Sirolimus Improves Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Patients with Severe Aplastic Anemia
Jakubowski, A. A.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Related Donor Screening: An Increasingly Complex Process
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Cluster of Fulminant Toxoplasmosis in T-Cell Depleted (TCD) and Cord Blood (CB) Stem Cell Transplant (SCT) Recipients: Impact of Aggressive Prophylaxis and Routine Monitoring By Toxoplasma PCR for High Risk Patients
Jalali, A.
Comparing the Results of Non-TBI Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) with and without CNS Involvement
James, B.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
James, C.
Combination Antifungal Therapy Experience at an Academic Health System
Posaconazole DR Tablet Serum Concentrations in the Bone Marrow Transplant Population: Association with Prevention or Treatment of Invasive Fungal Infections
Jamieson, K.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Janakiraman, N.
Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Acute Skin Graft Versus Host Disease Post Liver Transplantation: A Case Report
Jannini, F. D. N.
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Janowski, W.
Identifying the Need for a Regional Nurse–Led Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) Late Effects Follow up Program
Janusek, M.
Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
Jara, V.
Bone Health Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Characteristics and Preliminary Clinical Results of a Cohort of Patients in Santiago, Chile, Undergoing Haploidentical Hematopoietic Cell Transplantation with Postransplant Cyclophosphamide
Jarisch, A.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Jaroscak, J. J.
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Jefferies, J. L.
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Jehn, C.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Jenkins, T.
Ensuring Quality and Standardizing Care for BMT Patients in an Expanding Program
Jennings, L.
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Jennissen, C.
Best Practices: Immunization Strategies and Monitoring
Jenq, R.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Jerome, K. R.
Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients: Seasonality and Factors Associated with Progression to Lower Respiratory Tract Disease
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Jhanwar, S.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Ji, J.
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Jia, C.
Biomimetic Nanofibrous Mesh for Long-Term Preservation of Intestinal Epithelial Cells
Jiao, Y.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Jim, H.
Risk Factors for Depression and Fatigue Among Hematopoietic Cell Transplant (HCT) Recipients
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Jimenez, A. M.
Severe Mucositis with Bendamustine Etoposide Ara-C and Melphalan (Be-EAM) As Conditioning Regimen in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (AutoSCT)
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Jin, Z.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
The Significance of Daily Blood Cultures in Febrile Pediatric Hematopoietic Cell Transplant Recipients
Joaquin, J.
Weight Based Plerixafor Dosing Reduces Side Effects in Stem Cell Mobilization
Jodele, S.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
John, J.
Cytomegalovirus (CMV) Infection in Autologous Stem Cell Transplant (ASCT) Recipients in the Era of Rituximab (R) Use
John, J. M.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
John, T.
Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients
Johns, A.
Engraftment Failure or Aplastic Anemia: A Case Report
Johnston, L.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
Prevalence of Vitamin D Deficiency in Allogeneic HCT Recipients and Its Association with Graft Versus Host Disease
Johnston, P. B.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
CXCR4 Expression in Mantle Cell Lymphoma and Mobilization with Plerixafor for ASCT Does Not Negatively Impact Progression-Free Survival
Jol-van der Zijde, C. M.
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Jones, L. W.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Jones, R. J.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Jones, R. B.
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Jones, S. A.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Jordan, M. B.
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Jorgensen, J. L.
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Joshi, N.
Serotherapy with Alemtuzumab but Not ATG Is Associated with Increased Adenovirus Infection in Pediatric Recipients of Cord Blood Grafts
Jourdan, D.
The Perceived Value of the Case Manager Role By Blood and Marrow Transplant Patients
Development and Usage of Algorithms Demonstrate Cost Savings and Increased Efficiency in Peripheral Blood Stem Cell Mobilization and Collection
Jovanovic, B.
Impact of High-Resolution Typing for HLA-a, -B, -C and -DRB1 on Single-Unit Cord Blood Transplantation in Pediatric Patients
Ju, W. G.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Juarez, F.
Association of Polymorphisms in the HLA-C Locus with Disease Risk for Developing Acute Graft Vs. Host in Pediatric Patients with Allogeneic Hematopoietic Stem Cell
Juckett, M. B.
Difficult Conversations: Informed Consent and Advanced Care Planning
Discussing Serious News
June, C. H.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
New CARs and Used CARs for Leukemia and Beyond
E. Donnall Thomas Lecture
Justman, H. A.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Jyonouchi, S.
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency

K

Kabootari, M.
Comparing the Results of Non-TBI Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) with and without CNS Involvement
Kagaya, Y.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Kageyama, K.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Kahle, N.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Kahn, J.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Kaida, K.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Kaipe, H.
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Kaiume, H.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Kaji, D.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Kakihana, K.
The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Kakinuma, H.
Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines
Kalaycio, M. E.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
(CIBMTR Working Committee) Chronic Leukemia
Kalbacker, M.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
System Capacity Initiative Social Work Workforce Working Group
Kalpatthi, R.
Trend, Risk Factors and Outcome of Respiratory Syncytial Viral Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review
Kam, T.
Preparation of the New Graduate RN for Care of the Hematopoietic Cell Transplant Patient:: An Orientation Reconstruction Story
Kamani, N. R.
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Kambayashi, T.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Kamdar, M.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Kaminski, K.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Kamishohara, M.
Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines
Kanakry, C. G.
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Kanamori, H.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Kanaya, M.
CD155 Regulates Regulatory T Cell Population and Attenuates Acute Graft-Versus-Host Disease
Kanda, J.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Kanda, Y.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Kandula, V.
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Kane, M.
Bendamustine-Brentuximab: Bridging to Transplant
Kang, G.
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Kang, Y.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Kantarjian, H.
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Kantesaria, B.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Kao, G.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
Kapadia, E.
A Case Series of Related Bone Marrow Donors with Prolonged Prothrombin Times but No Perioperative Bleeding Complications
Kapke, J.
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Kaplan, I.
Ensuring Quality and Standardizing Care for BMT Patients in an Expanding Program
Kaplan, L. D.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Kapoor, J.
Encouraging Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation - Single Centre Experience from Resource Poor Country
Kapoor, N.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Presentation and Outcome of Zap 70 Deficiency
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
(CIBMTR Working Committee) Primary Immune Deficiencies, Inborn Errors of Metabolism and Other Non-Malignant Marrow Disorders
Kapoor, P.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Kapoor, V.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Karamehmet, E.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
Karavalakis, G.
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Kariya, R.
The MEK Inhibitior Trametinib Selectively Suppresses Gvhd, While Sparing GVT Effects
Kasner, M.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Katari, U. L.
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Katic, M.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Katigbak, K.
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
Kato, J.
Effect of Linozolid Administration on Myeloid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation
Transplant-Acquired Food Allergy Following Cord Blood Transplantation in Adult Patients
Kato, K.
Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Kato, K.
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Kato, M.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Kato, Y.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Katz, D.
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Kauffman, K.
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Kaul, E.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
Kavanagh, E. R.
Placental Growth Factor (PlGF) in Allogeneic Hematopoietic Cell Transplantation (HCT): Clinical, Immunologic, and Pathologic Correlates
Kawashima, N.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Kean, L. S.
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
T-Cell Transcriptome Analysis Reveals the Mechanisms Controlling Synergy Between Costimulation Blockade and mTOR Inhibition during Gvhd Prevention
Keating, A.
Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model
Keating, M.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Kebriaei, P.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Keenan, T.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Keever-Taylor, C.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Kekre, N.
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Comprehensive Meta-Analysis
Keller, J.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Keller, M. D.
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
Kelley, L.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Kelly, K. P.
The Perspectives of Stakeholders in Pursuing Hematopoietic Stem Cell Transplantation in Children and Adolescents: An Integrative Review
Kemp, T. J.
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
Kenderian, S. S.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Kendrick, S.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Kennedy, L.
Abstract 5246: Comparison of Outcomes of Two Preparative Regimens for Lymphoma Patients Who Are Receiving Autologous Hematopoietic Stem Cell Transplantations
Kernan, N. A.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Kerr, A.
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Kerridge, I.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Ketterling, R.
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Keyzner, A.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Bendamustine-Brentuximab: Bridging to Transplant
Keyzner, A.
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Khaled, S. K.
SGN-CD33A: Case Reports of Anti-Leukemic Activity and Bridge to Allogeneic Stem Cell Transplant (SCT) in Patients with Acute Myeloid Leukemia (AML)
Khaled, Y.
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients with Hematological Remission and Full Chimerism at Day 30
Khalid, S.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Khan, F.
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
Khan, M. K.
Factors Influencing Pulmonary Toxicity in the Setting of Total Body Irradiation-Based Myeloablative Conditioning in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Khan, S.
Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed By Autologous Stem Cell Transplantation: Experience at Skmch Lahore
Khan, S.
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Khan, T.
Preparation of the New Graduate RN for Care of the Hematopoietic Cell Transplant Patient:: An Orientation Reconstruction Story
Khan, T.
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Khandelwal, P.
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Kharfan-Dabaja, M.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Khattry, N.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Khazal, S.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Khera, N.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Khoein, B.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Khorana, A.
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
Khouri, I. F.
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Khoury, H. J.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Khuu, H.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Kiefer, D. M.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
Registry Efforts to Improve Success of Unrelated Donor Searching for African American Patients
Kiel, P.
Immune Reconstitution in HCT
Killock, D. M.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Kim, A.
Voriconazole Therapeutic Drug Monitoring in a Pediatric Hematopoietic Stem Cell Transplant Center
Pharmacoeconomic Impact of Thiotepa-Containing Conditioning Regimens in a Pediatric Hematopoetic Stem Cell Transplant Center
Kim, D.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Kim, G.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Kim, H. T.
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Clinical Endpoints in Allogeneic Hematopoietic Stem Cell Transplantation
Kim, H.
CXCR4 Expression in Mantle Cell Lymphoma and Mobilization with Plerixafor for ASCT Does Not Negatively Impact Progression-Free Survival
Kim, H. J.
Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model
Kim, J.
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Kim, S. W.
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Kim, S.
Factors Influencing Pulmonary Toxicity in the Setting of Total Body Irradiation-Based Myeloablative Conditioning in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Kimura, S.
The MEK Inhibitior Trametinib Selectively Suppresses Gvhd, While Sparing GVT Effects
Kindwall-Keller, T. L.
Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
King, R. J.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Consent
Kiniyalocts, S.
Increasing Adls Is Easy As 1-2-3
Kipgen, D.
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
Kirihara, T.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Kirov, I.
Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients
Kissell, D.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Kitko, C. L.
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Oral Abstracts - Session G - Pediatric Disorders
(CIBMTR Working Committee) Pediatric Cancer
Klaassen, J.
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Klein, A. K.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma
Klein, E.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Klein, L. M.
Single Donor Vs. Acrodose Platelets in Oncology Patients: A Single Institutional Experience
Klein, O.
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Klein-Geltink, R. I.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Klemp, K.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Klepac Pulanic, T.
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Kletzel, M.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Incidence and Risk Factors for Metabolic Syndrome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients- a Tertiary Care Center Experience
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Klichinsky, M.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Klingebiel, T. E.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Klingemann, H. G.
A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma
Klinger, M.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Klisovic, R.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Klumpp, T.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Knibbe, C. A.
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Knight, J.
Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences
Knight, R. J.
Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
Knudsen, A.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Knust, K.
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Kobayashi, H.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Kobayashi, H.
Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines
Kobayashi, T.
The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Kobos, R.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Kobulnicky, J.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Kobusingye, H.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Kodali, S.
Allogeneic Stem Cell Transplant Improves the Outcome of Patients with Acute Erythroleukemia: Single Center Analysis
Experience with Administration of Ruxolitinib after Allogeneic Stem Cell Transplantation (alloSCT) in Patients with Myelofibrosis
Kodera, Y.
CIBMTR Distinguished Service Award
Introduction
WBMT International Session: Global Donor Selection Challenges: Clinical Efficacy and Cost Performance
Oral Abstracts - Session K - Histocompatibility & Clinical Cellular Therapy
Koehne, G.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Koehne, G.
Cluster of Fulminant Toxoplasmosis in T-Cell Depleted (TCD) and Cord Blood (CB) Stem Cell Transplant (SCT) Recipients: Impact of Aggressive Prophylaxis and Routine Monitoring By Toxoplasma PCR for High Risk Patients
Koenig, M. K.
Spinal Cord Injection of Stem Cells for Pediatric ALS
Koh, A. Y.
Increased Incidence of Fatigue in Pediatric Hematopoetic STEM CELL Transplant Recipients
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Incidence and Outcome of Rhinovirus in Children Undergoing Hematopoietic Stem Cell Transplantation
Kohashi, S.
Effect of Linozolid Administration on Myeloid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation
Transplant-Acquired Food Allergy Following Cord Blood Transplantation in Adult Patients
Kohn, D. B.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Kohn, D. B.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Koklanaris, E.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Kokturk, N.
The Role of Tuberculin Skin Test As a Guide to Preventive Chemotherapy for Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplantation in a Region with Intermediate Prevalence and Routine BCG Vaccination: A Preliminary Report from Turkey
Kolb, E. A.
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Kolesnick, R.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Koliski, A.
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Kolitsopoulos, Y.
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Kolk, M.
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
Kollen, W.
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
Komanduri, K. V.
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
In Situ Manipulation of Tregs Via Combined IL-2 and TNFRSF25 Signaling Pre- and Post-Transplant: A Novel Approach to Regulate Gvhd By Marked Expansion of CD4+Foxp3+ T Cells
The MEK Inhibitior Trametinib Selectively Suppresses Gvhd, While Sparing GVT Effects
BMT Tandem Meetings Best Abstracts
Komatsubara, H.
Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines
Kondo, T.
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Kong, K. A.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Konstantinou, V.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Koons, C.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Koontz, S.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Koreth, J.
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Making PROGRESS: Updates from I and II GVHD Prophylaxis Studies
Oral Abstracts - Session E - GVH/GVL
Korngold, R.
Immune Reconstitution Analysis of Patients Undergoing Extracorporeal Photopheresis for the Treatment of Chronic Graft-Versus-Host Disease
Biomimetic Nanofibrous Mesh for Long-Term Preservation of Intestinal Epithelial Cells
Korula, A.
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Koshy, M.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Kosuri, S.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Kotecha, A.
Cytomegalovirus (CMV) Infection in Autologous Stem Cell Transplant (ASCT) Recipients in the Era of Rituximab (R) Use
Kothari, A.
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Koura, D.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Kozlova, A.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Kraft, W.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Krajewski, J.
The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease
Krajinovic, M.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Kramer, C.
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Kramer, K.
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Kramer, M.
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Krance, R. A.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Kraus, T.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Kreissman, S. G.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Kremers, W. K.
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Krenn, T.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Kreuter, J. D.
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Kreyenberg, H.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Krishnadasan, R.
Retrospective Review of Intravenous Pentamidine for Pneumocystis Pneumonia Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
Krishnamurti, L.
Sickle Cell/Thalassemia
Krishnan, A. Y.
"Salvage" Hematopoietic Cell Transplants for Multiple Myeloma
Case 3: Assessing the Case for Early Stem-Cell Transplantation
Recognizing VOD in the Transplant Setting: Risk Factors, Clinical Signs, and Beyond
Sat Lunch Introduction
Advances in Transplantation for Myeloma
BMT Tandem Saturday Concurrent Luncheon Symposium: Management of Multiple Myeloma: A Case-Based Discussion of the Role of Transplantation in Improving Patient Outcomes
(CIBMTR Working Committee) Plasma Cell Disorders and Adult Solid Tumors
Krivoy, M.
Implementation of Chemotherapy Order and Administration Checklists Ensures Adherence to National Chemotherapy Guidelines
Kröger, N.
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Kroning, C. M.
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Kropf, P. L.
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Kuba, L.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Kuball, J.
ALPHA/Beta T- CELL Depleted Allogeneic STEM CELL Transplantation from Matched Related and Unrelated DONOR Grafts in Patients with Poor Risk Leukemia
Kubota, A.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Kukreti, V.
Building a Quality Plan for a Blood and Marrow Transplant Program: Quality Framework and Indicator Development
Kumar, A.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Kumar, D.
The Clinical Utility of CMV specific IGRAs for Determining Protection Against CMV
Kumar, L.
Cyclophosphamide Followed By Busulphan in Place of Standard BuCy Regimen for Patients Undergoing Allogeneic Stem Cell Transplantation: A Preliminary Experience from a Single Centre in India
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Kumar, S. V.
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Kumar, S.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Case 2: The Role of Novel Agents as Consolidation and Maintenance Therapy following HDT/ASCT
Kündgen, L.
Complete Loss of HLA Class I Heterozygosity in a Patient with Acute Myeloid Leukemia
Kung, A.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
Kuo, L.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Kurahashi, S.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Kurdziel, K.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Kuriakose, E.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Kurihara, T. Jr.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Kurlander, R.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Kurokawa, M.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Kurosawa, S.
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Kurre, J.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
Kurtzberg, J.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
CBA
Kuruc, J.
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Kurup, S.
Chronic Graft Vs. Host Disease of the CNS - a Rare Autopsied Case
Kuruvilla, J.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Kutchmarek, B.
Outpatient Transplant Management Affects ANC Recovery Data Endpoin
Kuwahara, C.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Kuwatsuka, Y.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Kuypers, J. M.
Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients: Seasonality and Factors Associated with Progression to Lower Respiratory Tract Disease
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Kuzmuk, K.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Kwiatkowski, A.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Kwon, M.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Kwong, C. Y.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Kyle, R.
A Tribute To The Pioneers Who Brought Us Here: Testimony From BMT's Longest Survivor and Her Physician
Kyrcz-Krzemien, S.
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT

L

L'Heureux, J.
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Labastida-Mercado, N.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Reduced-Intensity Stem Cell Allografting for PNH Patients in the Eculizumab Era: The Mexican Experience
Labopin, M.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Is There a Stronger Graft-Versus-Leukemia Effect Using HLA-Haplo-Identical Donors Compared to HLA-Identical Sibling Donors?
Lacy, M.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Ladas, E. J.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Ladenstein, R.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Risk and Benefits of High Dose Treatment with Busulphan-Melphalan in High Risk Neuroblastoma: The European Experience
Ladomenou, F.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Laird, V.
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
The Significance of Daily Blood Cultures in Febrile Pediatric Hematopoietic Cell Transplant Recipients
Lake, K. E.
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
A Pilot Study of Donor Enteral Human Milk to Modulate the Gut Microbiome in Children Receiving Stem Cell Transplant
Lakshmi, K.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Lalmohamed, A.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Lam, S.
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Lamb, L.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
Lamprecht, M.
Levofloxacin Prophylaxis for Multiple Myeloma Patients Undergoing Autologous Transplant
Landau, H.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Landgren, O.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Landry, C.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Lane, A.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Lang, P.
Alpha/Beta TCR T-Cell Depleted Haploidentical HCT
Langston, A.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Lankester, A.
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
LaPlant, B.
CXCR4 Expression in Mantle Cell Lymphoma and Mobilization with Plerixafor for ASCT Does Not Negatively Impact Progression-Free Survival
Laport, G. G.
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Does Hematopoietic Cell Transplantation Impact PTCL?
BMT CTN 0701 Primary Results
Progress in Peripheral T-Cell Lymphoma
Oral Abstracts - Session M - Lymphoma/Multiple Myeloma & Leukemia
Lapteva, N.
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Larsen, E. K.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Laskin, B.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Lassiter, M.
Alternative to Inpatient Transplants
Latchford, T.
Ensuring Quality and Standardizing Care for BMT Patients in an Expanding Program
Lathrop, J. T.
ASBMT President's Symposium: Panel Discussion
Lauer, E.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Laughlin, M. J.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Laureys, G.
Pharmaceutical Care for Pediatric Oncology and Hematopoietic Stem Cell Transplantation Patients: Need for Education and Training
Lawrence, G.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Lawson, A.
2015 BMT Pharmacists Conference at the BMT Tandem Meetings: Welcome and Overview
Lazarus, H. M.
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
Lazaryan, A.
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Pre-Transplant Consolidation Chemotherapy for Acute Lymphocytic Leukemia (ALL) Does Not Impact Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Le, R. Q.
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Blood Stream Infection Is Frequent during Conditioning but Does Not Impact Allogeneic Transplant Outcomes in the Modern Era
Minor ABO Incompatibility Does Not Impact Non-Relapse Mortality in T-Cell Depleted HLA-Matched Sibling Transplantation
Leal Bento, M.
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Leboulch, P.
Early Results of a Phase I/ II Study of Gene Therapy for ß -Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-Vivo with a Lentiviral ß AT87Q -Globin Vector
Lebovic, R.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Ledesma, C.
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Lee, D. W.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Lee, D.
NOVEL Strategy to Enhance NK CELL Activity
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Lee, E.
Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
Lee, E. J.
Preventive Care Adherence and Associated Factors in a National Sample of Hematopoietic Cell Transplantation (HCT) Survivors Recruited for an Online Randomized Controlled Trial (RCT)
Lee, J. B. L.
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
Lee, L. E.
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Lee, M.
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
Lee, M.
Factors Associated with CMV Disease in Pediatric Hematopoietic Stem Cell Transplantation
Lee, M. N.
CMS Reimbursement Topic
Lee, S. J.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
A Biomarker Panel for Chronic Graft-Versus-Host Disease
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Risk Factors for Depression and Fatigue Among Hematopoietic Cell Transplant (HCT) Recipients
The Impact of Oral Chronic Graft-Versus-Host Disease on Global Measures of Quality of Life
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Leemhuis, T.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Leen, A. M.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
LeFever, A. V.
Stem Cell Infusion Adverse Reaction (SCIAR). a Review of Published Literature from Recent Years
Lehmann, L. E.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Factors Associated with CMV Disease in Pediatric Hematopoietic Stem Cell Transplantation
Lehner, J.
Use of Laboratory Data to Enhance Donor Experience and Implement a New Collection Device for HPC, Apheresis
Leiby, B.
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Leifer, L. J.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Leis, J.
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Leise, M.
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Leisenring, W.
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Leitman, S. F.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
LeMaistre, C. F.
A Network Approach to Standardization of BMT Pathways
A Network Approach to Creation and Maintenance of Standardized Standard Operating Procedures
Lemarie, C.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Lemberg, K.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Lendvai, N.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Lenihan, D.
Cardiovascular Considerations in HCT
Leonard, J. T.
Targeting BCL-2 and BCR-Abl Activity in Ph+ALL
Placental Growth Factor (PlGF) in Allogeneic Hematopoietic Cell Transplantation (HCT): Clinical, Immunologic, and Pathologic Correlates
Leslie, J.
Infectious Diseases Update
Lesokhin, A. M.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
LeStrange, N. J.
Related Donor Screening: An Increasingly Complex Process
Leung, K.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Leung, W.
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Levine, B. L.
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Levine, J.
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Biomarker Guided GVHD Scoring and Treatment
GVHD Therapy Based on Risk Assessment
(PEDS) Acute GVHD
Levings, M.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Levinson, A.
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
Levoy, K.
“Let's Get Physical” – Developing an Evidence-Based Exercise Protocol for Blood and Marrow Transplant (BMT) Survivors
Levy, R. B.
In Situ Manipulation of Tregs Via Combined IL-2 and TNFRSF25 Signaling Pre- and Post-Transplant: A Novel Approach to Regulate Gvhd By Marked Expansion of CD4+Foxp3+ T Cells
Oral Abstracts - Session I - GVH/GVL & Autologous Transplants
Levy-Assaraf, M.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Lewis, I.
(CIBMTR Working Committee) Autoimmune Diseases and Cellular Therapies
Lewis, M.
Endpoint Review Queries
Acute & Chronic GVHD Data Reporting/Case Studies
Lewis, V.
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
Leyva, A.
Growing Your Teaching Methodology in Bone Marrow Transplant (BMT) Staff Education: Going Beyond Powerpoint™
“Let's Get Physical” – Developing an Evidence-Based Exercise Protocol for Blood and Marrow Transplant (BMT) Survivors
Li, D.
Dnase I Treatment Reduces Gvhd in Mice
Li, J.
Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft Interaction
Li, L.
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Li, P.
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Li, S.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Li, Y.
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Li, Y.
High Doses of Myeloid Progenitor Cells Induce Tolerance in the Context of Autologous HSC Transplantation
Li, Z.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Liao, Y.
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Rescue of the Mucocutaneous Manifestations in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa (RDEB) By Human Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs)
Libby, E. N.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Liberman, S. R.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
Liberona, J.
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Liebers, N.
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Liegel, J.
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Liewer, S.
Mobilization Guideline Update: Strategies for Autologous and Allogeneic Hematopoietic Cell Transplantation
Lill, M. C.
Highlights from "Defining Quality and Value in Stem Cell Transplant" Meeting
Proposed FACT Outcome Measures and ASBMT Reimbursement Committee Update
Lim, A. B. M.
The Relationship Between Pre-Transplant 25-Hydroxy-Vitamin D Levels, Survival and Graft-Versus-Host Disease, in Allogeneic Haematopoietic Stem Cell Transplantation
Lin, F.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Lin, P.
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Lin, T. L.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Lindemans, C. A.
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
(CIBMTR Working Committee) Infection and Immune Reconstitution
Lindenberg, L.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Linderman, C.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Linscott, L.
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Lionberger, J.
Donor Derived Systemic Lupus Erythematosus (SLE) after Allogeneic Transplantation
Cerebral Venous Thrombosis after Autologous Stem Cell Transplantation
Lipton, J. H.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Lister, J.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) – a Single Institutio
Littleton, A.
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Litzow, M. R.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Stem Cell Transplantation & Palliative Care: An Oxymoron?
Liu, C.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Liu, D.
Abstract 5410: Dose-Escalated G-CSF Does Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation
Liu, F.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Liu, H.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Liu, H.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Liu, J.
Engraftment Failure or Aplastic Anemia: A Case Report
Liu, Y.
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Liu, Y.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Ljungman, P. T.
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Locatelli, F.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Locke, F. L.
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Locke, K.
Ixazomib Inhibits Dendritic Cell Maturation and Function
Locker, G. E.
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
Loeb, D.
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Loechelt, B.
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Loechelt, B. J.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Logan, A. C.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Logan, A. C.
Basic Technology of Next-Generation Sequencing: A New Approach to Measuring MRD
Logan, B. R.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Issues in Statistical Analysis of Transplant Data
Londono, D.
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Long, G. D.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Long-Boyle, J.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Longo, N. D.
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Loos, T.
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Lopez, E.
Unmanipulated Bone Marrow As Third Party Donor for Unrelated Cord Blood Transplant Decreases 100-Day Mortality in Children
Lopez, G.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Lopez-Bover, M.
Growing Your Teaching Methodology in Bone Marrow Transplant (BMT) Staff Education: Going Beyond Powerpoint™
“Let's Get Physical” – Developing an Evidence-Based Exercise Protocol for Blood and Marrow Transplant (BMT) Survivors
López-Corral, L.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Loren, A.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Want Kids? Preserving Fertility in HCT Recipients
(CIBMTR Working Committee) Regimen-Related Toxicity and Supportive Care
Lorenz, A.
Happy Birthday…Again: Educating BMT Nurses and Patients about Infusion of Stem Cells
Lotero, V.
Unmanipulated Bone Marrow As Third Party Donor for Unrelated Cord Blood Transplant Decreases 100-Day Mortality in Children
Loth, G.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Lown, R.
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
Lowsky, R.
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Lu, G.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Lu, K.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Lubin, M.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Lucas, K.
Voriconazole Therapeutic Drug Monitoring in a Pediatric Hematopoietic Stem Cell Transplant Center
Pharmacoeconomic Impact of Thiotepa-Containing Conditioning Regimens in a Pediatric Hematopoetic Stem Cell Transplant Center
Luck, J.
Growing Your Teaching Methodology in Bone Marrow Transplant (BMT) Staff Education: Going Beyond Powerpoint™
“Let's Get Physical” – Developing an Evidence-Based Exercise Protocol for Blood and Marrow Transplant (BMT) Survivors
Luger, S.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Lukez, A.
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Lum, L.
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Lund, T. C.
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Oral Abstracts - Session C - Pediatric Disorders
Luo, C.
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome
Luo, C.
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome
Luo, N.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Luo, W.
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Luo, Z.
Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model
Luon, D. K.
Contributing Factors to Renal Dysfunction during Engraftment Syndrome
Luong, R.
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells
Luskin, M. R.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Luznik, L.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
How to Do Haplo Transplants
Checkpoint Inhibitors Introduction
Oral Abstracts - Session M - Lymphoma/Multiple Myeloma & Leukemia
Checkpoint Inhibitors
Lyndale, P.
Early Intervention with HSCT Patients to Improve Access to and Knowledge of Palliative Care

M

Ma, Q.
Dnase I Treatment Reduces Gvhd in Mice
Maahs, S.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Macalalad, A. R.
Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
MacAskill, R.
Building a Quality Plan for a Blood and Marrow Transplant Program: Quality Framework and Indicator Development
Maciejewski, J.
Severe Mucositis with Bendamustine Etoposide Ara-C and Melphalan (Be-EAM) As Conditioning Regimen in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (AutoSCT)
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Mack, J. P.
Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Mackall, C. L.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Mackrell, M.
Growing Your Teaching Methodology in Bone Marrow Transplant (BMT) Staff Education: Going Beyond Powerpoint™
“Let's Get Physical” – Developing an Evidence-Based Exercise Protocol for Blood and Marrow Transplant (BMT) Survivors
MacMillan, M. L.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Response and Survival Following Second-Line Therapy in 113 Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
Point-Counterpoints
Madrigal, J. A.
A Change in Donor Medical Suitability Criteria Resulted in Decreased Rates of Donor Attrition at CT Stage in a Registry Study
Maeda, Y.
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Mageed, A. A.
Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
Magenau, J.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Magraner, J. M.
Tbo-Filgrastim Versus Filgrastim during Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation
Mahadeo, K. M.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Mahajerin, A.
Successful Treatment of Secondary Graft Failure Following Unrelated Cord Blood Transplant with Hematopoietic Growth Factors in a Patient with Fanconi Anemia
Mahapatra, M.
Peripheral Blood Stem Cell Transplant in Aplastic Anemia
Maher, O.
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Mahfouz, R.
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
Mahindra, A.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Mahmud, D.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Mahmud, N.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Mahnken, J.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Maiers, M.
The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
Maillard, I.
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
Majhail, N. S.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
30 Day Readmissions – a 4 Year Look Back of Multi-Disciplinary Efforts
Is G-CSF Still Needed Post-Transplant to Promote Engraftment in the Present Era? a Multi-Disciplinary Project to Evaluate Patient Safety Vs Cost Savings
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
30 Day Readmissions Rate- How Many Ways Can We Calculate Thee?
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Subcutaneous Ports for Outpatient Transplant Patients to Reduce the Risk of Central Line Associated Blood Stream Infections
What's "Hot" in Managing Menopausal Side Effects in Females AND Hormonal Side Effects for Males
Oral Abstracts - Session J - Late Effects/Quality of Life
Mak, K.
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Comprehensive Meta-Analysis
Makino, S.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Makino, T.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Malech, H. L.
(CIBMTR Working Committee) Primary Immune Deficiencies, Inborn Errors of Metabolism and Other Non-Malignant Marrow Disorders
Malinowski, A.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Mallouri, D.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Mallow-Corbett, S.
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
Malone, A.
Bendamustine-Brentuximab: Bridging to Transplant
Malone, A. K.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Maloney, D. G.
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
(CIBMTR Working Committee) Lymphoma
Maloy, M.
Related Donor Screening: An Increasingly Complex Process
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Malpass, J. K.
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Malroy, M.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Manasa, R.
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Manasanch, E.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
Mandala, A.
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Mangan, J.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Mangan, K. F.
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Mani, S.
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
Manjili, M.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Mann, E.
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Mann, J.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Mannis, G. N.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Mansour Riwes, M.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Marcantonio, E. E.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Marcellot, L.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Margolis, D. A.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
SAA: In the Current Era, Alternative Donor Transplants Rock
(PEDS) Acquired Marrow Failure in Children: Glass Half-Empty or Half-Full?
Margolis, D. A.
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Margossian, S.
Factors Associated with CMV Disease in Pediatric Hematopoietic Stem Cell Transplantation
Marin, D.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Maris, M. B.
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Mark, T.
(CIBMTR Working Committee) Plasma Cell Disorders and Adult Solid Tumors
Marmer, D. J.
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Marón, G. M.
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Marr, K. A.
Current and Future Concepts in Assessing Risks for Fungal Infections in SCT Recipients
Fungal Infections in BMT
Marsh, R. A.
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Marsh, S. G.
The Challenge of HLA in 2015
The Rapid Evolution of HLA: Complexities from Primates to Transplantation
Marshall, W. L.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Martagon-Herrera, N. A.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Martens, M.
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Martin, L.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Martin, M. E.
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Martin, P.
Highlights from "Defining Quality and Value in Stem Cell Transplant" Meeting
Martin, P. J.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
A Biomarker Panel for Chronic Graft-Versus-Host Disease
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Risk Factors for Depression and Fatigue Among Hematopoietic Cell Transplant (HCT) Recipients
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
How to Build a Long-Term Follow-up Program
Panel Discussion: GVHD and Co-Morbidities
Challenges to Successful Completion of Clinical Trials
ASBMT President's Symposium: Panel Discussion
CIBMTR General Assembly And Awards
Martin, P. L.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases
Martin, R.
A Successful Nurse Externship Program in an Inpatient Blood and Marrow Transplant Program
Martin, R.
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Martin, T. G.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Martinez, C.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Martinez, C.
Panelist: IT Best Practices and Challenges in Supporting BMT Research
Martinez, U.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Martínez-Laperche, C.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Martinez-Laperche, C.
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Martinez-Outschoorn, U.
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Mason, K.
The Relationship Between Pre-Transplant 25-Hydroxy-Vitamin D Levels, Survival and Graft-Versus-Host Disease, in Allogeneic Haematopoietic Stem Cell Transplantation
Mason, S.
Preparation of the New Graduate RN for Care of the Hematopoietic Cell Transplant Patient:: An Orientation Reconstruction Story
Massenkeil, G.
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Masszi, T.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Mathew, A.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Mathews, J.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Mathews, V.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
(CIBMTR Working Committee) Primary Immune Deficiencies, Inborn Errors of Metabolism and Other Non-Malignant Marrow Disorders
Mathewson, N.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Matlack, M.
CIBMTR Hot Topics
Mato, A. R.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Matos, J.
Biomimetic Nanofibrous Mesh for Long-Term Preservation of Intestinal Epithelial Cells
Matsuo, K.
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Matthay, K. K.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Matthias, J.
Outpatient Transplant Management Affects ANC Recovery Data Endpoin
Mattour, A. H.
Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant
Mattsson, J.
In Vitro Expanded Umbilical Cord Blood T Cells Used for Donor Lymphocyte Infusions after Umbilical Cord Blood Transplantation
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
HLA-C Mismatch without Impact on Outcome after Allogeneic HSCT
Risk Factors and Clinical Outcome for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Long-Term Stable Mixed Chimerism in Patients Undergoing HSCT for Non-Malignant Disorders
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype
Mau, L. W.
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Mauad, M. A.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Mauro, M. J.
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
Mauti, E.
Building a Quality Plan for a Blood and Marrow Transplant Program: Quality Framework and Indicator Development
May, W. S.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Mayer, S.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Mayor, J.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Mays, J.
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Maziarz, R. T.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
An Overview: How Much is One Life Worth? Identifying Costs and Developing Value Measures in HCT
Health Care Economics
McAfee, S. L.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
McBride, A.
Retrospective Review of Intravenous Pentamidine for Pneumocystis Pneumonia Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
McCall, J.
Development of an Instructional Video to Reinforce Patient Education Regarding Central Venous Catheter Care
McCall, R.
Panelist: IT Best Practices and Challenges in Supporting BMT Research
McCallen, M. R.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Medical Marijuana: Is Green and Leafy Really Good for You?
McCaman, L. D.
Developing a Comprehensive, Psychoeducational Program: The Bone Marrow and Stem Cell Transplant Orientation Group
McCann, M.
Piloting a Clinical Resource Nurse Role
McCarthy, P. L.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Data Collection for BMT CTN Myeloma Studies
(CIBMTR Working Committee) Regimen-Related Toxicity and Supportive Care
McCarty, J. M.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
McClune, B. L.
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
McCormack, S.
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
Viral-Specific T Lymphocytes for Treatment of Viral Infections in Primary Immunodeficiency
McCormick, K.
A Single Center Survey of Distress Amongst Bone Marrow Transplant Recipients
Rhythmic Entrainment: A Music Therapy Intervention to Elicit Relaxation and Decrease Anxiety for the Bone Marrow Transplant Recipient
McCormick, S.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
McCurdy, S. R.
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
McCutcheon, I. E.
Spinal Cord Injection of Stem Cells for Pediatric ALS
McDevitt, E.
C. the Difference with Steriplex
McFarren, A.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
McGavran, P.
Tbo-Filgrastim Versus Filgrastim during Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation
McGuire, T.
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
McGuirk, J. P.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo-Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Single Center Experience
McIntyre, E.
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
McKee, M.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
McKenna, D.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
(CIBMTR Working Committee) Autoimmune Diseases and Cellular Therapies
McKenna, L. A.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
McLain, N.
A Tribute To The Pioneers Who Brought Us Here: Testimony From BMT's Longest Survivor and Her Physician
McMillen, K. K.
Metabolic Syndrome Occurs within the First Year after Hematopoietic Cell Transplant
Prevalence of Vitamin D Insufficiency in Adult Hematopoietic Cell Transplant (HCT) Patients with Documented Osteopenia or Osteoporosis after Steroid Exposure: A Quality Assurance Study
Optimizing Transplant Ambulatory Care Utilizing Multidisciplinary Rounds
McMurchy, A.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
McNiece, I.
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
McPhearson, J.
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
McSweeney, P. A.
A Network Approach to Standardization of BMT Pathways
Meadows, T.
Use of Double Lumen Central Venous Cathethers for Hematopoeitic Stem Cell Pheresis
Meagher, R.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Mechoulam, R.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Medley, K.
Combination Antifungal Therapy Experience at an Academic Health System
Posaconazole DR Tablet Serum Concentrations in the Bone Marrow Transplant Population: Association with Prevention or Treatment of Invasive Fungal Infections
Implementing a Screening and Treatment Protocol for Latent Tuberculosis in Patients with Hematologic Malignancies in a Southern California Medical Center
Mehdikhani, H.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Mehta, A.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Mehta, J.
Abstract 5410: Dose-Escalated G-CSF Does Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Pain Following Hematopoietic Stem Cell Transplant: A Prospective Observational Study
Tbo or Not Tbo-That Is the Question!
Mehta, P. A.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Intravenous Pentamidine for Pneumocystis Carinii/Jiroveci Pneumonia (PCP) Prophylaxis
(CIBMTR Working Committee) Pediatric Cancer
Mehta, R. S. S.
Distinctions Between Effective and Ineffective AML-Specific Autologous Peripheral Blood (PB) Cytotoxic T-Lymphocytes (CTLs)
Myeloid Derived Suppressor Cells (MDSC)-like Acute Myeloid Leukemia (AML) Cells Are Associated with Resistance to Cytotoxic Effects of Autologous (Auto) T-Lymphocytes (CTLs)
Meier, J. A.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Meiers, S.
Welcome/Staff Introductions
Welcome
Meinzen, S.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Melaragno, A.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Melenhorst, J.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Mendizabal, A.
Welcome Address & BMT CTN Update
Mendoza, D.
Increasing Compliance in BMT Patients By Creating a Patient Education Binder
Mensen, A.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Mercer, J.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Merchant, M.
Stem Cell Infusion Adverse Reaction (SCIAR). a Review of Published Literature from Recent Years
Merchant, N.
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Mergen, N.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Meric, K.
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Merideth, M.
Women's Health and Hormonal Treatment Options for Therapeutic Amenorrhea and Contraception during the Peri-Transplant Period
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Merker, M.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Mertelsmann, A.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Merten, J.
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Mesa, R. A.
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Meshitsuka, S.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Messina, C.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Messner, H.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Mevorach, D.
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action
Meyer, C.
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Meyer, E.
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Meyers, G.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
Placental Growth Factor (PlGF) in Allogeneic Hematopoietic Cell Transplantation (HCT): Clinical, Immunologic, and Pathologic Correlates
Miano, T. A.
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Micallef, I. N.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
CXCR4 Expression in Mantle Cell Lymphoma and Mobilization with Plerixafor for ASCT Does Not Negatively Impact Progression-Free Survival
Michaelis, L. C.
Evaluating the Benefits of Non-Transplant Treatment Options
Michalski, M.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Michel, G.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Mick, R.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Mielcarek, M.
Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Allograft Recipients on High-Dose Glucocorticoids for Treatment of Graft-Versus-Host-Disease
Miklos, D. B.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Mikulandric, N.
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Milano, F.
Impact of Pre-Transplant Minimal Residual Disease in Patients with AML Undergoing Myeloablative Cord Blood Transplantation
Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral Nutrition in Patients Receiving Myeloablative Cord Blood Transplantation
Successful Engraftment and Full Donor Chimerism in Patients Undergoing Second Allogeneic Stem Cell Transplantation with Umbilical Cord Blood
Miles-Jay, A.
Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Allograft Recipients on High-Dose Glucocorticoids for Treatment of Graft-Versus-Host-Disease
Militano, O.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
Milius, B.
Stem Cell Transplant Interoperability Using BRIDG
Miller, G.
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Miller, H.
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Miller, J. S.
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
The Complex Process of Translational Development of NK Cells for Therapy
ASBMT President's Symposium : Panel Discussion
Miller, J. P.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Miller, K. B.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma
Miller, K.
Case Report: 52 Year-Old Male 11 Months after MUD for Angionimmunoblastic T Cell Lymphoma Developed Acute Fibrinous Organizing Pneumonitis Successfully Treated with Etanercept Suggesting TNF Alpha in the Pathogenesis in This Sub-Type of Pulmonary GVHD
Miller, M.
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Miller, R. P.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial
Miller, R.
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Miller, W. P.
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Milliken, S.
Combination Antiretroviral Therapy during Autologous Stem Cell Transplant for HIV Infected Patients with Haematological Malignancies
Milpied, N.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mims, A.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Anti CD20 Radioimmunotherapy and mTOR Inhibition in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas
Minas, N. M.
Monthly Internal Assessments Result in Successful CIBMTR Audit
Mineishi, S.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Miravete-Lagunes, K.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Mishra, A.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Mishra, P. C.
Peripheral Blood Stem Cell Transplant in Aplastic Anemia
Misra, A.
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Mitchell, D.
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
Mitchell, S. A.
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Mitchell, S.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Miyamoto, J.
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model
Miyamoto, T.
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Miyamura, K.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Miyazaki, K.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Miyazaki, K.
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Mizumaki, H.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Mizuno, K.
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Mo, K.
Introducing Care of the HCT Patient to New Graduate Nurses Using Problem Based Learning
Mobley, E.
Predictors and Outcomes of Intensive Care Utilization in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant at Mayo Clinic, Florida
Mock, S.
Increasing Adls Is Easy As 1-2-3
Moerke, T.
CIBMTR IT, Research Data Lifecycle & You
Panel: IT Best Practices and Challenges in Supporting BMT Research
Moffett, R.
Fall Innovations: A Multimodal Initiative to Decrease Falls in the Blood and Marrow Transplant Setting
Mohamed, S. Y.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Mohmand, S.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Mohr, N.
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Mohty, B.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Mohty, M.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Is There a Stronger Graft-Versus-Leukemia Effect Using HLA-Haplo-Identical Donors Compared to HLA-Identical Sibling Donors?
Moin, M.
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
Molldén, P.
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Molldrem, J.
CD4+CD25+ Invariant Natural Killer T Cells Are Enriched in Cord Blood: Implication on Immune-Regulation
Momméja-Marin, H.
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Monreal, J.
Tbo or Not Tbo-That Is the Question!
Montesinos, P.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Moore, B.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Moore, H.
Psychosocial Distress Screening: Application of the Oncology Standard to HCT
Moore, T. B.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Moreb, J. S.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Cyclophosphamide Is an Effective and Well-Tolerated Maintenance Therapy in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Moreno, A. D.
Severe Mucositis with Bendamustine Etoposide Ara-C and Melphalan (Be-EAM) As Conditioning Regimen in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (AutoSCT)
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Moreton, S.
NOVEL Strategy to Enhance NK CELL Activity
Mori, R.
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model
Mori, S.
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients with Hematological Remission and Full Chimerism at Day 30
Mori, S. I.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Mori, T.
Effect of Linozolid Administration on Myeloid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation
Transplant-Acquired Food Allergy Following Cord Blood Transplantation in Adult Patients
Morishima, Y.
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Moriuchi, Y.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Morris, C.
Recovery of Endogenous IgG Production Following Rituximab Treatment after HSCT
Nitazoxanide Is Effective Therapy for Norovirus Gastroenteritis after Chemotherapy and Hematopoietic Stem Cell Transplantation (HSCT)
Morris, E.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Morris, J.
Recovery of Endogenous IgG Production Following Rituximab Treatment after HSCT
Nitazoxanide Is Effective Therapy for Norovirus Gastroenteritis after Chemotherapy and Hematopoietic Stem Cell Transplantation (HSCT)
Morrow, A. L.
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
A Pilot Study of Donor Enteral Human Milk to Modulate the Gut Microbiome in Children Receiving Stem Cell Transplant
Morse, D.
Quality: BMT LOS and Readmission Rates
Mortari, A.
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
T-Cell Transcriptome Analysis Reveals the Mechanisms Controlling Synergy Between Costimulation Blockade and mTOR Inhibition during Gvhd Prevention
Moskowitz, C. H.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Mosso, C.
Characteristics and Preliminary Clinical Results of a Cohort of Patients in Santiago, Chile, Undergoing Haploidentical Hematopoietic Cell Transplantation with Postransplant Cyclophosphamide
Mossoba, M.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Mott, S. L.
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Mount, L.
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Mousquer, R. T.
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Moyer, A. M.
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Mudrick, C.
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
1202 Lab Samples: Best Practices
Mueller, C. R.
(CIBMTR Working Committee) Immunobiology
Mukherjee, R.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Müller, C.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Mulligan, K.
Increasing Adls Is Easy As 1-2-3
Mulvey, E.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Mumaw, C.
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Munker, R.
Allogeneic Transplant for Acute Biphenotypic Leukemia: Characteristics and Outcome in the CIBMTR Database
Munsell, M.
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Murata, M.
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Murk, J. L.
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
Murphy, E. A.
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Psychosocial Distress Screening: Application of the Oncology Standard to HCT
Murphy, W. J.
Advances in Understanding the Biological Role of NK Cells
Murray, C. K.
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Murray, D.
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
Murray, K.
Fall Innovations: A Multimodal Initiative to Decrease Falls in the Blood and Marrow Transplant Setting
Murray, L.
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Murray, S. N.
Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
Mussetter, A.
Panel Discussion: GVHD and Co-Morbidities
Mutahar, E.
Pseudotumor Cerebri Associated with All-Trans Retinoic Acid Treatment in Female Patients with Acute Promyelocytic Leukemia: A Case Series
Myers, K. C.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Mytilineos, J.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Complete Loss of HLA Class I Heterozygosity in a Patient with Acute Myeloid Leukemia

N

Na, I. K.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Nadamanee, A.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Nadel, H.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Nademi, Z.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Nadiminti, K.
Addressing the Need for Standardized Adverse Event (AE) Documentation within the Electronic Medical Record (EMR)
Nagafuji, K.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Nagalla, S.
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Nagamura-Inoue, T.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Nagarajan, R.
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Nagler, A.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action
Is There a Stronger Graft-Versus-Leukemia Effect Using HLA-Haplo-Identical Donors Compared to HLA-Identical Sibling Donors?
Naik, S.
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Naik, S.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Naina, H.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Nair, J.
Cyclophosphamide Is an Effective and Well-Tolerated Maintenance Therapy in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Najima, Y.
The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Nakamura, Y.
Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines
Nakano, N.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Nakashima, M.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Nakasone, H.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Nanda, R. H.
Factors Influencing Pulmonary Toxicity in the Setting of Total Body Irradiation-Based Myeloablative Conditioning in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Nandagopal, L.
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Naples, J.
Anicteric Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation in Children
Napurski, C.
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Naranjo, A.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Narkhede, M.
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Nasta, S. D.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Nath, C.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Nath, R.
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Allogeneic Stem Cell Transplant Improves the Outcome of Patients with Acute Erythroleukemia: Single Center Analysis
Experience with Administration of Ruxolitinib after Allogeneic Stem Cell Transplantation (alloSCT) in Patients with Myelofibrosis
Nath, R.
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Nathan, S.
Severe Mucositis with Bendamustine Etoposide Ara-C and Melphalan (Be-EAM) As Conditioning Regimen in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (AutoSCT)
Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
Nava, S.
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Neale, G. A.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Neale, M. C.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Negrete, F.
Characteristics and Preliminary Clinical Results of a Cohort of Patients in Santiago, Chile, Undergoing Haploidentical Hematopoietic Cell Transplantation with Postransplant Cyclophosphamide
Negrin, R.
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Nejadnik, B.
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Nelson, A. S.
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Nelson, A. S.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Nelson, C.
Twitter & Facebook: How to Get Started & Professional Use
Guiding Principles of Data Quality
Data Collection for BMT CTN Myeloma Studies
Neme, K.
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Nemecek, E. R.
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Neofytos, D.
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Ness, K.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Neudorf, S.
Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients
Neumann, J.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
African-American, Latino and Caucasian Patients' Experience before, during and after Stem Cell Transplantation: A Phenomenological Study
Neumeier, L.
Peri-Transplant Alemtuzumab Levels Dictate the Risks of Acute Gvhd and Mixed Chimerism
Neumon, B.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Nevo, N.
Outcome of Hematopoietic Stem Cell Transplantation for Children with Severe Combined Immunodeficiency (SCID). Seventeen Years Experience in Single Pediatric Transplantation Center
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Newbigging, S.
Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model
Newell, L. F.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
Placental Growth Factor (PlGF) in Allogeneic Hematopoietic Cell Transplantation (HCT): Clinical, Immunologic, and Pathologic Correlates
Ng, H. Y.
Race Influences the Response to Conventional Induction Chemotherapy in Asian Patients with Acute Myeloid Leukemia
Ng, J.
Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
Ngo, M.
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Nguyen, C. T.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Ngwube, A.
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Nichele, S.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Nichele, S.
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Nicholas, S. K.
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Nickeleit, V.
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Nieder, M. L.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Transplantation of Immunological Diseases
Niederwieser, D.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Haplo-HCT without T-Cell Depletion Vs. Unrelated Vs. Related (Post-transplant Cyclophosphamide) for Developing Countries
Nierkens, S.
Preclinical Development of Cord Blood-Derived Dendritic Cell-Based Immunotherapies after Hematopoietic Cell Transplantation in Children with AML
Upregulation of Class I MHC on Neuroblastoma Cells By NK Cell Exposure for Enhanced CTL Reactivity
Nieser, D.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Nieto, Y. L.
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
(CIBMTR Working Committee) Plasma Cell Disorders and Adult Solid Tumors
Nikaein, A.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
Nikiforow, S.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Nikpoor, N.
A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma
Nishida, A.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Nishihori, T.
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Nishikii, H.
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts
Noel, P.
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Nurse-Initiated Protocol for Central Venous Catheter (CVC) Selection for Blood and Marrow Transplant (BMT) Recipients
Nogai, H.
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Nooner, A.
Impact of Addition of Alcohol-Impregnated Port Protectors to Post Central Line Insertion Bundle in the Adult Blood and Marrow Transplant Population
Nordin, J. M.
Improving Bedside Communication and Promoting Patient-Centered Care through the Development and Use of Translation Flipbooks
Therapeutic Passes: Highlighting Caregivers' Attitudes and Beliefs Among the Pediatric Blood and Marrow Transplant Population
Norkin, M.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Nortman, S.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Norton, R. A.
A Team Approach to Decreasing Clabsi Rates in a Bmtu
Notarangelo, L. D.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Nowakowski, G. S.
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Nugent, D. J.
Successful Treatment of Secondary Graft Failure Following Unrelated Cord Blood Transplant with Hematopoietic Growth Factors in a Patient with Fanconi Anemia
Nuñez, J.
Medical Products of Human Origin/World Health Organization (MPHO/WHO - WBMT/TTS/ISBT/ICCBBA) Project: Regulatory Recommendations for MPHO
Nwachuku, A.
Hepatitis B Immune Globulin Prophylaxis of Viral Reactivation during Stem Cell Transplant
Nycz, M.
The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease

O

O'Brien, B.
Falls in BMT Patients
O'Brien, M. M.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
O'Brien, S.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
O'Brien, T. A.
Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning
O'Connor, M.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
O'Connor, O.
Program Overview
Emerging Treatment Options and Strategies for Patients Relapsing after Transplantation
BMT Tandem Luncheon Symposium: Post Transplantation Management Strategies for Patients with Lymphoma
O'Donnell, P. V.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
BMT CTN 1101 Haplo Bone Marrow Vs. Double Cord Blood Trasnplantation
(CIBMTR Working Committee) Donor Health and Safety
O'Hara, W. J.
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
O'Meara, A.
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
O'Reilly, R. J.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Ochoa-Bayona, J. L.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Ocqueteau, M.
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Odejide, O. O.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Odell, P.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Oesterheld, J.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Ogata, Y.
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Ogawa, H.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model
Oh, A.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Oh, Y.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Ohashi, K.
The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study
The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Okada, M.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Okada, S.
The MEK Inhibitior Trametinib Selectively Suppresses Gvhd, While Sparing GVT Effects
Okamoto, S.
Effect of Linozolid Administration on Myeloid Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation
Transplant-Acquired Food Allergy Following Cord Blood Transplantation in Adult Patients
Okamoto, S.
Future of Hematopoietic Stem Cell Transplantation in an Aging Country - Japanese Perspective
Okinaka, K.
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Olavarría, E.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Olaya, A.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Association of Polymorphisms in the HLA-C Locus with Disease Risk for Developing Acute Graft Vs. Host in Pediatric Patients with Allogeneic Hematopoietic Stem Cell
Olin, R. L.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Olivarez, K.
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Oliveira, J.
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Oliveira, M.
Development of an Instructional Video to Reinforce Patient Education Regarding Central Venous Catheter Care
Oliver, D. C.
Successful Engraftment and Full Donor Chimerism in Patients Undergoing Second Allogeneic Stem Cell Transplantation with Umbilical Cord Blood
Olmos, R.
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Olmsted, T.
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Olomajeye, A.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
Olsen, J.
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Olson, A.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Olson, C.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
Olson, E. A.
Sickle Cell/Thalassemia
Omel, MD, J.
(NMDP) CIBMTR Consumer Advocacy Committee Meeting
Omer, A.
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Onishi, Y.
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Ono, Y.
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Oon, C. Y.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Or, R.
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action
Oran, B.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Orange, J.
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Oravecz-Wilson, K.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Orchard, P.
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
How to Manage Patients with Metabolic Conditions
Ordemann, R.
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Orlowski, R. Z.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Orndoff, S.
Improving Transitions from the Inpatient to Outpatient Setting in BMT Patients
Orozco, J. J.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Ortel, T. L.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Osman, K.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Bendamustine-Brentuximab: Bridging to Transplant
Osmanov, D.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Osswald, M. B.
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
A Review of Radiographic Findings in Gvhd
Osterkamp, E.
Increasing Adls Is Easy As 1-2-3
Ota, S.
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Otani, J.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Oudshoorn, M.
A Tribute To Altruism: Celebration of 25 Million Volunteer Donors Worldwide
Ovanez, C.
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Owsley, E.
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Oyer, J. L.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Ozawa, Y.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Ozkaynak, M. F.
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
Özkök, S.
Recurrent Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT): Incidence, Clinical Manifestations, Risk Factors and Outcome

P

Paczesny, S.
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Paczesny, S.
GVHD Biomarkers: The Promises and Pitfalls of Personalized Medicine
ASBMT President's Symposium: Panel Discussion
Paff, Z.
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Page, K.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Pagliuca, A.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Pai, S. Y.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Paice, J.
Pain Following Hematopoietic Stem Cell Transplant: A Prospective Observational Study
Pakakasama, S.
Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases
Bacteremia during Neutropenic Episodes in Children Underwent Hematopoietic Stem Cell Transplantation Receiving Ciprofloxacin and Penicillin Prophylaxis
Palla, S. L.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Palmer, J.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Palmer, J.
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Palmer, J.
Cytogenetics Does Not Influence Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
Paluri, R.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Pamer, E. G.
Maintaining Microbiota Diversity following Allo-HSCT
Pan, Y.
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts
Pandey, V.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Pangilinan, Y.
“Let's Get Physical” – Developing an Evidence-Based Exercise Protocol for Blood and Marrow Transplant (BMT) Survivors
Panoskaltsis-Mortari, A.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Pao, J.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Papa-Rodriguez, T.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Papadopoulos, E.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Papalexandri, A.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Papanicolaou, G.
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Cluster of Fulminant Toxoplasmosis in T-Cell Depleted (TCD) and Cord Blood (CB) Stem Cell Transplant (SCT) Recipients: Impact of Aggressive Prophylaxis and Routine Monitoring By Toxoplasma PCR for High Risk Patients
Paplham, P.
Exploring Unmet Needs of Hematopoietic Cell Transplant Recipients
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Parameswaran, R.
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
Parameswaran, R.
NOVEL Strategy to Enhance NK CELL Activity
Parham, P.
Global Diversity of KIR Interactions with HLA Class I
Parikh, S.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Parini, R.
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Parisi, M. T.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Park, C.
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective
Park, H.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Park, J. R.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Parkin, B.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Parmar, S.
Weight Based Plerixafor Dosing Reduces Side Effects in Stem Cell Mobilization
Parmar, S.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Parmentier, J.
Nurses' Role in Decreasing Cardiopulmonary Damage in a Setting of Necessary Cardiopulmonary Toxic Therapy
Parmentier, M. B.
Nurses' Role in Decreasing Cardiopulmonary Damage in a Setting of Necessary Cardiopulmonary Toxic Therapy
Parran, L.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Parsons, S. K.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Pascual, C.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Pascual, M. J.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Pasquini, M. C.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Why, When and Where to Report Conditioning Drugs
Making PROGRESS: Updates from I and II GVHD Prophylaxis Studies
Autoimmune Disease
Pasquini, R.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Pastore, Y.
Outcomes of Bone Marrow or Cord Blood Matched Related Transplantation for Children with Sickle Cell Disease: Experience of a Canadian Center
Pate, A.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Patel, B.
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Patel, K.
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Patel, P.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Patel, P.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Patel, R. D.
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients with Hematological Remission and Full Chimerism at Day 30
Patel, S.
Pre-Transplant Consolidation Chemotherapy for Acute Lymphocytic Leukemia (ALL) Does Not Impact Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Patenia, R.
Dnase I Treatment Reduces Gvhd in Mice
Pathak, P.
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Patnaik, M.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Outcomes of Allogeneic Stem Cell Transplant in Patients with Chronic Myelomonocytic Leukemia (CMML) - a Single Institution Experience
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
ABO Blood Group Incompatibility Has No Impact on the Outcomes in Patients with Myeloid Neoplasms That Underwent Reduced Intensity Allogenic Hematopoietic Stem Cell Transplantation – a Single Institution Series of 148 Patients
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Etiology and Spectrum of Non-Relapse Mortality after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Adults with Myeloid Neoplasms
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Patterson, A. E.
Hardwiring Advance Care Planning in BMT: More Than Just the Paper
Improvement of Patient Education in Preparation for the Inpatient Transplant Stay
Paula, S.
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Pavletic, S. Z.
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
(CIBMTR Working Committee) Autoimmune Diseases and Cellular Therapies
Pavlock, T.
Increased Incidence of Fatigue in Pediatric Hematopoetic STEM CELL Transplant Recipients
Pawarode, A.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Payne, M.
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Payton, L. R.
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
Peck, A.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Pedersen, T. L.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Peggs, K. S.
Advances in T-Cell Therapies
Recent Advances in CMV: An Update on Pharmacologic and Cellular Therapies
Pelland, D.
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Penack, O.
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Penedo, F.
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Penney, L.
Optimizing Transplant Ambulatory Care Utilizing Multidisciplinary Rounds
Perales, M. A.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Social Media Task Force Outcomes
Presentation 1
Oral Abstracts - Session N - Leukemia & Immune Reconstitution
(CIBMTR Working Committee) Graft Sources and Manipulation
Pereboeva, L.
Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
Perelli, J.
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Perera, T.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
The Relationship Between Pre-Transplant 25-Hydroxy-Vitamin D Levels, Survival and Graft-Versus-Host Disease, in Allogeneic Haematopoietic Stem Cell Transplantation
Peres, E.
Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Acute Skin Graft Versus Host Disease Post Liver Transplantation: A Case Report
Perez, L. E.
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Pérez, M.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Association of Polymorphisms in the HLA-C Locus with Disease Risk for Developing Acute Graft Vs. Host in Pediatric Patients with Allogeneic Hematopoietic Stem Cell
Perez-Albuerne, E.
A Case Series of Related Bone Marrow Donors with Prolonged Prothrombin Times but No Perioperative Bleeding Complications
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Pérez-Corral, A.
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Pérez-Simón, J. A.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Pergam, S. A.
Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Allograft Recipients on High-Dose Glucocorticoids for Treatment of Graft-Versus-Host-Disease
Perkins, S. M.
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Perna, S. K.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Perrin, M.
Pre-Transplant Caregiver Education for out-Patient Multiple Myeloma Hematopoeitic Transplant Admission in New Day Hospital: Caregiver Role and Contract in Outpatient Transplant Patient Care
Perry, M. S.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Peters, T.
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective
Petersdorf, E. W.
ASBMT President's Symposium
ASBMT President's Symposium: Panel Discussion
Petersen, B.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Petersen, H.
Optimizing Data Collection
Peterson, J.
Introducing Care of the HCT Patient to New Graduate Nurses Using Problem Based Learning
Peterson, M. E.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
(Nursing) Hot Topics
Petiniot, L.
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Petrillo-Deluca, L.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Petroni, G.
Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused
Petropoulos, D.
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Petrovic, A.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Petryk, A.
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Petterle, R.
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Pfreundschuh, M.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Pham, T.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Phelan, R.
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Philip, M.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Piatt, J. H. Jr.
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Pickham, D.
Prevalence of Vitamin D Deficiency in Allogeneic HCT Recipients and Its Association with Graft Versus Host Disease
Pidala, J.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Pierini, A.
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts
Pilcante, J.
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Pillai, A.
CD3/CD28 Co-Stimulated Activation of PI3K-mTORC2-AKT Metabolic Programming Augments Granzyme B Expression and Direct Cytotoxicity in Expanded Human iNKT Cells
Non-Myeloablative TLI/ATG + Alkylator Conditioning Augments Bidirectional Immune Tolerance Via Regulatory MDSC in a Robust Murine Model of MHC-Mismatched BMT for Beta-Thalassemia
Pilonetto, D.
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Piñana, J. L.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Pinchasov, A.
Correlation Between Pre-Collection CD34 Blood Concentrations and CD34 Collection Yield in Difficult-to-Mobilize Patients Given Plerixafor. –a Retrospective Single Center Study
Pinner, L.
Engraftment in Sibling Allogeneic Stem Cell Transplant Recipients Following the Change in Bone Marrow Collection Devices
Pirl, W.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Pirsl, F.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Piryani, S.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Plantinga, M.
Preclinical Development of Cord Blood-Derived Dendritic Cell-Based Immunotherapies after Hematopoietic Cell Transplantation in Children with AML
Pleskow, J. D.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Podack, E. R.
In Situ Manipulation of Tregs Via Combined IL-2 and TNFRSF25 Signaling Pre- and Post-Transplant: A Novel Approach to Regulate Gvhd By Marked Expansion of CD4+Foxp3+ T Cells
Poetschger, U.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Pohlman, B.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
Poleski, M.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Polge, E.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Polite, B.
The Governmental View of Cancer Care: ASCO Statement on Medicaid Reform and How It May Impact Care Delivery for HCT Patients
Politikos, I.
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Pollack, J.
Metadata / BRIDG Integration Progress
Pollyea, D. A.
A Phase 2 Study of the Hedgehog Pathway Smoothened Inhibitor PF-04449913 to Reduce Relapse in High Risk Acute Leukemia and MDS Patients Following Allogeneic Stem Cell Transplantation
Ponce, D. M.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Ponce-de-Leon, S.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Popat, U. R.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
Safety and Efficacy of Non-Myeloablative (NMA) Melphalan-Based Conditioning for Haploidentical Allogeenic Stem Cell Transplantation (HaploSCT) in Patients with Advanced Lymphoma
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
(CIBMTR Working Committee) Chronic Leukemia
Pophali, P. A.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Popradi, G.
Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Porat, I.
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Porcelli, S.
CD4+CD25+ Invariant Natural Killer T Cells Are Enriched in Cord Blood: Implication on Immune-Regulation
Porrata, L. F.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
CXCR4 Expression in Mantle Cell Lymphoma and Mobilization with Plerixafor for ASCT Does Not Negatively Impact Progression-Free Survival
Porter, D. L.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Porter, D. L.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Pharamacodynamic Assessment Shows That CCR5 Surface Expression May Serve As an Indicator for Effective CCR5 Blockade in Allogeneic Stem Cell Transplant (alloSCT) Recipients Treated with Maraviroc
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Porteus, M. H.
Gene Editing Using Engineered Nucleases
Portilla, C. A.
Unmanipulated Bone Marrow As Third Party Donor for Unrelated Cord Blood Transplant Decreases 100-Day Mortality in Children
Pott, J. E.
Discharge Essentials: A Program for Preparing Adult Blood and Marrow Transplant Patients for Self -Care after Transplant
Potter, J.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
Potter, M.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
Potts, D. A.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Pourpak, Z.
Leukocyte Adhesion Deficiency Type I: The Outcome of Reduced- Intensity Conditioning Hematopoietic Stem Cell Transplantation
Powers, J.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
Powers, K.
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Pozotrigo, M.
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Prasad, V. K.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Presnell, S. E.
Late Onset Pulmonary Arterial Hypertension after Successful HSCT for Familial HLH
Press, O. W.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Preussler, J. M.
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Pro, B.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Prockop, S. E.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Prokop, L.
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
Prusakiewicz, E.
Discharge Essentials: A Program for Preparing Adult Blood and Marrow Transplant Patients for Self -Care after Transplant
Puck, J.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Pullarkat, V.
Cytogenetics Does Not Influence Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
Outcomes of Patients with Acute Lymphoblastic Leukemia (ALL) with Central Nervous System (CNS) Involvement Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT): A Single Center Retrospective Analysis
Pulsipher, M. A.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
PBMTC Business Meeting
(CIBMTR Working Committee) Donor Health and Safety
Punatar, S.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Punzel, M.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Purev, E.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Pusic, I.
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Puthenveetil, G.
Successful Treatment of Secondary Graft Failure Following Unrelated Cord Blood Transplant with Hematopoietic Growth Factors in a Patient with Fanconi Anemia

Q

Qayed, M.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Qazilbash, M. H.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Adverse Events during Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis Patients
Oral Abstracts - Session L - Lymphoma/Multiple Myeloma
Qin, X.
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome
Quade, A.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Quigg, T. C.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Quigley, W.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Quinlan, G.
Improving Transitions from the Inpatient to Outpatient Setting in BMT Patients
Quintero, K.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Quintero, M.
Unmanipulated Bone Marrow As Third Party Donor for Unrelated Cord Blood Transplant Decreases 100-Day Mortality in Children
Qureshi, M.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem

R

Raanani, P.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Rademaker, A.
Impact of High-Resolution Typing for HLA-a, -B, -C and -DRB1 on Single-Unit Cord Blood Transplantation in Pediatric Patients
Rader, C.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Rådestad, E.
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype
Radich, J.
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph+) Leukemias
What's in Your Genes? Implications of Cytogenetics for the HCT Recipient
Radojcic, V.
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
Raffel, G.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Rafii, S.
Differentiation of Stem Cells into Functional Tissues
Rajaee, R. G.
Spirituality in the AYA Population
Rajkumar, S. V.
Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
Ram, R.
Correlation Between Pre-Collection CD34 Blood Concentrations and CD34 Collection Yield in Difficult-to-Mobilize Patients Given Plerixafor. –a Retrospective Single Center Study
Risk Factors and Prognostic Scale for CMV Reactivation in CMV Seropositive Patients after Allogeneic Hematopoietic Cell Transplantation – a Single Center Cohort Study
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Ramadan, A.
Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia
Ramakrishnan, P.
NOVEL Strategy to Enhance NK CELL Activity
Ramanathan, M.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Allogeneic Stem Cell Transplant Improves the Outcome of Patients with Acute Erythroleukemia: Single Center Analysis
Experience with Administration of Ruxolitinib after Allogeneic Stem Cell Transplantation (alloSCT) in Patients with Myelofibrosis
Ramirez, A.
Twitter & Facebook: How to Get Started & Professional Use
Regulatory Requirements
Ramirez, N.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Association of Polymorphisms in the HLA-C Locus with Disease Risk for Developing Acute Graft Vs. Host in Pediatric Patients with Allogeneic Hematopoietic Stem Cell
Ramirez, O.
Unmanipulated Bone Marrow As Third Party Donor for Unrelated Cord Blood Transplant Decreases 100-Day Mortality in Children
Ramirez, P. A.
Bone Health Assessment in Patients Undergoing Hematopoietic Cell Transplantation
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Nutritional Assessment As Predictor of Complications Post Hematopoietic Cell Transplantation
Characteristics and Preliminary Clinical Results of a Cohort of Patients in Santiago, Chile, Undergoing Haploidentical Hematopoietic Cell Transplantation with Postransplant Cyclophosphamide
Ramos, C. A.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Oral Abstracts - Session N - Leukemia & Immune Reconstitution
Ramos, C.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Rampertaap, S.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Ramsey, S. D.
Estimated Cost-Effectiveness of Brentuximab Vedotin Vs. Best Supportive Care Following Autologous Stem Cell Transplant in Hodgkin's Lymphoma
Bone Marrow Transplantation in the Era of Cost Containment: Is there a Solution
Randall, J.
Psychosocial Distress Screening: Application of the Oncology Standard to HCT
Rao, K. V.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Rao, K.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Rao, M. B.
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Rashad, A.
Rescue of the Mucocutaneous Manifestations in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa (RDEB) By Human Cord Blood Derived Unrestricted Somatic Stem Cells (USSCs)
Rasheed, W. K.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Rashid, A.
Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed By Autologous Stem Cell Transplantation: Experience at Skmch Lahore
Rashidi, A.
Cytogenetic Patterns of Relapse Following Stem Cell Transplantation in Morphologic Complete Remission in Patients with Cytogenetically Abnormal Acute Myeloid Leukemia
Ratanatharathorn, V.
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Ravandi, F.
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Rayes, A.
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
Reardon, C. C.
Welcome and Introductions
Welcome
Reda, D.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Reddy, P.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
How to Write a Grant
Oral Abstracts - Session E - GVH/GVL
Reger, R.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Reiner, I.
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action
Remberger, M.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
HLA-C Mismatch without Impact on Outcome after Allogeneic HSCT
Risk Factors and Clinical Outcome for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Renard, M.
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Renaud, T. M.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Renner, R.
Metadata / BRIDG Integration Progress
Renshaw, J. S.
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
A Review of Radiographic Findings in Gvhd
Renteria, A. S.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Bendamustine-Brentuximab: Bridging to Transplant
Renteria, A. S.
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Reshef, R.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Pharamacodynamic Assessment Shows That CCR5 Surface Expression May Serve As an Indicator for Effective CCR5 Blockade in Allogeneic Stem Cell Transplant (alloSCT) Recipients Treated with Maraviroc
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Restrepo, M.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Rettinger, E.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Reu, F.
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Revankar, S.
Cytomegalovirus (CMV) Infection in Autologous Stem Cell Transplant (ASCT) Recipients in the Era of Rituximab (R) Use
Rexrode, D. O.
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Reyes, J. K.
HSCT Education: Bridging the Gap
Rezvani, A.
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Rezvani, A.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Rezvani, K.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
CD4+CD25+ Invariant Natural Killer T Cells Are Enriched in Cord Blood: Implication on Immune-Regulation
Rhodes, J. R.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Riaz, S.
Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed By Autologous Stem Cell Transplantation: Experience at Skmch Lahore
Ribeiro, L.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Richardson, P. G.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Managing VOD in the Transplant Recipient—a Changing Clinical Landscape
Richer, J. A.
Development of a Standardized Follow up for Pediatric Transplant Long Term Survivors By Family Physicians
Riches, M. L.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Infection Data--Why, When, and What?
Infection Data Reporting
Panelist: How Can Technology Further BMT Research
Richman, L. P.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Pharamacodynamic Assessment Shows That CCR5 Surface Expression May Serve As an Indicator for Effective CCR5 Blockade in Allogeneic Stem Cell Transplant (alloSCT) Recipients Treated with Maraviroc
Riddell, S.
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Riffkin, I.
Successful Engraftment and Full Donor Chimerism in Patients Undergoing Second Allogeneic Stem Cell Transplantation with Umbilical Cord Blood
Riggan-Stuelke, E.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Rimando, J.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Rimkus, C.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Ringden, O.
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Is There a Stronger Graft-Versus-Leukemia Effect Using HLA-Haplo-Identical Donors Compared to HLA-Identical Sibling Donors?
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Ringhoffer, M.
Complete Loss of HLA Class I Heterozygosity in a Patient with Acute Myeloid Leukemia
Ritchie, D. S.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
The Relationship Between Pre-Transplant 25-Hydroxy-Vitamin D Levels, Survival and Graft-Versus-Host Disease, in Allogeneic Haematopoietic Stem Cell Transplantation
Ritchie, E.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Ritz, J.
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
B-Cell Immunity in Chronic GVHD Introduction
Oral Abstracts - Session D - Allogeneic Transplants
B-Cell Immunity in Chronic GVHD
Ritzau, N.
Eliminating Cross Contamination from Intravenous Cyclosporine and Tacrolimus and Accurate Blood Sampling
Rivett, R.
Providing a Safety Net for Bone Marrow Transplant (BMT) Survivors: Nurses and Telephone Triage
Rizzari, C.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Rizzieri, D.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Rizzo, J. D.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Center Specific/Center Volume
CIBMTR Data Meeting Highlights
Roberts, C. H.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Robey, N.
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Robins, H.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Robitaille, N.
Outcomes of Bone Marrow or Cord Blood Matched Related Transplantation for Children with Sickle Cell Disease: Experience of a Canadian Center
Robitzsch, T.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Roboz, G.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Rocha, V. G.
(CIBMTR Working Committee) Graft Sources and Manipulation
Rodela, T.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Rodrigues, A. L. M.
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Rodrigues, M. C. D. O.
Removal of Chlorhexidine Gluconate-Impregnated Dressings Due to Skin Irritation in Patients Under Hematopoietic Stem Cell Transplantation
Catheter-Related Bloodstream Infections during Use of Chlorhexidine Gluconate-Impregnated Dressings
Rodriguez, M. A.
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Roepstorff, C.
Optimizing Data Collection
Rogosheske, J.
Cyclophosphamide Dose Weight Adjustment in Morbidly Obese with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation (HCT)
Roifman, C.
Presentation and Outcome of Zap 70 Deficiency
Rojas, P.
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Rom, E.
Correlation Between Pre-Collection CD34 Blood Concentrations and CD34 Collection Yield in Difficult-to-Mobilize Patients Given Plerixafor. –a Retrospective Single Center Study
Rome, S.
Transplant in the Morbidly Obese Patient
Romee, R.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Romeril, J.
AE Reporting/Case Studies
Rondelli, D.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Persistent Fatigue in Stem Cell Transplant Survivors: A Biobehavioral Perspective
Rondon, G.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Rooney, C. M.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Rosati, C.
The Introduction of a Pre-Admission Psychosocial Assessment Process for Pediatric Allogeneic Stem Cell Transplant Patients and Families
Administrative Director Webpage Demo
Rose, S. R.
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Rosenberg, A.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
Rosenblatt, H.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Ross, M.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Rossetti, J.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Rossi, C.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Roth, J.
Estimated Cost-Effectiveness of Brentuximab Vedotin Vs. Best Supportive Care Following Autologous Stem Cell Transplant in Hodgkin's Lymphoma
Roth, M.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Rouce, R. H.
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Rounds, S.
C. the Difference with Steriplex
Rovelli, A.
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
Rowe, J. M.
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action
Rowe, J.
Hardwiring Advance Care Planning in BMT: More Than Just the Paper
Rowe, J.
Life after Transplant: The Use of Group in Preparation for Transition Home
Rowe, K.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Rowe, R. G.
Factors Associated with CMV Disease in Pediatric Hematopoietic Stem Cell Transplantation
Rowley, S.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Rowlings, P.
Identifying the Need for a Regional Nurse–Led Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) Late Effects Follow up Program
Rox, J.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Roy, T. S.
Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
Roy, V.
Predictors and Outcomes of Intensive Care Utilization in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant at Mayo Clinic, Florida
Ruehle, K.
Monthly Internal Assessments Result in Successful CIBMTR Audit
Ruella, M.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Ruemenapp, K.
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Ruiz Delgado, G. J.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Ruiz, J. A.
Association of Polymorphisms in the HLA-C Locus with Disease Risk for Developing Acute Graft Vs. Host in Pediatric Patients with Allogeneic Hematopoietic Stem Cell
Ruiz-Arguelles, A.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Ruiz-Arguelles, G. J.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Reduced-Intensity Stem Cell Allografting for PNH Patients in the Eculizumab Era: The Mexican Experience
Ruiz-Delgado, G. J.
Donor Cell Leukemia: A Prospective Study of Its Identification and Treatment
Reduced-Intensity Stem Cell Allografting for PNH Patients in the Eculizumab Era: The Mexican Experience
Rush, B.
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Russell, G.
Abstract 5246: Comparison of Outcomes of Two Preparative Regimens for Lymphoma Patients Who Are Receiving Autologous Hematopoietic Stem Cell Transplantations
Ryan, C. E.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Ryan, M.
Chronic Graft Vs. Host Disease of the CNS - a Rare Autopsied Case
Ryan, T. D.
Prospective Echocardiographic Screening for Cardiac Dysfunction 100 Days after Transplant in Children and Young Adults after Stem Cell Transplant
Rybicki, L.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes

S

Saad, A.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Sabatino, M.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Saber, W.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Allogeneic Transplant for Acute Biphenotypic Leukemia: Characteristics and Outcome in the CIBMTR Database
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Sabo, J. D.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Sabo, R.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Sachdev, D.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Sadashiv, S.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) – a Single Institutio
Sadeghi, B.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Sadeghi, T.
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Safah, H.
A Network Approach to Standardization of BMT Pathways
Sahaf, B.
Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Sahdev, I.
Title - Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of “Late” Alemtuzumab
Sahoo, R. K.
Cyclophosphamide Followed By Busulphan in Place of Standard BuCy Regimen for Patients Undergoing Allogeneic Stem Cell Transplantation: A Preliminary Experience from a Single Centre in India
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Sahovic, E. A.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) – a Single Institutio
Saikia, T.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Saini, N.
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Sakamaki, H.
Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience
Sakellari, I.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Sakizli, E.
Determinants of Physical Activity Levels in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Salas Coronado, D. Y.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Salazar, L.
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Sales-Bonfim, C.
(CIBMTR Working Committee) Health Services and International Issues
Saliba, R.
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
Salit, R. B.
Successful Engraftment and Full Donor Chimerism in Patients Undergoing Second Allogeneic Stem Cell Transplantation with Umbilical Cord Blood
Salman, S. R.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Salzman, D.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Salzmann-Manrique, E.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Samaras, C.
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Sampol, A.
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Sanchez, M. E.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Sanchez, P.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Sanders, J. E.
Transplant Continuing Education Activities: Who Does This Affect and Examples on How to Comply
Sandler, E.
Safety and Feasibility of Administering Lactobacillus Plantarum to Children Undergoing Myeloablative Hematopoietic Cell Transplantation (HCT)
Sandmaier, B. M.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
(CIBMTR Working Committee) Acute Leukemia
Sankaranarayan, K.
Grading Acute GVHD: Getting It Right Every Time!
Santini, A.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Santos, B. N.
Removal of Chlorhexidine Gluconate-Impregnated Dressings Due to Skin Irritation in Patients Under Hematopoietic Stem Cell Transplantation
Catheter-Related Bloodstream Infections during Use of Chlorhexidine Gluconate-Impregnated Dressings
Saraf, S.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Sarantopoulos, S.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
B-Cell Activation Pathways in Chronic GVHD
(CIBMTR Working Committee) Autoimmune Diseases and Cellular Therapies
Sarkees, J. R.
Increased Incidence of Fatigue in Pediatric Hematopoetic STEM CELL Transplant Recipients
Sarmiento, M.
Clostridium Difficile Infection in Patients Undergoing Hematopoietic Cell Transplantation. Results from the Transplantation Group at the Catholic University Hospital in Santiago, Chile
Sasa, G.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Sasaki, K.
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Sato, K.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Sato, T.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Satwani, P.
High Hematopoietic Transplantation Comorbidity Index Is Not Associated with Increased Transplant Related Mortality: Review of a Large Cohort of Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation Following Busulfan-Based Regimens for Malign
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Higher Incidence of Grade III and IV Toxicities in Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation and Its Impact on Mortality at One Year Post-Transplant: A Retrospective Cohort Study of Pediatric Patients Undergoing Allogeneic Stem
Alemtuzumab Administration in Reduced Toxicity Conditioning (RTC) Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). What Matters Most – Timing or Donor Source?
The Clinical Significance of Non-Tuberculosis Mycobacterium (NTM) Infection in Pediatric Hematopoietic Cell Transplant (HCT) Recipients
Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
The Significance of Daily Blood Cultures in Febrile Pediatric Hematopoietic Cell Transplant Recipients
Saunders, I. M.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Saunthararajah, Y.
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
Sauter, C.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Management of Cytokine Release Syndrome (CRS) in Patients Undergoing Chimeric Antigen Receptor Modified (CAR) T-Cell Therapy Following Autologous Stem Cell Transplant (ASCT)
Savage, A.
Emergent Substitution of Fludarabine for Cyclophosphamide Due to Acute Cardiac Toxicity during Conditioning with Successful Engraftment
Savani, B. N.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Oral Abstracts - Session H - Pediatric Disorders & Late Effects/Quality of Life
(CIBMTR Working Committee) Late Effects and Quality of Life
Savic, R.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Savig, E. S.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Sayer, D.
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Sayre, P.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Scalora, A. F.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Scaradavou, A.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Schad, A.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Schafer, D.
Decreasing Clostirdium Difficile Infection Rates through Enhanced Practice Guidelines
Schafernak, K.
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Schaper, K.
Panelist: IT Best Practices and Challenges in Supporting BMT Research
Schatz, B. A.
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Schatz, D.
A Phase 2 Study of the Hedgehog Pathway Smoothened Inhibitor PF-04449913 to Reduce Relapse in High Risk Acute Leukemia and MDS Patients Following Allogeneic Stem Cell Transplantation
Schcolnik-Cabrera, A.
Reduced-Intensity Stem Cell Allografting for PNH Patients in the Eculizumab Era: The Mexican Experience
Schechter, T.
Neuroblastoma & VOD
Scheibenbogen, C.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Scheide, T.
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Scheinberg, P.
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Schembri, J.
Early Intervention with HSCT Patients to Improve Access to and Knowledge of Palliative Care
Scherer, F. F.
Excellent Outcome for Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation(HSCT) without Radiation: A Single Center Experience on 103 Patients
Viral Infections after Umbilical Cord Blood Transplant: A Retrospective Analisys of 156 Children Transplanted at a Single Institution
Schindler, J.
Instituting the Very Immunocompromised Alert (VIP) Protocol in a Community Hospital for a New Blood and Marrow Program
Schlagenhauf, B.
Justifying the Construction of a Flexible, Functional Hematopoietic Cell Transplant (HCT) Database, BRAIN
Schlegel, P. G.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Schmid, C.
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Schmidt, E. M.
Metabolic Syndrome Occurs within the First Year after Hematopoietic Cell Transplant
Prevalence of Vitamin D Insufficiency in Adult Hematopoietic Cell Transplant (HCT) Patients with Documented Osteopenia or Osteoporosis after Steroid Exposure: A Quality Assurance Study
Schmidt, H.
Beneficial Effects of G-CSF Dosage Adaption in Allogeneic Stem Cell Donors That Are at Risk for Poor Mobilization. Retrospective Dual Center Analysis of 5691 Allogeneic Stem Cell Mobilizations
Yield Prediction of Nucleated Cells As Well As CD34+ Progenitors in Allogeneic Bone Marrow Harvests Depends on Differentially Important Biological Donor Variables. a Retrospective Single Center Analysis of 1275 Allogeneic Bone Marrow Collections
Schmidt, T.
Crucial Conversations Overview
Crucial Conversations Interactive
Schmit-Pokorny, K.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
The Perceived Value of the Case Manager Role By Blood and Marrow Transplant Patients
Development and Usage of Algorithms Demonstrate Cost Savings and Increased Efficiency in Peripheral Blood Stem Cell Mobilization and Collection
Schneidawind, D.
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts
Schneiderman, J.
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Chronic Graft Vs. Host Disease of the CNS - a Rare Autopsied Case
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Scholler, J.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Schrezenmeier, H.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Complete Loss of HLA Class I Heterozygosity in a Patient with Acute Myeloid Leukemia
Schriber, A.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Schriber, J.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Schuler, C.
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Schultz, A.
Addressing the Need for Standardized Adverse Event (AE) Documentation within the Electronic Medical Record (EMR)
Schultz, C. L.
Progression of Cerebral Vascular Disease Post Transplant in a Child with Prior Sickle Cell Disease
Schultz, K.
Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
Schultz, K. R.
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Schulz, G.
Production, Implementation, and Utilization of a Multidisciplinary Assessment for Those Undergoing Hematopoietic Cell Transplantation
The Perspectives of Stakeholders in Pursuing Hematopoietic Stem Cell Transplantation in Children and Adolescents: An Integrative Review
Schutte, J.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Schuver, B. B.
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Schwartz, S.
The Significance of Daily Blood Cultures in Febrile Pediatric Hematopoietic Cell Transplant Recipients
Schwerdtfeger, R.
Influence of Stem Cell Source (bone marrow versus peripheral blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Scigliano, E.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Bendamustine-Brentuximab: Bridging to Transplant
Scott, M.
Related Donor Screening: An Increasingly Complex Process
Scrivani, C.
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Seber, A.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Report from Regional Group - LABMT
Panelist: How Can Technology Further BMT Research
Seftel, M.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Building a Quality Plan for a Blood and Marrow Transplant Program: Quality Framework and Indicator Development
Selby, G. B.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Sell, M.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Sellers, K.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
Semidei-Pomales, M.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Semidei-Pomales, M.
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Sengeløv, H.
Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
Sengupta, K.
Safety and Efficacy of Low Dose Liposomal Amphotericin B for Prophylaxis of Invasive Fungal Infection in Haematopoietic Stem Cell Transplantation- a Single Center Experience
Senol, E.
The Role of Tuberculin Skin Test As a Guide to Preventive Chemotherapy for Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplantation in a Region with Intermediate Prevalence and Routine BCG Vaccination: A Preliminary Report from Turkey
Seo, S.
Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients: Seasonality and Factors Associated with Progression to Lower Respiratory Tract Disease
Recurrent Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT): Incidence, Clinical Manifestations, Risk Factors and Outcome
Serafino, S.
30 Day Readmissions – a 4 Year Look Back of Multi-Disciplinary Efforts
Is G-CSF Still Needed Post-Transplant to Promote Engraftment in the Present Era? a Multi-Disciplinary Project to Evaluate Patient Safety Vs Cost Savings
30 Day Readmissions Rate- How Many Ways Can We Calculate Thee?
Subcutaneous Ports for Outpatient Transplant Patients to Reduce the Risk of Central Line Associated Blood Stream Infections
Serody, J. S.
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Serrano, D.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Seth, A.
Non-Myeloablative TLI/ATG + Alkylator Conditioning Augments Bidirectional Immune Tolerance Via Regulatory MDSC in a Robust Murine Model of MHC-Mismatched BMT for Beta-Thalassemia
Seth, T.
Peripheral Blood Stem Cell Transplant in Aplastic Anemia
Seto, A.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Shadman, M.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Shah, A. J.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Shah, A. J.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Shah, A.
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Shah, G. L.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
Gain of Chromosome 1q Portends Worse Prognosis in Multiple Myeloma Patients with Treated with Novel Agent Based Induction Regimens Even after Autologous Transplantation
Shah, J.
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Shah, N.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Clinical Outcomes of Multiple Myeloma Patients with TP53 Gene Deletion after Autologous Stem Cell Transplantation: The MD Anderson Cancer Center Experience
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Outcome of Patients with Systemic Light Chain (AL) Amyloidosis with Concurrent Renal and Cardiac Involvement
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Outcome of Patients with Multiple Myeloma with t(4;14) after Autologous Hematopoietic Stem Cell Transplantation
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
BMT CTN 1401 Study
Shah, N. N.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Shaheen, M.
Pre-Conditioning Steroids and Hydroxyurea Followed By Reduced Toxicity Conditioning (RTC) with ATG-Bu-FLU Is Safe and Effective in Allo-Sib-HSCT in Adolescents and Adults with Sickle Cell Anemia (SCA)
Shalala, D. E.
ASBMT Public Service Award
ASBMT Business Meeting And Awards
Shanafelt, T.
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Shanahan, L.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Shanbhag, S.
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Shanley, R.
Cyclophosphamide Dose Weight Adjustment in Morbidly Obese with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation (HCT)
Pre-Transplant Consolidation Chemotherapy for Acute Lymphocytic Leukemia (ALL) Does Not Impact Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Shapiro, J.
ASBMT Pharmacy SIG Update
ASBMT Pharmacy SIG New Practitioner Award Presentation
Sharf, S. E.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
(ADMIN) Best of Abstract Submissions
Shargian, L.
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Sharma, A.
Cyclophosphamide Followed By Busulphan in Place of Standard BuCy Regimen for Patients Undergoing Allogeneic Stem Cell Transplantation: A Preliminary Experience from a Single Centre in India
Sharma, K.
Developing a Haploidentical Transplant Program: An Indian Experience
Sharma, M.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Sharma, P.
Outcomes of Allogeneic Stem Cell Transplant in Patients with Chronic Myelomonocytic Leukemia (CMML) - a Single Institution Experience
Sharma, S.
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Sharp, J. G.
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
Sharpe, A. H.
Biology of the PD-1 Pathway
Sharpe, C.
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
Shaughnessy, P. J.
Tbo-Filgrastim Versus Filgrastim during Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation
A Network Approach to Creation and Maintenance of Standardized Standard Operating Procedures
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Shaw, B. E.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
A Proven and Probable Case of Pre-Existing IgA Nephropathy Exacerbated By Administration of G-CSF
A Change in Donor Medical Suitability Criteria Resulted in Decreased Rates of Donor Attrition at CT Stage in a Registry Study
How to Pick a Donor and Product?
Panel: How Can Technology Further BMT Research
(CIBMTR Working Committee) Donor Health and Safety
Shaw, K. L.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Shaw, P. J.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Shaw, S.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Shea, T. C.
Abstract 5968: Evaluation of the Impact of Anti-Thymocyte Globulin (ATG) on Post-Hematopoietic Cell Transplant (HCT) Outcomes in Patients Undergoing Allogeneic HCT
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Shealy, M.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Shearer, W.
Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Shearin, S.
A Network Approach to Creation and Maintenance of Standardized Standard Operating Procedures
Shelton, C.
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Shelton, T.
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Shen, T.
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
How I Treat Ocular Graft-Versus-Host Disease: Bandage Contact Lens Therapy
Shen, Y.
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Shenoy, S.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Reduced Intensity Transplantation for Inherited Bone Marrow Failure Syndromes
The Perspectives of Stakeholders in Pursuing Hematopoietic Stem Cell Transplantation in Children and Adolescents: An Integrative Review
(CIBMTR Working Committee) Primary Immune Deficiencies, Inborn Errors of Metabolism and Other Non-Malignant Marrow Disorders
Shepherd, N.
Impact of Addition of Alcohol-Impregnated Port Protectors to Post Central Line Insertion Bundle in the Adult Blood and Marrow Transplant Population
Shestova, O.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Shi, Q.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Shibuya, A.
CD155 Regulates Regulatory T Cell Population and Attenuates Acute Graft-Versus-Host Disease
Shibuya, K.
CD155 Regulates Regulatory T Cell Population and Attenuates Acute Graft-Versus-Host Disease
Shimizu, I.
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Shimoji, S.
Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation
Shimoni, A.
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action
Shin, J.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Shinde, S.
Outcomes of Allogeneic Stem Cell Transplant in Patients with Chronic Myelomonocytic Leukemia (CMML) - a Single Institution Experience
Shindo, T.
The MEK Inhibitior Trametinib Selectively Suppresses Gvhd, While Sparing GVT Effects
Shingaki, S.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Shinn, L.
Engraftment in Sibling Allogeneic Stem Cell Transplant Recipients Following the Change in Bone Marrow Collection Devices
Shoemaker, K.
Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms
Shono, Y.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
Shoop, K. M.
Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
Shore, T. B.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Shouval, R.
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Showel, M.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Shpall, E. J.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
CMVpp65-Specific T Cells Generated from Naïve T Cell Populations Recognize Atypical but Not Canonical Epitopes and May be Protective in Vivo
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
Autologous Hematopoietic Stem Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) in the Inpatient (Inpt) Vs. Outpatient (Outpt) Settings: Impact of Hematopoietic Stem Cell Comorbidity Index (HCT-CI)
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
CD4+CD25+ Invariant Natural Killer T Cells Are Enriched in Cord Blood: Implication on Immune-Regulation
Expansion and Enhanced Homing of Cord Blood
Stem Cell Biology
Shpilberg, O.
Risk Factors and Prognostic Scale for CMV Reactivation in CMV Seropositive Patients after Allogeneic Hematopoietic Cell Transplantation – a Single Center Cohort Study
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Shreve, N.
Trend, Risk Factors and Outcome of Respiratory Syncytial Viral Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review
Shubar Ali, A. S.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Shufeld, M.
Developing a Comprehensive, Psychoeducational Program: The Bone Marrow and Stem Cell Transplant Orientation Group
Shugarman, I.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Shukla, N.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Shulkin, B. L.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Shune, L.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
Shustov, A. R.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Shwartz, S.
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Sideroff, M.
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Siebel, C.
Early Post-Transplant Notch Signaling Activity Is Critical for the Differentiation of Pathogenic Alloantigen-Specific T Cells Mediating Acute Graft-Versus-Host Disease
Siegel, J.
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Sigal, G.
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Sikes, N.
A Model for Building a New Adult Blood and Marrow Program
Silva, J.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Silveira, R. C. D. C. P.
Removal of Chlorhexidine Gluconate-Impregnated Dressings Due to Skin Irritation in Patients Under Hematopoietic Stem Cell Transplantation
Catheter-Related Bloodstream Infections during Use of Chlorhexidine Gluconate-Impregnated Dressings
Silver, A.
Meeting Retrospective: Defining Quality and Value in Stem Cell Transplant 2014 Forum
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Silver, R.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Silverman, M.
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Silvin, C.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Simmons, G. L.
Case Report: 52 Year-Old Male 11 Months after MUD for Angionimmunoblastic T Cell Lymphoma Developed Acute Fibrinous Organizing Pneumonitis Successfully Treated with Etanercept Suggesting TNF Alpha in the Pathogenesis in This Sub-Type of Pulmonary GVHD
Simms-Waldrip, T.
Nasal Endoscopy in the Evaluation of Prolonged Febrile Events in Children Undergoing Hematopoietic STEM CELL Transplantation
Incidence and Outcome of Rhinovirus in Children Undergoing Hematopoietic Stem Cell Transplantation
Simpson, A.
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Simpson, E.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Sindhuvi, E.
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Singh, A. K.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo-Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Single Center Experience
Singh, H. K.
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Sito, E.
Journaling As a Tool for the Professional Development of the New Graduate RN in Hematopoietic Stem Cell Transplant (HSCT)
Skeens, M.
Anicteric Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation in Children
Skerrett, D.
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Skinner, R.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Slack, J. L.
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Slaper-Cortenbach, I.
ALPHA/Beta T- CELL Depleted Allogeneic STEM CELL Transplantation from Matched Related and Unrelated DONOR Grafts in Patients with Poor Risk Leukemia
Slater, S.
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
Slatter, M.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Slopis, J. M.
Spinal Cord Injection of Stem Cells for Pediatric ALS
Slovak, M. L.
Cytogenetics Does Not Influence Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
Smith, A. R.
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Smith, C. C.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Smith, C. A. M.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Smith, C.
A Phase 2 Study of the Hedgehog Pathway Smoothened Inhibitor PF-04449913 to Reduce Relapse in High Risk Acute Leukemia and MDS Patients Following Allogeneic Stem Cell Transplantation
Smith, C.
Chronic Graft Vs. Host Disease of the CNS - a Rare Autopsied Case
Smith, H.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
Smith, K.
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Smith, L. P.
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Smith, O. M.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Smith, O.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Smith, P. B.
Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure or Autologous Recovery Following the First UCBT
Smith, R. P.
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Smith, S. M.
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
Are There Effective Therapies for PTCL?
(CIBMTR Working Committee) Lymphoma
Smith, S. D.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Smyth, E.
Impact of High-Resolution Typing for HLA-a, -B, -C and -DRB1 on Single-Unit Cord Blood Transplantation in Pediatric Patients
Snydman, D. R.
Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
Sobecks, R.
Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation
30 Day Readmissions – a 4 Year Look Back of Multi-Disciplinary Efforts
Is G-CSF Still Needed Post-Transplant to Promote Engraftment in the Present Era? a Multi-Disciplinary Project to Evaluate Patient Safety Vs Cost Savings
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant
The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes
30 Day Readmissions Rate- How Many Ways Can We Calculate Thee?
Socié, G.
Mismatched Unrelated Donor Allo-SCT for AML after Reduced Intensity or Ablative Conditioning Regimen- a Report from the Acute Leukemia Working Party of the EBMT
Soerensen, J.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Soff, G. A.
Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab
Soiffer, R. J.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Emerging Role of Post-Transplant Therapies in Lymphoma
Sokolic, R.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Solan, L.
Evaluation of Donor KIR2DL1 Allelic Polymorphism in the Setting of T-Cell Repleted Haploidentical Transplantation
Solano, C.
Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results
Solders, M.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Solders, M.
Decidual Stromal Cells As Treatment for Acute Graft Versus Host Disease
Solh, M.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients with Hematological Remission and Full Chimerism at Day 30
Soma, T.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Sondermeijer, H.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Song, D.
CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
Song, S.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Soni, A.
Successful Treatment of Secondary Graft Failure Following Unrelated Cord Blood Transplant with Hematopoietic Growth Factors in a Patient with Fanconi Anemia
Soni, S.
Early Results of a Phase I/ II Study of Gene Therapy for ß -Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-Vivo with a Lentiviral ß AT87Q -Globin Vector
Sonnenburg, J. L.
The Intestinal Microbiota: A Frontier Within
Sorror, M. L.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Sotiropoulos, D.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Sourkes, B. M.
A Multidisciplinary Care Team Perspective on Children's Emotional Experience in Isolation for Stem Cell Transplantation
Sousa, A. M.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Southworth, D.
Non-Medical Readiness in Pediatric Bone Marrow Transplant: Improving the Discharge Process Using a Multidisciplinary Team Approach
Spahn, A.
1202 Lab Samples: Best Practices
Spaulding, M.
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Spel, L.
Upregulation of Class I MHC on Neuroblastoma Cells By NK Cell Exposure for Enhanced CTL Reactivity
Spellman, S.
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Spencer, H. E.
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
Spencer, H. T.
Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
Spierings, E.
Predicted Indirectly Recognizable Hla Epitopes (PIRCHE) Provide a Novel Strategy to Individualize Donor Selection That Optimizes Survival Chances
Spitzer, T. R.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Sprague, K. A.
Extracorporeal Photophoresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of Gvhd
A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma
Sproat, L. O.
Abstract 5671: Folinic Acid Rescue after Methotrexate GVHD Prophylaxis to Reduce Mucositis and Improve the Probability of Day +11 Methotrexate Administration - Role of the Hematopoietic Cell Transplant Pharmacist in Development of Program Guidelines
Ruxolitinib Prior to Allogeneic Stem Cell Transplant: The Experience at Mayo Clinic Arizona
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Spyropoulos, A.
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
Srinivasan, A.
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Srinivasan, M.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Srinivasan, S.
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Srinivasarao, N. K.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Srivastava, A.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Stadtmauer, E. A.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Data Collection for BMT CTN Myeloma Studies
Stafford, L.
Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases
Stafylidis, V.
The Implementation of a Quality Management System (QMS) According to FACT-Jacie Standards Improves the Safety Level in the Collection, Processing and Clinical Departments of the Bone Marrow Transplantation Program
Stednick, Z.
Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients: Seasonality and Factors Associated with Progression to Lower Respiratory Tract Disease
Recurrent Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT): Incidence, Clinical Manifestations, Risk Factors and Outcome
Steenstra, K.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Stegenga, K.
From Fertility to Facebook: Transplant Issues in Generations Y & Z
Stein, A. S.
SGN-CD33A: Case Reports of Anti-Leukemic Activity and Bridge to Allogeneic Stem Cell Transplant (SCT) in Patients with Acute Myeloid Leukemia (AML)
Steinberg, A.
Donor Cell Cardiac Myeloid Sarcoma Following Umbilical Cord Transplantation
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Bendamustine-Brentuximab: Bridging to Transplant
Steinberg, S. M.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Plasma IL-7 and IL-15 Levels Vary Greatly after Low-Intensity Conditioning and May be Associated with Clinical Outcome in Recipients of High-Dose Sirolimus Gvhd Prophylaxis
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Predictive Models Using NIH Criteria and Clinical Characteristics Define Diagnosis, Disease Activity and Risk Factors for Chronic Ocular Graft-Versus Host Disease
Steinherz, P. G.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Stenstrup, E.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Staff Led QI
ONS SIG Meeting
Stentz, J.
Transplant Continuing Education Activities: Who Does This Affect and Examples on How to Comply
Steppan, D.
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Stevens, C.
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Stevenson, P. A.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Stevenson, W.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Steward, C. G.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Stewart, S.
Preventive Care Adherence and Associated Factors in a National Sample of Hematopoietic Cell Transplantation (HCT) Survivors Recruited for an Online Randomized Controlled Trial (RCT)
Stickney Ferguson, S.
Psychosocial Distress Screening: Application of the Oncology Standard to HCT
Stiff, P. J.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Stikvoort, A.
Risk Factors and Clinical Outcome for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Long-Term Stable Mixed Chimerism in Patients Undergoing HSCT for Non-Malignant Disorders
An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype
Stiller, T.
Outcomes of Patients with Acute Lymphoblastic Leukemia (ALL) with Central Nervous System (CNS) Involvement Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT): A Single Center Retrospective Analysis
Stinson, P.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Stockerl-Goldstein, K.
Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)
Stokes, D.
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Stopsack, K.
Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Comprehensive Meta-Analysis
Storb, R. F.
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Storek, J.
Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT
Storer, B. E.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
A Biomarker Panel for Chronic Graft-Versus-Host Disease
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Metabolic Syndrome Occurs within the First Year after Hematopoietic Cell Transplant
Strahm, B. R.
Pediatric MDS: One Disease - One Treatment?
Stratton, P.
Women's Health and Hormonal Treatment Options for Therapeutic Amenorrhea and Contraception during the Peri-Transplant Period
Early Diagnosis of Labial Fusion Enables Medical Treatment in an Office Setting
Stricherz, M.
HCT in Fanconi Anemia
Stricker, S.
American Society of Hematology (ASH) Meeting Updates
Best Pharmacy Abstract Award Announcement
Stritesky, G.
Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
Stroncek, D. F.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Stuart, R.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Anti CD20 Radioimmunotherapy and mTOR Inhibition in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas
Study Group, T. D.
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Stuhler, G.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Styles, L.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Subramani, K.
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Sucak, G. T.
The Role of Tuberculin Skin Test As a Guide to Preventive Chemotherapy for Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplantation in a Region with Intermediate Prevalence and Routine BCG Vaccination: A Preliminary Report from Turkey
Determinants of Physical Activity Levels in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Suessmuth, Y.
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Suffredini, A. F.
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Sugita, J.
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Sugumar, D.
Donor Derived Systemic Lupus Erythematosus (SLE) after Allogeneic Transplantation
Cerebral Venous Thrombosis after Autologous Stem Cell Transplantation
Sullivan, K.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Sullivan, K.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Sulski, G.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Sumi, M.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Sumstad, D.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Sun, C.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Sun, L.
High Doses of Myeloid Progenitor Cells Induce Tolerance in the Context of Autologous HSC Transplantation
Sun, Y.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Sun, Y.
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Sundberg, B.
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
Sundin, M.
Risk Factors and Clinical Outcome for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Long-Term Stable Mixed Chimerism in Patients Undergoing HSCT for Non-Malignant Disorders
Sung, A. D.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Sung, D.
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
Sung, J. A. M.
Ex Vivo Expanded Multi-Specific Cytotoxic T Lymphocytes Derived from HIV+ Patients and HIV Negative Donors Using GMP Compliant Methodologies Recognize Multiple HIV Antigens and Suppress HIV Replication
Sunkara, A.
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Sunthankar, S.
Pre-Hematopoietic Stem Cell Transplantation Lung Function and Pulmonary Complications in Children
Supancic, S.
First Report on an Ongoing Pilot Clinical Study Incorporating Hyperbaric Oxygen into Autologous Peripheral Blood Stem Cell Transplantation
Sureda, A.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Positive Pre-Allogeneic Hematopoietic Cell Transplantation (alloHCT) PET Scan in Patients with Non-Hodgkin Lymphoma (NHL) Predicts Higher Risk of Relapse but Has No Impact on Survival
Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis
(CIBMTR Working Committee) Lymphoma
Sutton, K. S.
Improved Outcomes Following Drug-Resistant Immunotherapy in a Hunan Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme
Sutton, S.
Risk Factors for Depression and Fatigue Among Hematopoietic Cell Transplant (HCT) Recipients
Suzuki, K.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Svahn, B. M.
Alternative to Inpatient Transplants
Swan, G.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Sweetenham, J.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Sweiss, K.
Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)
Switzer, G. E.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Health-Related Quality of Life Among Older Adult Related Hematopoietic Stem Cells (HSC) Donors (>60 yrs.) Is Equivalent to or Better Than That of Younger Adult Related Donors (18-60 yrs.)
Sykes, M.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Symes, L.
African-American, Latino and Caucasian Patients' Experience before, during and after Stem Cell Transplantation: A Phenomenological Study
Symons, H. J.
Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Syrjala, K. L.
Preventive Care Adherence and Associated Factors in a National Sample of Hematopoietic Cell Transplantation (HCT) Survivors Recruited for an Online Randomized Controlled Trial (RCT)
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
Managing Mental Health and Lifestyle Needs After Transplant
Szabolcs, P.
Distinctions Between Effective and Ineffective AML-Specific Autologous Peripheral Blood (PB) Cytotoxic T-Lymphocytes (CTLs)
Myeloid Derived Suppressor Cells (MDSC)-like Acute Myeloid Leukemia (AML) Cells Are Associated with Resistance to Cytotoxic Effects of Autologous (Auto) T-Lymphocytes (CTLs)
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Oral Abstracts - Session H - Pediatric Disorders & Late Effects/Quality of Life
Szer, J.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
The Relationship Between Pre-Transplant 25-Hydroxy-Vitamin D Levels, Survival and Graft-Versus-Host Disease, in Allogeneic Haematopoietic Stem Cell Transplantation
Szetela, A.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Szymanski, S.
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients

T

Tabassum, N.
Trend, Risk Factors and Outcome of Respiratory Syncytial Viral Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review
Taggart, C.
A Pilot Study of Donor Enteral Human Milk to Modulate the Gut Microbiome in Children Receiving Stem Cell Transplant
Takagi, S.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Takahashi, S.
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Takatsuka, Y.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Takeda, W.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Takeuchi, S.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Talano, J. A.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Talbert, G.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Tamaki, H.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Tamari, R.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Tambini, E. L.
BMT in the Outpatient Setting
Tan, B.
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Tan, X.
Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Tanaka, R.
Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines
Tanaka, T.
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Taner, T.
Liver Transplantation for Hepatic Graft-Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study
Taniguchi, K.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Taniguchi, S.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Tanosaki, R.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Taplitz, R.
Combination Antifungal Therapy Experience at an Academic Health System
Posaconazole DR Tablet Serum Concentrations in the Bone Marrow Transplant Population: Association with Prevention or Treatment of Invasive Fungal Infections
Implementing a Screening and Treatment Protocol for Latent Tuberculosis in Patients with Hematologic Malignancies in a Southern California Medical Center
Tarek, N.
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Tarin, R.
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Tarquini, S.
The Introduction of a Pre-Admission Psychosocial Assessment Process for Pediatric Allogeneic Stem Cell Transplant Patients and Families
Taur, Y.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
Tavares, R.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Tawara, I.
Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia
The MEK Inhibitior Trametinib Selectively Suppresses Gvhd, While Sparing GVT Effects
Taylor, A.
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Taylor, C.
Tbo-Filgrastim Versus Filgrastim during Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation
Taylor, C.
Use of Laboratory Data to Enhance Donor Experience and Implement a New Collection Device for HPC, Apheresis
Taylor, L.
Welcome
Taylor, T.
High Incidence of Osteoporosis in a Natural History Cohort of Patients with Moderate to Severe Chronic Graft-Versus-Host Disease and Risk Factor Analysis
Tayshetye, P.
Comparison of Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) to BEAM As Conditioning Regimens for Autologous Peripheral Blood Stem Cell Transplantation in Non-Hodgkins Lymphoma
Tegtmeier, B. R.
Quality: BMT LOS and Readmission Rates
Teh, J. B.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Teira, P.
Outcomes of Bone Marrow or Cord Blood Matched Related Transplantation for Children with Sickle Cell Disease: Experience of a Canadian Center
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease
Development of a Standardized Follow up for Pediatric Transplant Long Term Survivors By Family Physicians
Telford, W.
T Regulatory Cell Kinetics Are Altered in a Target Organ of Chronic Gvhd, Resulting in a Low T Regulatory to T Effector Memory Cell Ratio
Temel, J.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Tena, N.
Non-Medical Readiness in Pediatric Bone Marrow Transplant: Improving the Discharge Process Using a Multidisciplinary Team Approach
Tenorio-Rojo, A. P.
Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning
Teo, E. C.
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Teplick, A.
Successful Use of Cryopreservation and Shipping of CD34-Selected Mismatched Related Donor Grafts for Treatment of Children
Terakura, S.
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Teranishi, Y.
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model
Terwey, T.
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Teshima, T.
Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
CD155 Regulates Regulatory T Cell Population and Attenuates Acute Graft-Versus-Host Disease
Tessier, T.
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Tetlow, M. C.
Therapeutic Passes: Highlighting Caregivers' Attitudes and Beliefs Among the Pediatric Blood and Marrow Transplant Population
Tetz, G.
Dnase I Treatment Reduces Gvhd in Mice
Teusink, A.
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Renal Complications in Fanconi Anemia (FA) Patients Undergoing Hematopoietic Cell Transplant (HCT) Using a Uniform Radiation-Free Approach
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Intravenous Pentamidine for Pneumocystis Carinii/Jiroveci Pneumonia (PCP) Prophylaxis
Tewari, P.
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Thakar, M.
Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Non-myeloablative Haploidentical HCT with InVivo TCD and NK Addback
Thall, P.
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Tham, V. W.
Race Influences the Response to Conventional Induction Chemotherapy in Asian Patients with Acute Myeloid Leukemia
Thirlwell, S.
Efforts to Reduce Compassion Fatigue Among BMT Nurses: 2015 Update
Hardwiring Advance Care Planning in BMT: More Than Just the Paper
Thomas, C.
Predictors and Outcomes of Intensive Care Utilization in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant at Mayo Clinic, Florida
Thomas, D.
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Thomas, D.
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Thomas, D.
Allogeneic Stem Cell Transplantation (Allo-SCT) for the Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL); Evaluation of Minimal Residual Disease and Prognostic Factors at the MD Anderson Cancer Center (MDACC)
Thomas, T. D.
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Thompson, A. A.
Early Results of a Phase I/ II Study of Gene Therapy for ß -Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-Vivo with a Lentiviral ß AT87Q -Globin Vector
Thompson, P. A.
Results of Allogeneic Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Thrasher, A.
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Thunberg, S.
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
Thurman, N.
Single Dose Plerixafor and Multi-Day Apheresis: Skip Dosing Enables Cost Efficient Mobilization for Patients Close to Achieving Treatment Goals
Thurston, A.
CMV and EBV Reactivation after Allogeneic Transplantation
Thus, K. A.
Predicted Indirectly Recognizable Hla Epitopes (PIRCHE) Provide a Novel Strategy to Individualize Donor Selection That Optimizes Survival Chances
Tian, L.
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Tian, X.
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation
Tichelli, A.
Managing Cardiovascular Health After Transplant
Tierney, K.
Prevalence of Vitamin D Deficiency in Allogeneic HCT Recipients and Its Association with Graft Versus Host Disease
ASBMT Nursing SIG Meeting
Till, B. G.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Tillman, C.
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Tipirneni, E.
Allogeneic Stem Cell Transplant Improves the Outcome of Patients with Acute Erythroleukemia: Single Center Analysis
Experience with Administration of Ruxolitinib after Allogeneic Stem Cell Transplantation (alloSCT) in Patients with Myelofibrosis
Tisdale, J. F.
Gene Addition Strategies Using Lentiviral Vectors
Alternative Therapies for Sickle Cell Introduction
(PEDS) Alternative Therapies for Sickle Cell - Beyond MSD BMT
Tokunaga, M.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Tokunaga, M.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Tolar, J.
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Introduction
Tombleson, R.
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Tompkins, C.
Pulmonary Complications
Tonon, J. A.
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Toor, A. A.
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Topiwala, N.
Crucial Conversations Overview
Crucial Conversations Interactive
Törlén, J.
An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype
Torloni, A. S.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Toro, J. J.
A Quality Improvement Project to Decrease Clostridium Difficile Associated Infection in a Bone Marrow Transplant Unit: A Multidisciplinary Approach
Torrano, V.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Toubai, T.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Touloumenidou, T.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Towlerton, A. M.
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Townsend, J.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Traeger, L.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Traer, E.
Targeting BCL-2 and BCR-Abl Activity in Ph+ALL
Tram, K.
Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
Registry Efforts to Improve Success of Unrelated Donor Searching for African American Patients
Trapp, M. A.
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Treister, N.
The Impact of Oral Chronic Graft-Versus-Host Disease on Global Measures of Quality of Life
Tricot, A.
Addressing the Need for Standardized Adverse Event (AE) Documentation within the Electronic Medical Record (EMR)
Tricot, G. J.
A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department
Trifilio, S.
Abstract 5410: Dose-Escalated G-CSF Does Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation
Tbo or Not Tbo-That Is the Question!
Trinkaus, K.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Triplett, B. M.
Updated Results from the Ongoing US Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease
Trippett, T. M.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Trottier, B.
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Response and Survival Following Second-Line Therapy in 113 Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
Tsai, N. C.
Cytogenetics Does Not Influence Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
Tse, W. T.
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS
Overall Survival (OS) of Pediatric Patients with Moderate to Severe Chronic Graft Vs. Host Disease (CGVHD). a Single Institution Experience
Tsuji, M.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Tsujitani, M.
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model
Tsukada, N.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Tuazon, S.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Tucker, A.
Production, Implementation, and Utilization of a Multidisciplinary Assessment for Those Undergoing Hematopoietic Cell Transplantation
Tucker-Seeley, R. D.
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Tujigiwa, H.
Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation
Tunccan, O. G.
The Role of Tuberculin Skin Test As a Guide to Preventive Chemotherapy for Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplantation in a Region with Intermediate Prevalence and Routine BCG Vaccination: A Preliminary Report from Turkey
Turner, B.
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Tye, M.
Mobilization Algorithms Streamline the Role of UNC Hospitals' BMT Nurse Coordinators
Tyner, J.
Targeting BCL-2 and BCR-Abl Activity in Ph+ALL
Tzannou, I.
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)

U

Uberti, J.
Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Uchida, N.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study
Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Udo de Haes, J.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
Ueda, M.
Early Response to Initial Induction Chemotherapy in Acute Myeloid Leukemia (AML) and Outcomes after Allogeneic Hematopoietic Cell Transplant (HCT)
Ueki, S.
Prediction of Skin Trouble in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using Generalized Additive Model
Ueki, T.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Ueno, M.
The Blood Concentration of Tacrolimus Is Affected By Pir Following Cord Blood Transplantation
Delayed and Sudden Lymphocyte Recovery Is the Predictive Sign of Primary Graft Failure Following CBT, Single Institute Analysis of 105 CBT
Uhl, L.
Managing Transfusion Support of the Stem Cell Transplant Patient
Uhlin, M.
In Vitro Expanded Umbilical Cord Blood T Cells Used for Donor Lymphocyte Infusions after Umbilical Cord Blood Transplantation
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
HLA-C Mismatch without Impact on Outcome after Allogeneic HSCT
Risk Factors and Clinical Outcome for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
Long-Term Stable Mixed Chimerism in Patients Undergoing HSCT for Non-Malignant Disorders
An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype
Uhm, J.
Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Ulicny, J.
Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
Ullrich, E.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
Ulrich, B.
Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia
Ulrickson, M. L.
Chemo-Mobilization of Autologous Hematopoietic Progenitor Cells (HPCs) with a Single Dose of Pegfilgrastim and Supplemental Filgrastim in Patients with Multiple Myeloma and Lymphoma: A Practical Schema
Umyarova, E.
Anti CD20 Radioimmunotherapy and mTOR Inhibition in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas
Unger, R.
Predictive Limitations of Hematopoietic Stem Cell Transplantation Associated Mortality: A Machine Learning in-Silico Analysis of the EBMT - Acute Leukemia Working Party Registry
Urbanek, A.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Utsunomiya, A.
Impact of Chromosomal Abnormalities in the Recipients of Allogeneic Hematopoietic Stem Cell Transplantation with Adult T-Cell Leukemia / Lymphoma
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Uy, G. L.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Uzunel, M.
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions

V

Vachon, M. F.
Development of a Standardized Follow up for Pediatric Transplant Long Term Survivors By Family Physicians
Vago, L.
The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
Valdez, B. C.
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma
Comparison of the Cytotoxicity of Cladribine and Clofarabine When Combined with Fludarabine and Busulfan in AML Cells: Enhancement of Cytotoxicity with Epigenetic Modulators
The Histone Deacetylase Inhibitor SAHA Sensitizes Lymphoma Cells to Combination of Cladribine and Gemcitabine with DNA Alkylating Agent Busulfan
Valent, J.
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantaiton in Primary Amyloidosis
Valteau-Couanet, D.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Valukas, C.
Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
van Besien, K.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Weight Based Plerixafor Dosing Reduces Side Effects in Stem Cell Mobilization
van de Ven, C.
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
van den Brink, M. R. M.
Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
van der Ploeg, A. T.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
van der Steen, D.
Upregulation of Class I MHC on Neuroblastoma Cells By NK Cell Exposure for Enhanced CTL Reactivity
van der Wagen, L.
ALPHA/Beta T- CELL Depleted Allogeneic STEM CELL Transplantation from Matched Related and Unrelated DONOR Grafts in Patients with Poor Risk Leukemia
van Duin, D.
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
van Hasselt, P. M.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
van Kesteren, C.
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
van Reij, L.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
van Schanke, A.
No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil
van Tol, M.
Thymoglobulin® Exposure Is Influencing CD4+ Immune Reconstitution As a Predictor for Improved Overall Survival in Paediatric Haematopoietic Cell Transplantation: Towards Individualised Dosing
Vance, E.
Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantion (Haplo-HCT) from a Second Related Donor
Vandenbroucke, J.
Stability of High Concentration Etoposide (10mg/ml) in Physiologic Saline for Use in Conditioning Regimens
Vandenbussche, K.
Stability of High Concentration Etoposide (10mg/ml) in Physiologic Saline for Use in Conditioning Regimens
Vander Lugt, M.
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Vandusen, H.
Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation
Vanness, D.
Administrative Claims Data for Cost Analyses in Hematopoietic Cell Transplantation: The Good, the Bad and the Ugly
Varni, J. W.
Related PBSC Donors Experience Higher Levels of Pain and Donation-Related Symptoms and Less Complete Rates of Recovery Compared to Unrelated Donors: Primary Analysis of the Related Donor Safety Study (RDSafe)
Vasu, S.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Vaughn, G.
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Vaughn, J.
Long-Term Outcomes of Patients with Advanced Mantle Cell Lymphoma Treated with Allogeneic Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning
Vazzana, K.
Immune Reconstitution Analysis of Patients Undergoing Extracorporeal Photopheresis for the Treatment of Chronic Graft-Versus-Host Disease
Veerapathran, A.
IL-12/23p40 Neutralization in Combination with Sirolimus for Prevention of Acute Graft Vs. Host Disease
Velangi, M.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Velardi, E.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Vennerstrom, J.
Neuroblastoma Stem Cells: Identifying Two New Classes of Drugs with in-Vitro Activity in Cell Populations with High Side-Population Profiles
Ventimiglia, M.
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Vera, J. F.
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Verneris, M. R.
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
(CIBMTR Working Committee) Immunobiology
Versluijs, A. B.
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Versluys, B.
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
Vesely, S. K.
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Vesole, D. H.
Transplant for Multiple Myeloma - Are We Approaching a Cure?
Vey, N.
Comparison of Haploidentical T-Replete HSCT Followed with Post-Transplant
High Dose Cyclophosphamide (PT-HDCy) with Matched Related (MRD) or Unrelated (UD) HSCT in Patients in or after the 6TH Decade
Veys, P.
Allogeneic Haematopoietic Stem Cell Transplantation for Systemic Onset Juvenile Idiopathic Arthiritis
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Immunodeficiencies in Older Children and Adults
BMT Tandem Meetings Best Abstracts
HCT for Rare Non-Malignant Disorders
Vieira, A. K.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Vij, R.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Villa, K. F.
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
Villa, M.
Abstract 5410: Dose-Escalated G-CSF Does Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation
Tbo or Not Tbo-That Is the Question!
Vindeløv, L.
Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
Vinh, D. C.
Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Vinks, A.
Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic STEM CELL Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)
Micafungin Anti-Fungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Cell Transplantation (HCT) - Can We Give Higher Dose, Less Frequently? - a Pharmacokinetic (PK) Study
Virani, S.
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Viswabandya, A.
The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation – a Phase II Study
Allogeneic Stem Cell Transplantation Is Superior to Immunosuppressive Therapy in Children with Aplastic Anaemia – a Single Centre Analysis from India
Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major
Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India
Voelkel, G.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Vogel, P.
Non-Myeloablative TLI/ATG + Alkylator Conditioning Augments Bidirectional Immune Tolerance Via Regulatory MDSC in a Robust Murine Model of MHC-Mismatched BMT for Beta-Thalassemia
Vogelsang, G.
Physician-Reported CR+PR at 6 Months Predicts Subsequent Survival in Patients with Chronic Gvhd
Voit, L. L.
Clinical Outcomes of HLA-DPB1 Mismatches in 10/10 HLA-Matched Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant
Voller, D.
Grading Acute GVHD: Getting It Right Every Time!
Volodin, L.
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Lack of Early Oncofertility Education in Hematologic Cancer Patients Potentially Referable for HSCT
Raising the Bar of Oncofertility Care in HSCT Patients: Implementation of an Oncofertility Education and Referral Program
Improving Communication Barriers from Consult to Evaluation in Hematopoietic Stem Cell Transplant
von Stackelberg, A.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Vonderheide, R. H.
A Survival Benefit for Reduced Intensity Allogeneic Transplants from Young Unrelated Donors Compared to Older Sibling Donors Depends on the Graft CD8 T-Cell Content
Pharamacodynamic Assessment Shows That CCR5 Surface Expression May Serve As an Indicator for Effective CCR5 Blockade in Allogeneic Stem Cell Transplant (alloSCT) Recipients Treated with Maraviroc
Vora, A.
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK
Vruwink, J.
A Study of Dietary Intake and the Relationship to Neutrophil Engraftment Among Outpatient Hematopoietic Stem Cell Transplant Patients with Multiple Myeloma
Vulic, A.
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Vuong, L.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Adult Patients with Acute Lymphoblastic Leukemia (ALL) with Induction Failure or after Relapse: Cure By Allogeneic Stem Cell Transplantation (SCT), but High Risk of Relapse
Vusirikala, M.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Vyas, G.
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Vyas, P.
Molecular and Cellular Determinants of Disease Relapse in AML

W

Wada, S.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Wadhwani, N. R.
Chronic Graft Vs. Host Disease of the CNS - a Rare Autopsied Case
Wadsworth, K.
Selection of DPB1 T-Cell Epitope Permissive Matching Likely for Patients with 10/10 Unrelated Donors
Waghmare, A.
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Wagner, E.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Wagner, J.
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
Wagner, J.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Wagner, J. E.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture
Prevention of Acute Gvhd By Ex Vivo Expanded Umbilical Cord Blood Derived Regulatory T Cells (Treg)
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Preservation of Ovarian Function after Hematopoietic Cell Transplantation (HCT): More Possible Than We Thought?
Fanconi Anemia
Wagner, J. L.
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Wakaruk, B.
Panel: IT Best Practices and Challenges in Supporting BMT Research
Wake, A.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group
Wald, D.
NOVEL Strategy to Enhance NK CELL Activity
Waldvogel, S.
1202 Lab Samples: Best Practices
Walewski, J.
The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Wali, Y.
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study
Walker, T.
Impact of Addition of Alcohol-Impregnated Port Protectors to Post Central Line Insertion Bundle in the Adult Blood and Marrow Transplant Population
Walko, C. M.
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
Wallace, G.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Prospective Pilot Study Evaluating Sleep Disruption in Children and Young Adults Undergoing Stem Cell Transplantation
Incidence and Outcome of Pediatric Hematopoietic Transplant Patients Diagnosed with the New Classification Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI)
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Good Outcome of RSV Infection without Ribavirin Treatment in Pediatric Bone Marrow Transplantation
Late Endocrine Effects Remain Prevalent Despite Reduced Intensity Chemotherapy for Hematopoietic Stem Cell Transplantation in Children and Young Adults
Reduced Incidence of Infections in Very Young Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Waller, E. K.
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Walsh-Chocolaad, T.
Best Practices: Immunization Strategies and Monitoring
ASBMT Pharmacy SIG Lifetime Achievement Award Presentation
Walters, M.
Early Results of a Phase I/ II Study of Gene Therapy for ß -Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-Vivo with a Lentiviral ß AT87Q -Globin Vector
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Wang, H. L.
Allogeneic Transplant for Acute Biphenotypic Leukemia: Characteristics and Outcome in the CIBMTR Database
Wang, H.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Wang, H.
Biomimetic Nanofibrous Mesh for Long-Term Preservation of Intestinal Epithelial Cells
Wang, J.
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Wang, J.
Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome
Wang, R.
A Phase II Study of Bandage Contact Lenses for Ocular Graft-Versus-Host Disease
Wang, T.
Clinical Outcomes Among Unrelated Donor Transplant Recipients for Acute Myelogenous Leukemia As a Function of Socioeconomic Status and Related Transcriptome Differences
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Ward, D. V.
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
A Pilot Study of Donor Enteral Human Milk to Modulate the Gut Microbiome in Children Receiving Stem Cell Transplant
Ward, L.
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
Warneke, S.
BMT Outcomes for Rare Pediatric Diseases at the Medical University of South Carolina
Warrell, W. A.
Time to Huddle: Improving Team Morale and Productivity in a BMT Outpatient Clinic
Warren, E. H.
Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated with Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Warren, M.
Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant
Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT
Watakabe, K.
Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Intensified Myeloablative Conditioning for Refractory Hematologic Malignancies
Watkins, B. K.
Defining the Primate T Cell Transcriptome during Gvhd: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in Gvhd Pathogenesis and Prevention
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
T-Cell Transcriptome Analysis Reveals the Mechanisms Controlling Synergy Between Costimulation Blockade and mTOR Inhibition during Gvhd Prevention
Watt, A.
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
Watts, N.
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
Watz, E.
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
Wautelet, S.
High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics
Impact of Gender: Female Matched Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients
Weaver, C. E.
A Single Center Survey of Distress Amongst Bone Marrow Transplant Recipients
Rhythmic Entrainment: A Music Therapy Intervention to Elicit Relaxation and Decrease Anxiety for the Bone Marrow Transplant Recipient
Weber, C.
Is G-CSF Still Needed Post-Transplant to Promote Engraftment in the Present Era? a Multi-Disciplinary Project to Evaluate Patient Safety Vs Cost Savings
Weber, D. J.
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)
Weber, E.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Wegener, W.
A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Weinberg, R.
Treatment of High-Risk Sickle Cell Disease (SCD) with Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation with T-Cell Addback (IND 14359)
Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait Prior to Haploidentical Stem Cell Transplantation in Their Children with High-Risk Sickle Cell Disease
Weiner, D. J.
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Weiner, J.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Weisdorf, D. J.
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Allogeneic Transplant for Acute Biphenotypic Leukemia: Characteristics and Outcome in the CIBMTR Database
FDG-PET Interpreted By Deauville Criteria Prior to Allogeneic Transplantation Predicts Outcomes in Patients with Relapsed or Refractory Hodgkin Lymphoma
Cyclophosphamide Dose Weight Adjustment in Morbidly Obese with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation (HCT)
Pre-Transplant Serum Biomarkers Predict Early Relapse in Classical Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Late Onset Acute Gvhd (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
Response and Survival Following Second-Line Therapy in 113 Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
How to Unravel the Chromosomes or How to Understand and Report Cytogenetic Data
ASBMT Lifetime Achievement Awardee
Introduction
ASBMT Business Meeting And Awards
WBMT International Session: Global Donor Selection Challenges: Clinical Efficacy and Cost Performance
Weiss, M.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Comparison of Engraftment Syndrome with G-CSF Versus GM-CSF after Autologous Hematopoietic Progenitor Cell Transplantation for Multiple Myeloma
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation
Management of Catheter-Related Thrombosis in Patients Undergoing Autologous Stem Cell Transplantation
Wells, D.
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
Werther, N.
Title - Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of “Late” Alemtuzumab
West, A.
"When the Going Gets Rough the Tough Get Going," a BMT Unit's Clabsi Reduction Quest
West, K.
Therapeutic Drug Monitoring of Tacrolimus in Allogeneic Hematopoietic Transplant Patients in a Single Oncology Center
Westermann, J.
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Westervelt, P.
Transplant Outcomes in Older Patients Are Comparable to Outcomes in Younger Patients after Hopkins' Non-Myeloablative Flu Cy TBI + PT-Cy Regimen
Westgren, M.
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Whitfield, A. R.
Late Onset Pulmonary Arterial Hypertension after Successful HSCT for Familial HLH
Whitlock, J.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Wickline, M.
Providing a Safety Net for Bone Marrow Transplant (BMT) Survivors: Nurses and Telephone Triage
Wiggins, M. A.
Rates of Infection and Pathogen Detection for Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
A Review of Radiographic Findings in Gvhd
Wijburg, F. A.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Wikell, H.
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
Wild, D.
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation
Willasch, A.
Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience
William, B. M.
NOVEL Strategy to Enhance NK CELL Activity
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
Williams, D. A.
Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study
Williams, D.
Hepatitis B Immune Globulin Prophylaxis of Viral Reactivation during Stem Cell Transplant
Williams, E. P.
The Effect of Race, Socioeconomic Status, and Collection Center Size on Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Experiences at National Marrow Donor Program (NMDP) Collection Centers
Williams, K. M.
Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation
BOS after HCT: Preceding Events, Diagnostic Characteristics, and Natural History of Patients Treated on a Prospective Trial
A Multi-Institutional Retrospective Study Suggests That Optimal Enteral Nutrition (EN) Influences Outcomes after Hematopoietic Stem Cell Transplantation in Children and Adults
Novel Imaging Analysis of the Marrow Compartment after Myeloablative HSCT Reveals the Kinetics and Degree of Myeloablation and Cell Recovery
Williams, L.
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Williams, P. G.
Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Williams, S. F.
Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
Wilson, B.
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Wilson, C.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Wilson, J.
Ex-Utero Plus in Utero Collection of Umbilical Cord Blood (CB) for Banking Yields Higher Total Nucleated Cell Counts (TNC) Compared to Either Procedure Alone
Windreich, R. M.
Forced Deflation PFT: A Novel Method to Evaluate Lung Function in Infants and Young Children
Wingard, J. R.
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (HCT) Survivors: A Qualitative Study
An Update in Diagnostic Strategies and Treatment of Fungal Infections in SCT Recipients
Oral Abstracts - Session F - Allogeneic Transplants & Supportive Care & Graft Processing
Winters, J.
Updated Results of the Mayo Clinic Risk Adapted Algorithm for Peripheral Blood Stem Cell Mobilization Utilizing G-CSF and Plerixafor
Wischmeier, J.
Show Me the Evidence: Is the Routine Use of Premedication for Transfusion Really Necessary?
Witte, D.
Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing
Witzig, T. E.
Feasibility of Hematopoietic Stem Cell Transplantation for T-Prolymphocytic Leukemia. Experience of a Large Referral Center
Woda, B. A.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Wolf, D.
In Situ Manipulation of Tregs Via Combined IL-2 and TNFRSF25 Signaling Pre- and Post-Transplant: A Novel Approach to Regulate Gvhd By Marked Expansion of CD4+Foxp3+ T Cells
Wolf, J. L.
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission
Case 1: Should All Transplant-Eligible Patients Receive Early HDT and ASCT, or can Transplantation be Delayed in Some Cases?
Wolf, R.
The Incidence and Outcomes of Oral Mucositis Among Allogeneic Stem Cell Transplantation Patients: A Systematic Review and Meta-Analysis
Wolff, T.
Related Donor Screening: An Increasingly Complex Process
Wolfs, T.
Respiratory Virus (RV) from Broncho Alveolar Lavage (BAL) Prior to Hematopoietic Cell Transplantation (HCT): A Strong Predictor for Allo-Immune Mediated Lung Syndromes (allo-LS)
Wolownik, K.
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
Wong, G. C.
Race Influences the Response to Conventional Induction Chemotherapy in Asian Patients with Acute Myeloid Leukemia
Wong, H.
CT Scan Frequently Misses the Diagnosis of Posterior Reversible Encephalopathy Syndrome (PRES) after Stem Cell Transplant
Wong, H. C.
Race Influences the Response to Conventional Induction Chemotherapy in Asian Patients with Acute Myeloid Leukemia
Wong, K.
Identification of Respiratory Viral Infection in Haematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
Wood, B.
Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT)
Wood, B. L.
Impact of Pre-Transplant Minimal Residual Disease in Patients with AML Undergoing Myeloablative Cord Blood Transplantation
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Wood, W.
Prospective Longitudinal Study of Late Acute Graft Versus Host Disease after Hematopoietic Cell Transplantation: A Report from Chronic Gvhd Consortium
Hematopoietic Cell Transplantation Multidisciplinary Care Teams: Burnout, Moral Distress and Career Satisfaction
Wood, W. A.
Prognostic Importance of Functional Capacity for Pre-Transplant Risk Assessment Among Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation
Survival without Progressive Impairment As a Novel Endpoint in Chronic Graft-Versus-Host Disease
Woodburn, J.
Use of Laboratory Data to Enhance Donor Experience and Implement a New Collection Device for HPC, Apheresis
Woodland, D.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Woolfrey, A. E.
How to Select a Donor
Oral Abstracts - Session C - Pediatric Disorders
Woost, P.
DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT)
Workman, J.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving
Worth, L. L.
Spinal Cord Injection of Stem Cells for Pediatric ALS
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Wu, C.
Bone Mineral Density (BMD) Improves in Survivors in Their Second Decade Post-Allogeneic Stem Cell Transplantation and Is Influenced By Body Mass Index (BMI) and Age
Wu, D.
Pretransplant Minimal Residual Disease (MRD) Positivity Independently Predicts Survival in a Unselected Cohort of Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Wu, E. Q.
Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
Wu, F.
Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Strategy
Wu, J.
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Wu, J.
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Wu, J.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Wu, K. L.
Stem Cell Transplantation & Palliative Care: An Oxymoron?
Wu, M. F.
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Wu, Q.
Outcomes of Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Wulf, G.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Wynn, R. F.
Hematopoietic Cell Transplantation for MPS Patients Is Safe and Effective: Results after Implementation of International Guidelines
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Health-Related Quality of Life and Perception of Care of Mucopolysaccharidosis Type I - Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: A Parents' Perspective
"WE CAN Work IT out": The Development of a Consensus Approach to Decision Making in Allogeneic STEM CELL Transplantation in the UK

X

Xiao, K.
Paradoxical Effect of Donor Cytomegalovirus (CMV) Status on CMV Reactivation after T-Cell Depleted (TCD) Stem Cell Transplantation (SCT)
Xie, H.
Recurrent Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT): Incidence, Clinical Manifestations, Risk Factors and Outcome
Viral Load in Hematopoietic Cell Transplant Recipients Infected with Human Rhinovirus Correlates with Burden of Symptoms
Xu, K.
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome

Y

Yahr, A.
Effectively Targeting Burkitt Lymphoma By ANTI-CD20 Chimeric Antigen Receptor (CAR) Modified Expaneded Natural Killer CELLS Combined with a Histone Deacetylase Inhibitor, Romidepsin in Vitro and in Humanized NSG MICE
Yamamoto, G.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Yamamoto, H.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Yamashita, T.
Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
Yang, H.
Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
Yanik, G.
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis Gvhd Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Yao, D. C.
ATG Use and Post-Allogeneic Transplant Viral EBV, CMV, HHV-6 and HHV-8 Reactivation
Yates, B.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Yau, Y. Y.
Leukapheresis Safely and Effectively Yields Lymphocyte Populations Sufficient for Chronic Gvhd Research
Ye, C.
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Yeager, A. M.
Retrospective Review of Intravenous Pentamidine for Pneumocystis Pneumonia Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
Yee, D.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Yegin, Z. A.
Determinants of Physical Activity Levels in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Yeh, J.
Levofloxacin Versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation
Adverse Events during Peripheral Blood Hematopoietic Stem Cell Mobilization in Light Chain Amyloidosis Patients
Yen, R.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Yeshurun, M.
Risk Factors and Prognostic Scale for CMV Reactivation in CMV Seropositive Patients after Allogeneic Hematopoietic Cell Transplantation – a Single Center Cohort Study
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
Yi, J. C.
Preventive Care Adherence and Associated Factors in a National Sample of Hematopoietic Cell Transplantation (HCT) Survivors Recruited for an Online Randomized Controlled Trial (RCT)
Yoneyama, A.
Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases
Yoshihara, S.
Low Incidence of Human Herpesvirus 6 Reactivation in Unmanipulated HLA-Haploidentical Related Stem Cell Transplantation with Corticosteroid As Graft-Versus-Host Disesase Prophylaxis
Yoshihara, S.
Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
Yoshiki, Y.
Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma –a Single Institute Analysis of 10 Cases
Induction Therapy with Bortezomib-Cyclophosphamide-Dexamethasone (BCD) for Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma
Yoshimitsu, M.
Risk Stratification of Outcomes Among Patients with Adult T-Cell Leukemia/Lymphoma Receiving Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the JSHCT ATL Working Group
Young, J. W.
Double-Unit Cord Blood (CB) Transplantation (DCBT) Combined with Haplo-Identical Peripheral Blood CD34+ Cells (HaploCD34+) Is Associated with Enhanced Neutrophil Recovery, Universal Haplo Rejection, and Frequent Pre-Engraftment Syndrome
Extension of Minority Transplant Access Using Domestic Units Supports the Importance of Public CB Bank Funding: An 884 Patient Analysis
In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT)
Young, J. A. H.
More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors
Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Young, L.
IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality
Yu, H.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Allogeneic Stem Cell Transplant Improves the Outcome of Patients with Acute Erythroleukemia: Single Center Analysis
Yu, J.
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Yu, J. K.
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Yue, B.
The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)
Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft Vs. Host Disease
Yun, S.
Fibrinogen-Coated Nanospheres Prevent Thrombocytopenia-Related Bleeding
Yunfeng, D.
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Yurch, M.
Improving Internal CIBMTR Data Audits: Process Improvement and Time Saving

Z

Zahid, F.
Venous Thromboembolism Is Hematopoietic Stem Cell Transplant Patients– a Meta-Analysis and Systemic Review
Zaidman, I.
Outcome of Hematopoietic Stem Cell Transplantation for Children with Severe Combined Immunodeficiency (SCID). Seventeen Years Experience in Single Pediatric Transplantation Center
Outcome of Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Hemoglobinopathy. Fifteen Years Experience in One Pediatric Transplant Center
Zakak, N.
High Disease-Free Survival (DFS) Supports Continued Investigation of Double-Unit Cord Blood Transplantation (DCBT) in Children with High-Risk Acute Leukemia Especially in the Setting of Single Units with Low Dose and/or a High Degree of HLA-Mismatch
Zakari, A.
In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2
Zambidis, E.
Successful Reduced Intensity Alternative Donor Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Non-Malignant Disorders
Induced Pluripotent Stem Cells: Current State of the Art and Potential Clinical Applications
Zapata, M.
Haploidentical Stem Cell Transplantation As a Therapeutic Option in Children with Previous Cord Blood Transplantation and Graft Failure. Successful Results in a Mexican Hospital
Zecchin, V.
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies in Brazil - a Survey of the Working Group on Paediatric Transplantation of the Brazilian Society of Bone Marrow Transplantation
Zelenetz, A. D.
Successful Salvage of High-Risk B-Cell Non-Hodgkin & Hodgkin Lymphoma (NHL/HL) with Double-Unit Cord Blood Transplantation (DCBT) Provides a Platform for Further Optimization
Zerva, P.
Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia
Zhan, T.
Pegfilgrastim and Planned Plerixafor for Autologous Stem Cell Mobilization Is Safer Than and As Effective As Chemo-Mobilization in Patients with Hematological Malignancies
Zhang, A.
MHC Class I Chain-Related Gene a (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Stem Cell Transplants (HSCT) for Hematological Malignancies: A CIBMTR Study
Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)
Zhang, B.
Upfront Alternate Donor HSCT for Children with Severe Aplastic Anemia: A Single Center Prospective Clinical Trail Outcome
Zhang, H.
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia
Zhang, J.
Targeting ST2 Alleviates Graft-Versus-Host Disease Mortality and Maintains Graft-Versus-Leukemia
Zhang, J.
Abstract 5410: Dose-Escalated G-CSF Does Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation
Zhang, K.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Alemtuzumab, Fludarabine, and Melphalan Reduced Intensity Conditioning Hematopoietic Cell Transplantation: Experience in over 200 Pediatric and Young Adult Patients with Primary Immune Deficiency, Metabolic, and Marrow Failure Disorders
Zhang, M. J.
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen
Summarizing GVHD and GVL Effects in Transplant Studies
Zhang, Q.
A Biomarker Panel for Chronic Graft-Versus-Host Disease
Zhang, S.
Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
Zhang, X.
A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with Malignant and Non-Malignant Disease
Zhao, C.
Abstract 5410: Dose-Escalated G-CSF Does Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation
Zhao, Q.
Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen
Zhao, Y. A.
Secondary Graft Failure in Allogeneic Stem Cell Transplantation for Myelofibrosis - a Single Institution Experience
Zheng, P.
Siglec-G Expression on Donor T Cells Controls Severity of Gvhd
Zhou, C.
Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Zhou, S. X.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Zhou, X. K.
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated with Poor Engraftment and Increased Non-Relapse Mortality
Zhou, X.
IGF1R- and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
Zhou, Z.
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Adequate and Predictable Stem Cell (SC) Collection and Low Incidence of Neutropenic Fever (NF) with Cyclophosphamide (C) and G-CSF Mobilization in Multiple Myeloma (MM) : A Single Center Analysis
Tbo or Not Tbo-That Is the Question!
Zhou, Z.
Allogeneic Stem Cell Transplant Improves the Outcome of Patients with Acute Erythroleukemia: Single Center Analysis
Zhou, Z.
Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
Zienkiewicz, C.
Increasing Compliance in BMT Patients By Creating a Patient Education Binder
Zigmond, M.
Contributing Factors to Renal Dysfunction during Engraftment Syndrome
Zilberberg, J.
Biomimetic Nanofibrous Mesh for Long-Term Preservation of Intestinal Epithelial Cells
Zino, E.
The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
Zito, L.
The IMPACT of Amino Acid Variability Defines a Functional Distance Predictive of Permissive HLA-DPB1 Mismatches in Hematopoietic CELL Transplantation
Zitsman, J.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Monkeys
Phenotype, Function and Expansion of Regulatory T Cells in the Cynomolgus Macaque (Macaca fascicularis)
Zoghi, B.
Characteristics of Extramedullary Plasmacytomas in Patients Undergoing Autologous Transplant for Diagnosis of Multiple Myeloma in the Era of Triple Targeted Therapy
Zollikofer, C.
Donors with KIR-Bx Haplotypes Improve Outcome of Unrelated Hematopoietic Stem Cell Transplantation for Recipients with a Myeloid Malignant Disease and a C1 Ligand Phenotype
Complete Loss of HLA Class I Heterozygosity in a Patient with Acute Myeloid Leukemia
Zonder, J.
Outcomes of Second Autologous Stem Cell Transplant in Patients with Renal Dysfunction
Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing Autologous Stem Cell Transplant
Zou, F.
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Zuckerman, T.
Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease Is Safe and Effective: 1 Year Follow-up and Mechanism of Action
Zugmaier, G.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Zwaan, C. M.
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Zwaveling, J.
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z